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Chapter I. 
 
Introduction. 
 
 
 
 
Chapter I.I 
Introduction to Cervical Cancer  
 
1.  Incidence of Cervical cancer 
According to the International Agency for Research on Cancer, 
gynecological cancers accounted for 19% of the 5.1 million estimated new 
cancer cases, the 2.9 million cancer deaths and the 13 million 5-year prevalent 
cancer cases among women in the world in 2002 [1]. Global estimations for 
cervical cancer arrive at 468,000 new cases and 233,000 deaths in 2000 year [2]. 
The frequency of occurrence of cervical cancer differs significantly between 
countries, from 0.4% in Israel to 5.3% in Colombia [3] of all cancers. More than 
80% of all cases occur in developing countries [1], which emphasizes the need 
for considerable prophylactic efforts, especially in third-world countries. 
However, the risk of death in developed countries is also high. In the USA, 
cervical cancer accounts for 1.3% of all deaths due to cancer among women [4]. 
In the Netherlands 583 new cervical cancer cases were  diagnosed in 2003, 
compared to 644 in 2002 (http://www.ikcnet.nl/). The incidence of cervical 
cancer in the Netherlands has been decreasing at a rate of approximately 2% 
annually since 1990. This is mostly due to the nation-wide program for early 
diagnosis of cancer. 
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2.  Diagnosis 
Cervical cancer originates from dysplastic lesions of various degrees. 
Diagnosis is largely based on biopsy of the epithelium of the cervix. For 
screening purposes Papanicolau and Trout (1941) introduced the smear test for 
cytomorphological analysis of epithelial cells [5], scraped from the cervix, 
which is still in use till now (known in Netherland as KOPAC-B). In many 
developed countries, population-based screening by Pap smear tests are 
routine procedures, organized and financed by the respective governments. 
Many third-world countries have no such preventive and prophylactic 
measures. The histological cervical intraepithelial neoplasia (CIN) scoring 
system was introduced by Richart in the 1960’s [6]. The third kind of test is 
based on the Bethesda classification [7], which attempts to distinguish cases 
which are more- or less- likely to progress into serious (aggressive) types of 
epithelial lesions. Table 1 compares the different histological and cytological 
scoring systems and nomenclatures [8]. 
 
Table 1. Histological and cytological abnormalities (nomenclature and scoring 
systems) 
Histology Cytology 
Dysplasia CIN  Bethesda  Papanicolaou 
Normal  Normal  Within normal limits  Pap 1 
Benign atypia  Inflammatory atypia  Benign cellular changes  Pap 1 
Atypical cells  Squamous atypia  ASCUS  Pap 2 
Mild Dysplasia  CIN I  Low-grade SIL  Pap 3A1 
Moderate Dysplasia  CIN II  High-grade SIL  Pap 3A2 
Severe Dysphasia  CIN III  High-grade SIL  Pap 3B 
Carcinoma in situ  CIN III  High-grade SIL  Pap 4 
(Microinvasive) 
cancer 
(Microinvasive) 
cancer 
(Microinvasive) cancer  Pap 5 
SIL:squamous intra-epithelial lesion. 
 
To classify the different stages of cervical cancer, the International Federation 
of Gynecology and Obstetrics (FIGO) has agreed on a five stage division [9] 
(Table2).  Chapter I 
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Table 2. FIGO classification (staging) 
FIGO stage Description 
0  Carcinoma in situ (preinvasive carcinoma) 
I  Cervical carcinoma confined to uterus  
IA 
 
Invasive carcinoma diagnosed only by microscopy. All microscopically 
visible lesions  even with superficial invasion  are stage IB 
IA1 
 
Stromal invasion no greater than 3.0 mm in dept and 7.0 mm or less in 
horizontal spread 
IA2 
 
Stromal invasion more than 3.0 mm and not more than 5.0 mm with a 
horizontal spread of 7.0 mm or less 
IB  Clinically visible lesion confined to the cervix or microscopic lesion 
greater than IA2 
IB1  Clinically visible lesion 4.0 cm or less in greatest dimension 
IB2  Clinically visible lesion more than 4.0 cm in dimension 
II 
 
Tumour invades beyond the uterus but not to the pelvic wall or to lower 
third of the vagina 
IIA  Without parametrial invasion  
IIB  With parametrial invasion 
III 
 
Tumour extends to pelvic wall and/or involves lower third of vagina 
and/or causes hydronephrosis or non-functioning kidney 
IIIA  Tumour involves lower third of vagina; no extension to pelvic wall 
IIIB  Tumour extends to pelvic wall and/or causes hydronephrosis or non-
functioning kidney 
IVA  Tumour invades mucosa of bladder or rectum and/or extends beyond the 
true pelvis 
IVB  Distant metastasis 
 
Table 3. 
Life-table analysis of 291 patients with all stages of cervical carcinoma (follow-
up, 38,9 months) 
Age %  5-year  survival 
≤45 56 
>45 64 
FIGO stage   
I 72 
II 42 
III or IV  24 
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Early or advanced stage of patients are treated differently [10, 11, 12]. Survival 
rates are close to 100% for  stage IA  and much worse for stage III and IV [13], 
Table 3 [14]. 
 
3.   Human Papilloma Virus (HPV) 
HPV is a sexually transmitted virus which has the potential to cause 
cervical cancer. However, in the large majority of women the infection is 
cleared, so in fact cervical cancer is a rare complication of HPV infection. HPVs 
are non-enveloped double stranded DNA viruses. Their DNA is 8 kb in size 
and in circular form. The DNA encodes a long control region without protein 
coding sequences, early proteins (E1-E8) and late proteins (L1-L2). DNA is 
packaged within a capsid shell made of the major and minor capsid proteins L1 
and L2, respectively. Purified L1 protein has the property of self-assembly into 
an empty shell [15]. The virus can multiply episomally, (which is known for 
HPV 16 strain) or in an integrated form with the preference differing from one 
strain to another [16]. Consequently, viral load of different strains does not 
necessarily represent severity of infection, because the integrated form with 
less viral load can cause more persistent disease than episomal one with higher 
viral load. Similar to other integrating viruses, the HPV seems to be capable of 
insertional mutagenesis and deregulation of proto-oncogenes or tumor 
suppressors. There is one report described consistent upregulation of the MYC 
proto-oncogene (v-myc myelocytomatosis viral oncogene homolog (avian)) 
[16]. 
At present more than 100 different HPV types have been identified. They 
differ significantly in carcinogenic potential [17]. Therefore, detection of a 
papilloma virus infection does not necessarily imply a high risk of cervical 
cancer. In most cases, HPV infections are transient, with 70% of newly infected 
individuals clearing the virus within 1 year and 90% of them showing no trace 
of HPV within 2 years [18, 19, 20]. Persistent infection causes the greatest risk 
and is probably enhanced with high-risk types of HPV (16 and 18). Recent 
studies in the United Kingdom showed that 34% of infected women carried 
these high-risk variants of HPV. Risk of having a persistent infection differed 
also between the analyzed social groups. It was higher in non-white women, in 
unmarried women or women cohabiting, in hormonal contraceptive users and 
in current smokers [21]. In Durango, Mexico, only 4.8% of all women were 
found to be HPV-positive. However, 75% of them carried the high-risk HPV 
strains, 16 and 18 [22]. 
The E5, E6 and E7 proteins are mostly responsible for the development of 
the disease. At present, two HPV proteins, E6 and E7, were found to interact 
and block p53 and pRB in infected cells [23]. Since these are two major 
regulators of cell cycle progression and apoptosis, infected cells appear to gain 
a proliferative advantage over non-infected cells.  The full list of targets for E6 Chapter I 
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and E7 is much broader and includes proteins involved in DNA replication 
and control of cell division [24].  
 
4.  Markers in use/trial for HPV and or cervical cancer 
It is important to realize that different biomarkers may serve different 
goals (e.g. markers for early detection such as HPV DNA detection in cervical 
scrapings, markers for premalignant lesions likely to progress such as Ki-67 in 
CIN lesions or markers for monitoring response to therapy such as serum 
SCC). Dysplastic cells show increased cell cycling. Therefore, markers of cell 
cycle progression might be a logical choice as biomarkers for cervical cancer. 
Ki-67 is one of the known antigens related to cell cycle progression [25]. 
Though its function is not known, it is measured with antibodies. Numerous 
studies confirmed the diagnostic value of this marker in identifying HPV 
infection and the extent of the cervical neoplasia [26]. Other markers are based 
on the idea that infected cells are more actively cycling, therefore they are 
enriched in S-,G2 and M-phase proteins such as PCNA, Cdc6, Mcm5 etc [27]. 
Others proposed staining for the cell senescence marker p16INK4a [28], or for 
chromosomal aberrations such as aneuploidy [29]. Aberrant methylation of 
tumor suppressor genes is another concept-driven approach towards the 
discovery of potential cancer-related markers [30].  
A separate group of markers are those directly related to the presence of 
HPV. Examples are the E6 and E7 proteins and squamous cell carcinoma 
antigen (SCC). SCC is a serine protease inhibitor [31] and it is not viral protein, 
though it is induced upon HPV infection. Approximately 60% of the patients 
with cervical cancer show elevated levels of serum SCC when all FIGO stages 
were included [32]. SCC levels increase with the stage of the disease and 90% 
of women test positive when at an advanced stage [33, 34]. Monitoring SCC 
levels during a patient’s treatment, for example, with radiotherapy, provides 
useful information for further management of the disease [35]. 
Another potential group of biomarkers are disease-induced proto-
oncogenes. An example is the HCCR protein originally identified as human 
cervical cancer oncogene [36]. Its level in blood was shown to be elevated in 
hepatocellular carcinoma and breast cancer, however, its role in cervical cancer 
(despite the original name) remains unclear. Some biomarkers are related to 
the immune response and/or suppression thereof. Transforming growth factor 
β1 (TGF- β1) is a well-known cytokine with immunosuppressive activity. Its 
downstream target PAI1 appeared to be a good prognostic marker for cervical 
cancer, whereas TGFβ1 itself was a poor indicator [37]. 
Normal cervical epithelium is not keratinized. However, infected cells 
undergo complex changes of expressions of keratins, which affect cell functions 
and interactions. Keratinization is therefore an essential component of the 
disease. The spectrum of expressed keratins in normal and infected cervical 
epithelium was studied over the last 20 years and early reports were Introduction 
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summarized in 1985 [38]. Recently Shadeo et al. [39] use a genome-wide SAGE 
(Serial analysis of gene expression) tagging technique. They found one isoform 
of keratin (KRT6A) as one of a few proteins forming a specific expression 
signature of neoplastic cervical epithelium at the mRNA level. In general, 
however, expression of keratins is extremely complex, so it is not very 
reproducible from one study to another. Recently, keratins were suggested as 
valuable markers not only for HPV- but also for Epstein Barr Virus-related 
tumors [40].  
 
5.  Vaccination against HPV 
HPV infections may escape the immune response because they are often 
restricted to epithelial cells. Only about 60% of infected women carried 
detectable antibodies against HPV [41]. The first trial of a monovalent vaccine 
targeting the L1 protein 6 years ago showed good protection against new 
infections and the development of lesions [42]. 
Vaccination trials with a bivalent vaccine against L1 protein from  HPV 16 
a n d  1 8  w a s  r e p o r t e d  i n  2 0 0 4  [ 4 3 ] .  L a s t  y e a r  t h e  U . S .  F o o d  a n d  D r u g  
Administration issued a license for a quadrivalent vaccine against L1 protein 
from types 6, 11, 16 and 18 [15]. This triggered initiation of national and 
worldwide programs of vaccination. In the Netherlands, the minister of health 
recently suggested a full vaccination program for young women, which should 
reduce the risk of infection to a minimum. This program has not yet been 
implemented to date. A recent survey shows that most but not all pediatricians 
support the idea of a large-scale vaccination campaign [44]. It must be noted 
that vaccination can reduce infection with the above-mentioned types of HPV 
to about 20-70% in one vaccination campaign (calculated based on a 90% 
efficiency of the vaccine, as reported by Markowitz et al. [15]). Such a program 
is thus not absolutely effective and must be seen as a long-term measure. Other 
types HPV must likely also be included in vaccine production to increase 
coverage. Therefore routine preventive screening and early diagnosis remain 
important.  
In conclusion: a variety of biomarkers, serving different purposes have 
been described in cervical cancer. The ideal biomarker with a high sensitivity 
and specificity, also present in premalignant and early stage cervical neoplasia 
which can be determine in easy available body fluids such as serum, is not yet 
available. Chapter I 
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Chapter I.II 
Sample Preparation of Body Fluids for Proteomics Analysis 
 
Natalia Govorukhina and Rainer Bischoff  
This is an updated version of a book chapter entitled: Sample preparation of 
body fluids for proteomics analysis; in: Proteomics of human body fluids: 
Principles, Methods, and Applications, Ch. 2, 31-71 (2007); (Visith 
Thongboonkerd, Ed.), Humana Press (Totowa, New Jersey, USA). 
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1. Introduction 
1.1. Proteomics of Human Body Fluids 
The analysis of human body fluids constitutes one of the most important 
approaches to the diagnosis of disease and in following therapeutic 
interventions. Human body fluids carry information about the status of the 
organism that may help in the recognition of physiological misbalances when 
overt pathological symptoms are not yet present. Analyzing the constituents of 
body fluids presents a number of challenges, the most difficult being the 
discrimination between variability in composition caused by an ongoing 
disease process and natural variability. The composition of body fluids varies 
due to endogenous, possibly pathological, processes and many environmental 
influences such as diet and life style and the way the organism deals with them 
(e.g., metabolism and detoxification). This variability is most obvious when one 
is analyzing samples from different persons (cross-sectional studies) but is also 
present, albeit to a lesser extent, when one is analyzing samples from the same 
person over a given time period (longitudinal studies). Variability cannot be 
avoided but may be reduced by careful selection of the study population. At 
any rate, the discovery of disease-related changes in the composition of body 
fluids requires the study of a significant number of samples from patients and 
controls and a careful statistical interpretation of the results.  
From an analytical chemistry point of view, body fluids constitute highly 
complex biological samples containing cells, proteins, peptides, and many 
metabolites. Thus, preparation of body fluids is unavoidable prior to 
determining the concentration or amount of a given set of constituents. Sample 
pretreatment and all further downstream steps will affect the ultimate 
analytical result and must therefore be carefully controlled and validated. It is 
not easy to give a general overview of sample pretreatments for body fluids, 
since each of them requires an adapted protocol, which in turn needs to be 
tailored to certain groups of analytes. In this chapter we focus on sample 
pretreatments for the analysis of proteins and peptides in serum. Although 
serum is just one example of a body fluid, albeit an important one, we will use 
it to highlight general principles of sample pretreatments that have a bearing 
on other kinds of body fluids.  
The first step after taking a blood sample from a patient is to treat it in a 
way that makes it suitable for storage and subsequent analysis. A common 
initial step is to separate blood cells from soluble components, for example, by 
low-speed centrifugation. During sampling and centrifugation, it is pivotal to 
avoid disruption or activation of cells, notably hemolysis of red blood cells 
(which is shown by an orange to red color of the supernatant) and activation of 
platelets, which may lead to degranulation. The remaining supernatant, the 
blood plasma, may be stored as such in the case anticoagulants were added 
during collection to prevent blood clotting. Alternatively, blood clotting may 
be allowed or induced by leaving plasma at room temperature for a few hours. Introduction 
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Deciding whether to store plasma or serum for subsequent analyses is 
important. Although plasma is easier to prepare, it requires the presence of 
efficient anticoagulants for long-term stability. The components of the 
coagulation, fibrinolytic, and complement systems are all sensitive to contact 
with unnatural surfaces, such as plastic containers, glass, or injection needles, 
and there is a risk of activating these systems during processing steps (e.g., 
during chromatography or solid-phase extraction). The preparation of serum 
requires coagulation of the plasma, which is a complex biochemical process 
that may be difficult to control. In most hospital or laboratory settings, 
coagulation is effectuated at room temperature for 1 to 4 h. During this time the 
endogenous coagulation system is activated, leading to a cascade of proteolytic 
events that results in the formation of a fibrin-containing blood clot, which is 
usually removed by centrifugation. 
It is obvious that activating a proteolytic system can have serious 
consequences for subsequent proteomic analyses, and some authors have 
noted that the coagulation time affects the resulting serum [1,3] However, 
proteolytic events associated with coagulation are highly controlled due to the 
sequence specificity of the major proteases (thrombin, factor Xa) and their well-
defined location in the coagulation pathway (factor VIIIa, factor XIa) (Figure 1). 
It is thus not clear whether the coagulation time affects the final 
composition of the proteome significantly, but there are indications that the 
lower molecular weight part, the so-called peptidome, is altered (Schulz-
Knappe, personal communication). 
In our initial studies, which applied tryptic digestion prior to LC-MS 
analysis (the shotgun approach), we have not observed major changes in the 
resulting profiles (Figure 2). 
It is, however, important to validate this sample processing step carefully 
within the context of the overall analytical scheme (e.g., the complete protein 
vs the shotgun and peptidomics approach), because coagulation time is not 
well controlled in most laboratory or hospital settings and experience shows 
that it is hard to impose strict rules on hospital personnel with respect to this 
parameter. Finally, for retrospective studies on already acquired and stored 
serum samples, it is not possible to influence this step; thus the decision here is 
whether to include these samples in the analysis or not. Chapter IV of this 
thesis will deal in detail with the effect of clotting time on the serum protein 
profile. 
 Chapter I 
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Figure 1.  Overview of the intrinsic and extrinsic coagulation pathways. Both pathways are 
activated during preparation of serum from blood plasma. Proteolytic activity associated with 
coagulation may affect the profile of low-molecular-weight proteins and peptides used for 
peptidomics analysis. F, factor; PK, protein kinase; PKa, protein kinase A; TAFI, tissue 
angiogenesis factor inhibitor; TFPI, tissue factor pathway inhibitor; TPA, tissue plasminogen 
activator; UPA, urokinase plasminogen activator. Reproduced with permission from Tapper H, 
Herwald H. Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood 
2000;96:2329–2337. Introduction 
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Figure 2. Correlation map of LC-MS data sets obtained from the analysis of serum (male) after 
depletion and tryptic digestion. Coagulation at room temperature was allowed to proceed for 1, 2, 
4, 6, or 8 h. As indicated in this plot, high correlation of all data sets was found, with correlation 
coefficients above 0.8 in each case. 
 
The way samples are initially treated determines in part what kind of 
analytes can be detected and quantified. Although this is true for any kind of 
analyte, it is particularly critical for the analysis of proteins and peptides, 
which are susceptible to degradation, precipitation, chemical modification (e.g. 
oxidation), adsorption to the walls of containers, and so on. Establishing a well-
controlled and reproducible sampling procedure is therefore critical for any 
study involving human body fluids [4-7]. The proteomes in body fluids differ 
significantly from intracellular or tissue-derived proteomes, which are the 
subject of most proteomics studies. Systemic body fluids, like blood, sample 
the whole organism and give an average picture of the physiological state of 
that organism at a given point in time. Notably, blood contains a few high-
abundance proteins that are to a large extent produced and secreted by the 
liver. In contrast, urine is a much more dilute body fluid that samples the Chapter I 
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metabolic end products from blood. Its composition is greatly influenced by 
the status of the kidneys. Although every body fluid presents particular 
challenges with respect to sample pretreatment, it is fair to say that blood is 
one of the most difficult body fluids to analyze. 
  In the following, we will highlight a number of options for sample 
pretreatment prior to proteomics analysis. Our focus will be directed at serum, 
but the principles are applicable to other body fluids. We will try to emphasize 
that there are strategic choices to be made early on in the analytical procedure 
that will determine the final result. 
 
1.2. Methodological Overview 
There is no single approach to proteomics in body fluids. It is likely that 
the comprehensive analysis of the proteome of any given body fluid is still 
beyond our reach despite great methodological advances in recent years. A 
major challenge is the concentration range  o f  p r o t e i n s  i n  m o s t  b o d y  f l u i d s ,  
which spans more than 11 orders of magnitude [8] (Figure 3). 
 
 
Figure 3. Concentration range of proteins found in human plasma. It is noteworthy that there is a 
difference of more than 11 orders of magnitude between the most concentrated and the very low-
abundance proteins. Reproduced with permission from Anderson NL, Anderson NG. The Human 
Plasma Proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845–867. Introduction 
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Furthermore, it is difficult to predict the number of proteins in body fluids 
owing to processing events (like the generation of smaller proteins and 
peptides from larger precursors, posttranslational modifications, and the fact 
that proteins can enter body fluids by well-defined pathways like secretion) as 
well as cell and tissue turnover as a result of necrosis or apoptosis. From a 
methodological point of view, the proteome of a body fluid may be roughly 
divided into high- and low-molecular-weight compartments (Figure 4).  
 
 
 
Figure 4. Schematic overview of different approaches of sample preparation. The main initial 
difference is whether undigested or trypsin-digested proteins are being analyzed. A second level of 
differentiation comes into play when one is deciding whether to analyze the high- or the low-
molecular-weight (MW) fraction of the proteome. High-molecular-weight proteins are best 
analyzed by 2D electrophoresis, whereas peptides are more amenable to high-performance liquid 
chromatography (HPLC) coupled to mass spectrometry. 
 
This discrimination is rather arbitrary and is mostly defined by the size-
dependent separation method used for prefractionation. 
Body fluids have been prefractionated by ultrafiltration with membranes of 
various cutoff values [9-11]. Although ultrafiltration appears to be an easy 
separation methodology with an apparently clear-cut separation mechanism, 
its application to complex biological samples shows that discrimination 
between proteins above and below the nominative cutoff of the membrane is 
never complete [11]. Effects such as adsorption of proteins to the membrane, 
the generation of a polarization layer close to the membrane surface, and 
deformation of the pores in relation to the g-force can all affect filtration. Chapter I 
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Ultrafiltration is also performed on a large scale in patients with renal 
insufficiency, and membrane material has been the source for many studies of 
bioactive proteins and peptides below approximately 20 kDa [12-14]. Although 
the kidney itself is performing much more complex tasks than just 
ultrafiltration, urine may be considered an ultrafiltrate of blood and thus has a 
considerably lower concentration of high molecular- weight proteins. 
An elegant combination of ultrafiltration and chromatography is based on 
restricted access materials (RAMs), which have an adsorbing internal pore 
surface and a non-adsorbing external surface [15,16]. The pore diameter in 
most RAMs is about 6 nm, which corresponds roughly to a cutoff value of 20 
kDa. RAM chromatography has been integrated into analytical systems with 
the goal of analyzing the low-molecular-weight part of the proteome of blood 
diafiltrates [17,18] or artificial cerebrospinal fluid [19]. Although a clear 
enrichment of the low-molecular-weight fraction was observed, a considerable 
amount of albumin was still present even after RAM chromatography. 
The decision whether to work with undigested proteins or to digest 
proteins with trypsin prior to further analyses is of principal importance in an 
analytical scheme (Figure 4). Performing separations of very complex mixtures 
of proteins is difficult, owing to the wide range of physicochemical properties 
and the possibility that proteins will denature, aggregate, or even precipitate 
under separation conditions. The most universally applicable separation 
method for proteins is 2D polyacrylamide gel electrophoresis (2D-PAGE), 
whereby all proteins are denatured from the beginning and kept in a 
denatured state throughout separation. This reduces the risk of aggregation 
and precipitation with subsequent loss of proteins as well as that of proteolysis. 
There is no comparable universal chromatographic method, and it is thus 
necessary to develop an appropriate fractionation scheme for groups of 
proteins or individual proteins. However, as 2D-PAGE has limitations with 
respect to low-molecular-weight proteins of 10 to 20 kDa and hydrophobic or 
basic proteins, alternatives are being developed. 
One approach is based on the so-called shotgun method, whereby the 
complete protein mixture is digested with trypsin (other proteases are 
conceivable as well for this purpose but are not widely used) and the generated 
peptides are separated by 2D or 3D high-performance liquid chromatography 
(HPLC) [20-23]. Shotgun proteomics has the advantage of overcoming many of 
the difficulties related to very hydrophobic or otherwise intractable proteins at 
the expense of rendering the separation problem quite daunting. Assuming 
that serum contains about 105 different protein forms, each of which generates 
50 tryptic peptides, one has to deal with a mixture of about 5 x 106 peptides to 
be separated. Fortunately, not all peptides need to be separated into single 
peaks, and not all peptides of each protein need to be identified by mass 
spectrometry to trace them back to the protein of origin. A drawback of the 
shotgun method is that not all regions of a protein are covered by the analysis, Introduction 
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which may mean that some possibly relevant posttranslational modifications 
or processed forms are missed. Nevertheless, the excellent separation capacity 
of HPLC for peptides compared with complete proteins and the much easier 
identification of peptides by tandem mass spectrometry have accelerated the 
use of shotgun proteomics in the biomarker discovery area. The daunting 
separation problem posed by this approach has also driven recent new 
developments in HPLC stationary phase chemistry and technology that 
increase separation efficiency and reduce analysis time [24-28]. 
The presence of a few high-abundance proteins in body fluids such as 
albumin has driven developments to deplete these proteins specifically and 
thus to increase the loading capacity by a factor of 5 to 10 [29-35] or even 30 to 
50, depending on the number of proteins that are depleted (e.g. ProteoPrep® 20 
Plasma Immunodepletion kit, www.Sigma-Aldrich.com removes the 20 most 
abundant serum proteins). In addition to increasing the protein or peptide 
load, depletion also augments the capacity to detect peptides derived from 
lower abundance proteins [36]. It has been shown, however, that depletion of 
high-abundance proteins does not proceed without the loss of some low-
molecular-weight proteins and peptides [37]. It is thus important to decide 
whether to deplete or rather try to design a fractionation strategy that deals 
with high-abundance proteins such as albumin or immunoglobulins in another 
way [38]. 
Arguably, very low-abundance proteins in the ng/mL to pg/mL range 
cannot be detected in complex protein mixtures such as serum even after 
depletion. Many regulatory proteins such as cytokines or some of the known 
tumor-specific markers reside in this concentration range and are presently 
measured by immunological methods. To reach into this lower concentration 
range, it is often necessary to enrich a given set of proteins by affinity 
chromatography using highly selective antibodies or group-specific ligands 
like lectins. The use of protein-specific antibodies limits the scope of the 
analysis to those proteins that are recognized. Group-specific affinity ligands 
such as lectins or antibodies directed at a common structural element such as 
phosphotyrosine represent a compromise between the comprehensive 
proteomics approach, which often fails to detect low-abundance proteins, and 
the highly specific methods. For example, lectins have been applied to the 
discovery of tumor-specific glycoprotein markers, since tumor cells often 
produce proteins with aberrant glycosylation patterns [39-41]. Lectins have 
also been used to enrich glycoproteins from complex protein mixtures or 
glycopeptides from tryptic digests of such mixtures [42-45]. In general, targeted 
approaches require a hypothesis concerning the role that different kinds of 
proteins may play in a given disease in order to chose appropriate affinity 
ligands for enrichment. 
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2. Sample Preparation 
2.1. Preparation of Plasma and Serum 
Between two fundamentally different compartments of the blood, namely, 
blood cells and the actual fluid, most clinical analyses are done on derivatives 
of the fluid, like plasma or serum. Discussion continues on whether serum or 
plasma should be used, but this may also depend on the general practice of the 
hospital that provides samples for analysis, notably, whether samples are 
analyzed from existing collections. Preparation of plasma requires addition of 
anticoagulants, such as EDTA, citrate, and/or heparin, whereas serum contains 
no extra additives. Serum lacks components of the coagulation system, such as 
thrombin and fibrinogen, since they are part of or become entrapped in the 
blood clot and are thus removed from the serum. In addition, other proteins or 
peptides that have some binding affinity to the clot may be partially depleted. 
Being a proteolytic process, coagulation generates peptide fragments from 
larger proteins that may especially affect the composition of the peptidome. 
Interestingly, comparison of plasma made with EDTA, citrate, or heparin also 
shows variation in protein composition [46]. 
Sampling blood for plasma or serum preparation is routine in most 
hospital laboratories and a reasonably standardized procedure is in place using 
commercial reagents and materials. However, most laboratory technicians and 
nurses are not aware of the specific requirements of proteomics and thus need 
to be informed. Very restrictive standard operating procedures (SOPs), notably 
with respect to the coagulation time and conditions, are often difficult to follow 
in routine hospital operations. Biomarkers discovered thus far therefore need 
to be robust enough to be useful in a routine clinical laboratory, and very 
unstable proteins or peptides are probably not of interest in the long run.  
Recently, Schulte et al. [2] reported that a considerable number of peptides 
were found in serum but not in human plasma. The authors suggest that these 
peptides appeared as a result of a clotting-related proteolytic activity. This 
might be indicative of artifacts generated as a result of the clotting reaction, 
which is disturbing with respect to peptidomics. The authors therefore propose 
to use human plasma for this purpose. 
An example of the preparation of plasma for biomarker discovery by 
Peptidomics® (Schulz-Knappe, personal communication) involves taking a 
blood sample from a superficial vein of the cubital region. The blood sampling 
procedure should not take longer than 1 min, and EDTA is used as the 
anticoagulant. Prior to collection, the first sample (approximately 2.5 mL) is 
discarded. To remove platelets, the sample is centrifuged at 2,000g for 10 min. 
The final plasma sample (approximately 1.5 mL) should be frozen within 30 
min after being taken and stored at -80°C. Serum is made by letting a fresh 
blood sample coagulate (with or without thrombin as activator) and either 
filtering it through a gel or collecting the liquid fraction after centrifugation. 
Although their hypothesis has not been proven, Sorace and Zhan [47] suggest Introduction 
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that variations in coagulation might be a significant factor in obscuring clinical 
proteomics data sets. The source of variation can be both technical and natural. 
Schulte et al. [2] found that a naturally occurring Val-34 to Leu mutation in the 
activation peptide of factor XIII (FXIIIA) not only affected the process of blood 
clotting but also correlated with a lower incidence of myocardial infarction and 
ischemic stroke and an increased risk of hemorrhagic stroke. According to our 
results (see chapter IV of this thesis), different clotting times ranging from 1 to 
8 h in the preparation of serum samples resulted in highly correlated liquid 
chromatography-mass spectrometry (LC-MS) data sets when analyzing serum 
proteins after depletion and trypsin digestion. Correlation coefficients above 
0.8 were found for all samples after selecting the 37 top information-rich m/z 
traces using the CODA component detection algorithm [48] (Figure 2). 
 
2.2. Removal of High-Abundance Proteins 
As the presence of abundant proteins in most biofluids used for diagnostic 
purposes decreases the capacity of analytical methods to detect low-abundance 
proteins or peptides, a range of approaches has been developed to reduce the 
total amount of protein. Blood serum is a complex mixture of thousands of 
proteins and peptides. However, few of the serum proteins are present in 
extremely high amounts compared with the rest of the serum components. 
(human serum albumin [HSA] constitutes 57–71% and γ-globulins 8–26% of 
the total of all human serum proteins). The 10 most abundant proteins account 
for 97% of all the protein content in plasma [8]. In a recent publication, it is 
stated that the search for specific markers occurs in a fraction of less than 1% of 
all plasma proteins [49]. 
Removal of these high-abundance proteins increases the loading capacity 
of the analytical system by a factor of 5 to 10 and thus improves the detection 
of low-abundance proteins. Several affinity columns are presently on the 
market based on dye ligands or antibodies for albumin removal and protein A 
or G for the removal of immunoglobulins [50]. Technically simple approaches 
that allow processing of multiple samples in parallel based on HSA- and IgG-
binding spin columns or filters have been developed [51]. For HSA binding, 
two types of stationary phases are generally used: (1) those based on dye 
ligands such as Cibacron-Blue and derivatives thereof [52], and (2) those based 
on specific antibodies against human serum albumin [51] raised in mammals 
(IgG) but also in chickens (IgY), as recently described [31]. HSA was also 
successfully removed by affinity capture on immobilized phage-derived 
peptides [53]. Recently, a synthetic peptide derived from protein G was used 
for HSA affinity chromatography and depletion of HSA from human plasma 
[54]. The column could easily be regenerated with alkaline treatment owing to 
the stability of the peptide, and its specificity and capacity were quite high. 
However, the column is presently not commercially available. Removal of IgG 
is exclusively done by well-established methods based on immobilized protein Chapter I 
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A, protein G, or protein L, owing to their high affinity and selectivity [55-60]. 
Comparative studies of HSA- and IgG-binding columns based on Poros® 
polystyrene-divinylbenzene beads (Applied Biosystems) [32]  as well as on 
Mimetic Blue (ProMetic BioSciences) and HiTrap Blue (Amersham Biosciences) 
for HSA removal have been performed [33]. 
We tested several approaches specifically to reduce the level of high-
abundance proteins in serum based on either specific antibodies, dye ligands 
(for albumin), or protein A or G (for γ-globulins) [30]. Analysis by sodium 
dodecyl sulfate (SDS)-PAGE (Figure 5) and LC-MS after tryptic digestion of the 
remaining proteins (Figure 6), showed that reduction with albumin-directed 
antibodies was most effective, albeit not complete [36].  
 
 
 
Figure 5. Depletion of albumin and γ-globulins from human serum. In each lane 8 to 10 μg of 
protein were loaded, and gels were stained with Coomassie Blue G-250. (A) POROS Anti-HSA and 
POROS Protein G columns. (B) HiTrap Blue and HiTrap Protein G columns. (C) Merck Albumin 
Removal column and HiTrap Protein G column. (D) Aurum Serum Protein column. Lanes: 1, 
standards; 2, crude serum; 3, depleted serum; 4, bound protein eluted from albumin-depleting 
columns; and 5, bound γ-globulins eluted from columns. Labeled protein bands: 1, serotransferrin; 
2, α1-antitrypsin; 3, albumin; 4, 5, γ-globulins, heavy and light chains, respectively. Reproduced 
with permission from Govorukhina NI, Keizer-Gunnink A, van der Zee AGJ, de Jong S, de Bruijn 
HWA, Bischoff R. Sample preparation of human serum for the analysis of tumor markers: 
comparison of different approaches for albumin and [gamma]-globulin depletion. J Chromatogr A 
2003;1009:171–178. 
 
In our initial studies, which applied tryptic digestion prior to LC-MS 
analysis (the shotgun approach), we have not observed major changes in the 
resulting profiles (Figure 2). 
A more recently introduced multiple affinity removal column, which 
depletes certain high-abundance proteins (albumin, IgG, IgA, transferrin, Introduction 
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haptoglobin, and α1-antitrypsin [50]), proved to be most effective in our hands 
and provided more reproducible results during LC-MS analysis regarding 
retention times and peak areas than previously evaluated methods [61,62]. 
Similar results were recently published for 2D gel electrophoresis (Figure 7) 
[50]. Recently immunoaffinity materials have been introduced that remove the 
20 most abundant proteins (ProteoPrep® 20 Plasma Immunodepletion kit/ spin 
columns (www.Sigma-Aldrich.com)) or the 14 most abundant proteins (Hu-14 
Spin Cartridges (www.home.agilent.com)). 
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Figure 6. Efficiency (A) and selectivity (B) of albumin removal from human serum using an anti-
albumin immunoaffinity column. (A) Extracted ion chromatogram of m/z =575.3 (doubly charged 
molecular ion of peptide LVNEVTEFAK; positions 41–50 in human serum albumin) of tryptic 
digests of human serum (upper trace; peak height 3.2 x 107) or of human serum after depletion 
with an anti-albumin immunoaffinity column (lower trace; peak height 4.6 x 105). (B) Extracted ion 
chromatogram of m/z x 393.3 (doubly charged molecular ion of peptide IVDLVK; positions 193–
198 in human α1-antitrypsin) of tryptic digests of human serum (upper trace; peak height 16,052) or 
of human serum after depletion with an antialbumin immunoaffinity column (lower trace; peak 
height 32,607). Note the much cleaner detection of this peptide fragment after depletion and the 
increased overall peak height. Reproduced with permission from Bischoff R, Luider TM. 
Methodological advances in the discovery of protein and peptide disease markers. J Chromatogr B 
2004;803:27–40. Chapter I 
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Figure 7. 2D electrophoresis of crude (70 μg protein) and depleted (6-protein multiple affinity 
removal column, 100 μg protein) serum samples. On the right side is a zoom view of the area 
containing albumin. Reproduced with permission from Bjorhall K, Miliotis T, Davidsson P. 
Comparison of different depletion strategies for improved resolution in proteomic analysis of 
human serum samples. Proteomics 2005;5:307–317. 
 
Removal of high-abundance proteins by ultrafiltration through cellulose 
filters with a cutoff of 30 kDa proved to be less successful [11]. Many known 
“landmark” proteins of low molecular weight (<30 kDa) were missing upon 2D 
gel electrophoresis. Ultrafiltration has, however, the advantage of allowing one 
to concentrate the low-molecular-weight fraction of the proteome and was 
found to be useful for analysis of low-molecular-weight proteins (LMWs) by 
LC-MS after prefractionation by strong cation-exchange HPLC [10]. To prevent 
binding of LMWs to serum carriers, particularly albumin, 20% acetonitrile was 
used. In the resulting fraction, the authors could identify 314 unique proteins 
including cytokines, growth factors, and transcription factors, which are 
proteins of low abundance that are very difficult to detect by other methods 
without serum depletion. This method of sample preparation at a cutoff of 10 
kDa was recently used to analyze the LMW fraction of pooled serum from 
patients with ovarian cancer by nanoLC-electrospray ionization-fourier Introduction 
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transform ion cyclotron resonance (ESI-FT-ICR)-MS and analyzed statistically 
[9]. 
A quite different set of methods uses electrophoretic approaches to 
fractionate complex samples and to separate high-abundance proteins from 
those of low abundance. The basic principle is based on preparative isoelectric 
focusing and/or free-flow electrophoresis in solution, whereby the crude 
sample is prefractionated in a specially designed chamber according to the 
different electrophoretic mobilities or isoelectric points of the proteins. The 
HSA-rich fraction was discarded, and other fractions were pooled or analyzed 
separately. The method was originally reported more than 10 years ago [63] 
and is still in limited use [64-66]. Some commercially available systems can be 
used for electrophoretic prefractionation (e.g., the Zoom IEF fractionator® 
[Invitrogen] or the system produced by Weber). 
There is one particular problem associated with the removal of serum 
albumin and globulins. These proteins appear to fulfill the function of carriers 
for less abundant proteins [37,67]. This is especially critical for LMWs, since 
they can escape kidney clearance only when bound to high-molecular-weight 
carrier proteins. Many of these LMWs are found to be associated with the 
development of cancer and could therefore be extremely important biomarkers 
(see ref. 37). Binding of LMWs to high-abundance, high-molecular-weight 
proteins may be used advantageously based on a two-step procedure, whereby 
abundant carrier proteins are first specifically bound to the corresponding 
affinity column followed by elution of the bound LMWs using a gradient 
[37,67]. 
 
2.3. Targeted Enrichment of Individual Proteins or Protein Families 
Since many disease-specific biomarkers are likely of low to very low 
abundance in body fluids, it is a major challenge to detect them using profiling 
methods. Reaching the required concentration sensitivity  often requires 
complex, well-designed protocols of enrichment and fractionation that are 
rather time-consuming. A concept of a multi-dimensional fractionation system 
(MDFS) was recently proposed and discussed  [68].  Based on a given 
hypothesis about the disease mechanism, it is therefore often advisable to use 
targeted, affinity-based methods for enrichment prior to analysis. A 
combination of proteomics technology with targeted enrichment that does not 
require a very “sharp” hypothesis is based on group-specific ligands like 
lectins [69-70] in case of glycoproteins, or activity-based probes (ABPs) in the 
case of proteases or other enzymes [71-77]. 
 
2.3.1. Lectins 
Glycosylation of proteins is a posttranslational modification that is easily 
affected by cellular growth conditions. Modifications of glycosylation patterns 
are therefore often observed in fast growing cancerous cells compared with Chapter I 
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their quiescent counterparts [39,78]. Analysis of the carbohydrate portion of 
proteins is a rather complex task, since the glycosyl moiety is usually a 
branched chain polymer with an enormous variety in length, composition, and 
complexity. Studies of glycoproteins can be divided into two types: 1) 
identification of the proteins and their glycosylation sites and 2) the more 
demanding analysis of the structure of the attached glycosyl residues 
themselves.  
Glycosyl residues can be linked to the protein core via asparagine (N-
linked glycans) or bound via serine or threonine (O-linked glycans). For N-
linked glycans, N-acetylglucosamine (GlcNAc) is the first monosaccharide in 
the chain, whereas N-acetylgalactosamine (GalNAc) is most often found for O-
linked glycans. In addition to being potentially interesting as biomarkers, 
failure of proper glycosylation can cause severe abnormalities [79]. 
Although the exact structure of glycosylated proteins varies considerably, 
probably all known glycoproteins can be enriched by lectin affinity 
chromatography [80]. There are several commercially available lectin affinity 
columns, which differ in specificity and are used widely in early stages of the 
isolation of glycoproteins [81]. The specificity of many lectins is known (Table 
1), allowing the rational design of complementary enrichment schemes.  
 
Table 1: Selected lectins with their specificities. 
Lectin Specificity 
Concanavalin  A  (ConA)  glucosyl and mannosyl residues of N–
linked oligosaccharides 
Wheat germ agglutinin 
(WGA) 
chitobiose core (di-N-acetylglucosamine) 
and N-acetylneuraminic acid 
Peanut agglutinin (PNA)  T antigen (Galb1-3GalNAc) found in O-
glycans of mucin-type proteins 
Aleuria aurantia (AAL)  L-fucose–containing oligosaccharides 
Galectines N-acetyllactoseamine  (LacNAc)-containing 
glycans found in both N- and O-glycans 
 
Recently five lectins, concanavalin A (Con A), wheat germ agglutinin 
(WGA), jacalin, lentil lectin (LCA), and peanut lectin (PNA) were tested for 
capturing glycoproteins from human serum [41]. At first, the authors depleted 
the high-abundance proteins with a multiple affinity depletion column 
followed by enrichment on single- or multiple-lectin affinity columns. The 
enriched proteins were eluted with buffers containing specially selected sugars. 
The resulting fractions were analyzed by LC-MS after digestion with trypsin. 
Figure 8 gives an example of how the analysis of proteins in serum can be 
f o c u s e d  t o  a  s u b s e t  c o n t a i n i n g  a  f u c o s e  r e s i d u e  b y  p r i o r  e n r i c h m e n t  o n  a  
column containing the fucose-specific Lotus tetragonolobus agglutinin (LTA) 
[43]. Introduction 
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Figure 8. Enrichment of fucose-containing peptides in serum proteins after tryptic digestion. An 
LTA lectin affinity column was used to select the peptides followed by deglycosylation and 
reversed-phase HPLC. Reproduced with permission from Xiong L, Andrews D, Regnier F. 2003. 
Comparative proteomics of glycoproteins based on lectin selection and isotope coding. J Proteome 
Res 2003;2:618–625. 
 
2.3.2. Activity-Based Profiling of Proteases 
Standard proteomics techniques give information about the relative 
abundance of proteins and possibly posttranslational modifications. In most 
cases, however, these techniques do not provide information about biological 
activity. In recent years another branch of proteome analysis has developed to 
tackle this problem with the development of affinity-labeling techniques, 
generally called activity-based protein profiling (ABPP) [82-85]. This line of 
research focuses on profiling the activity of families of enzymes like the various 
types of proteases. A derivative of this work is to use affinity ligands, like 
protease inhibitors, to enrich classes of proteins based on their activity [76]. 
Arguably, it is the activity of enzymes that is involved in disease development 
and that may therefore serve as biomarkers rather than the abundance, since 
most enzymes are present as inactive proforms that are activated upon 
appropriate (or inappropriate) stimuli. 
ABPs have been described for cysteine proteases [84,86-88], serine 
hydrolases, including serine proteases [73,89], and also metalloproteases [71,90-
92]. In most cases the labels contain biotin, which allows one not only to 
visualize but also to isolate the labeled proteins. Even in vivo labeling, for 
example, in tissue biopsies or cells in culture is feasible [84]. By employing this 
strategy, sample depletion for abundant proteins can be bypassed as long as 
the inhibitors or other affinity ligands are sufficiently specific and nonspecific Chapter I 
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binding to the support materials can be minimized. Figure 9 gives an example 
of how strongly some proteins may bind to materials used for the 
immobilization of affinity ligands and how nonspecific binding may be 
overcome by chemical derivatization of the surface. 
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Figure 9. Binding of the catalytic domain of matrix metalloprotease-12 (MMP-12) to unmodified 
controlled porosity glass beads (S), silanized with a diol layer () or silanized and then coupled 
to a reversible MMP inhibitor () (Dr. Robert Freije, unpublished data). 
 
Nonspecific binding to affinity ligands or the surfaces on which they have 
been immobilized makes stringent controls necessary. For example, preparing 
non-functionalized “control” materials and competing with the affinity 
interaction by adding an excess of ligand to the binding buffer are common 
ways of assessing specificity. Some authors have also denatured the proteins 
by heat treatment prior to binding as a control. As an example, a complex 
mixture of extracellular serine hydrolases was successfully identified by MS 
after the hydrolases were enriched by affinity chromatography. In addition, 
resolution of protein bands on SDS-PAGE was improved upon deglycosylation 
of the enriched enzymes [93,94]. 
Successful affinity-based profiling requires suitable affinity ligands. To 
address a wider range of proteins based on their activity, combinatorial 
chemistry approaches have been developed [95]. A new promising concept of 
in vivo click chemistry protein labeling utilizing the copper(I)-catalyzed azide-
alkyne cycloaddition reaction was recently introduced [96]. However, this 
method is mostly limited to catalytically active proteins, such as enzymes. A 
great number of protein-protein interactions, however, remain largely 
unexplored. 
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2.4. Protein Chip Technology (SELDI-TOF-MS) 
Since natural body fluids are too complex to analyze directly, investigators 
are in constant search of new techniques of subfractionation prior to MS. Most 
often prefractionation is done by LC or electrophoresis, but simple 
adsorption/washing/desorption methods are finding more widespread use, as 
they are rather fast and can be automated more easily. In classical matrix-
assisted laser desorption/ionization mass spectrometry (MALDI-MS), 
prefractionated protein samples are digested with trypsin prior to analysis 
(peptide mass fingerprinting). In this version all peptides are indiscriminately 
deposited on the MALDI target plate and entrapped in the light-absorbing 
matrix. 
The central idea of surface-enhanced laser desorption/ionization (SELDI) 
is to use adsorptive surfaces, mainly based on well-known chromatographic 
principles, to bind a subfraction of proteins from a sample and to analyze the 
bound proteins or peptides by MALDI-MS. By varying the adsorptive surface, 
different groups of proteins can be bound and analyzed. This technology has 
more recently been further developed and commercialized under the trade 
name ProteinChip® (Ciphergen Biosystems, Palo Alto, CA) and has found 
widespread application, notably in the medical and clinical research 
community [97]. The original mass spectrometer was a simple linear MALDI-
time of flight (TOF) system, but interfaces have now been developed that allow 
coupling of the ProteinChip technology to tandem mass spectrometers of the 
quadrupole- TOF hybrid type. 
The key components of this technology are Protein Chip Arrays and the 
Protein Chip Reader. The array comprises a set of different surfaces, such as a 
hydrophobic, hydrophilic, or metal chelate to which the biological samples are 
added. The unbound proteins are washed away, and the bound fraction is 
subjected to MS analysis. Optionally, it is possible to digest the bound proteins 
with trypsin to facilitate their identification. However, since most chips bind 
many diverse proteins, interpretation of the results after trypsin digestion is 
not always obvious because it is not straightforward to link the observed 
peptides back to the proteins that gave rise to an increased or decreased peak 
in the original spectrum. As a recent example of this approach, cystatin C was 
suggested as a biomarker in the diagnosis of Creutzfeld-Jakob disease [98]. 
Direct fragmentation of the high-molecular-weight ions to obtain sequence 
information for identification would be most advantageous. This has recently 
been facilitated due to ion activation mechanisms such as Electron 
Capture/Transfer Dissociation or Infrared Multiphoton Dissociation [99-104]. 
As with any mass spectrometric method dealing with highly complex 
mixtures, there is a competition between different molecules to ionize (also 
known as ion suppression). It is thus unlikely that the mass spectrum obtained 
from a ProteinChip will give a true representation of the proteins or peptides 
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therefore generate rather simple mass spectra, which can be easily analyzed. A 
number of applications of SELDI-TOF to biological samples, notably plasma, 
serum, or urine, have shown that samples taken from patients differ 
significantly from those from healthy controls or from patients with other 
kinds of disease, opening the possibility of discriminating patient groups and 
performing early diagnosis of, for example, ovarian or breast cancer [105-106]. 
However, recent efforts to reproduce these results have met with limited 
success, and the jury is still out on whether this fairly straightforward approach 
to sample preparation will lead to clinically relevant results [107-109]. 
Probably one of the most impressive studies using SELDI-TOF in recent 
years was the detection of an antiviral factor secreted by CD8 T-cells upon 
infection with HIV-1 in immunologically stable patients, which was identified 
as a member of the α-defensin family by subsequent isolation and protein 
sequencing [110]. This factor had been known since 1986 but had eluded 
identification for 15 years [111].  
 
2.5. Automated Sample Preparation Using Magnetic Beads 
The automation of sample preparation in light of increasing sample 
throughput and reproducibility is an important aspect of clinical proteomics. In 
analogy to the previously described ProteinChips, it is possible to prepare 
samples by adsorption/washing/desorption on magnetic beads (or other kinds 
of beads). Magnetic beads are an effective tool for fast concentration of diluted 
samples and for the crude separation of proteins and peptides prior to MS 
analysis. Magnetic beads are widely used in automated immunoassays, cell 
purification, and more recently, the detection of bacterial pathogens. Mostly, 
the assay is targeted at individual proteins, like prostate-specific antigen (PSA), 
which is captured with a biotinylated anti-PSA antibody (anti-F-PSA-M30-IgG) 
and subsequently bound to streptavidin-coated magnetic beads [112]. This 
approach, however, is targeted to a specific protein and is not applicable to 
proteomic studies in a broad context. In another example, magnetic 
nanoparticles modified with vancomycin were used to trap Gram-positive 
bacteria [113]. The method was able to detect Staphylococcus aureus in a 3-mL 
urine sample at a concentration of 7 x 104 CFU/mL (colony-forming units) by 
MALDI-TOF-MS. A combination of affinity trapping with MS has also been 
successful in detecting bacterial and viral infections based on immobilized 
lectins [114,115]. Application of magnetic beads to clinical proteomics has 
emerged only recently mainly based on adapted liquid handling systems [116]. 
Serum was precipitated with ethanol to remove larger proteins, and the 
remaining polypeptides in the supernatant were bound to reversed-phase 
super-paramagnetic silica beads. The washed and eluted peptides were 
profiled by MALDI-TOF/TOF-MS with the possibility of performing partial 
sequencing and identification by MS/MS. Four hundred polypeptides were 
detected in 50 μL serum (range 0.8–15 kDa), and discrimination between Introduction 
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samples from brain tumor patients and healthy controls was 96.4% based on a 
learning algorithm.  The number of examples of protein enrichment with 
magnetic beads has been steadily increasing over the last years [117-120]. 
 
2.6. Analysis of Other Body Fluids 
Sample preparation is equally important for proteomics and peptidomics 
in other body fluids, and many of the methods and considerations developed 
for serum are suitable. Urine is probably the second most relevant body fluid 
after blood for general proteome studies, owing to its availability. Urine is in 
fact filtered blood plasma, so it might be representative of the protein spectrum 
of blood, but with lower protein concentrations. In normal conditions the 
kidney restricts passage of plasma proteins above approx 40 kDa during 
filtration in the glomeruli. Proximal renal tubules reabsorb filtered proteins 
and degrade them. Total amounts of secreted protein per voiding vary from 1 
to 10 mg, whereas in pathology, the protein concentrations can dramatically 
increase [121,122]. Urine collects the metabolic end products of the organism 
destined for excretion, and its composition is therefore more variable than that 
of serum or plasma. In particular, the composition and concentration of 
proteins and peptides in urine are strongly affected by nutrition, the day/night 
cycle, and the health status of the kidneys. It is thus important to try to control 
and document these parameters as accurately as possible. 
Although protein concentration in urine is much lower than in serum 
(approximately 1000-fold) and filtration takes place in the kidneys, albumin is 
still the major protein. Proteome maps of human urinary proteins were 
recently constructed after LC-MS analysis of trypsin-digested unfractionated 
urine [123,124], by 2D electrophoresis after acetone precipitation [125],  and 
after depletion of high-abundance proteins (albumin and IgG) by ultrafiltration 
and 2D electrophoresis [126]. An equivalent of urine, human hemofiltrate, was 
also analyzed by restricted access chromatography to select the peptidome 
followed by 2D HPLC and MS [17,18]. Urine has furthermore been analyzed by 
capillary electrophoresis coupled to electrospray ionization (CE-MS) [127,128]. 
Combined with new analysis software, this analytical method is presently 
under further investigation. Normalization of the data obtained to an internal 
standard that takes biological variation into account is critical for urine [128]. 
This has been common practice in clinical chemistry for a long time, and 
creatinine is widely used for this purpose. However, whether creatinine is also 
a suitable normalization standard for proteomics and peptidomics studies in 
urine is questionable. Normalization based on the total protein content or the 
area under the curve of the HPLC-UV trace may be preferable. It remains to be 
seen whether the urinary spectrum of proteins and peptides can be successfully 
used to detect human diseases short of those related to the kidney or general 
inflammation.  Chapter I 
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Urine samples should be collected under sterile conditions, cooled down, 
and treated with protease inhibitors. The next steps of sample pretreatment 
vary from one publication to the next. For example, proteins can be 
concentrated by precipitation with trifluoroacetic acid followed by 
centrifugation [129]. The resulting sample can be further applied to 1D or 2D 
electrophoresis, or subjected to solid-phase extraction and trypsin digestion 
followed by LC-MS analysis. Pieper et al. [126] compared urinary proteomes of 
healthy and renal cell carcinoma patients. Initially, cooled samples with added 
protease inhibitors were cleared by centrifugation and concentrated by 
membrane filtration. Samples were further desalted and fractionated by gel 
filtration on Superdex G-75. The resulting sample of more than 30 kDa proteins 
was passed through a depleting column specific for albumin, IgG, and α-1-acid 
glycoprotein. The final comparative analysis was done by 2D electrophoresis 
and mass spectrometry. Urine samples were recently used for comparative 
studies of normal and lung cancer patients [130]. The collected urine samples 
were first desalted by gel filtration (PD-10 columns) followed by lyophilization. 
The pellet was resuspended in phosphate buffer, extracted with methanol/ 
chloroform, and precipitated with trichloroacetic acid/acetone to remove 
organic acids and lipids. Finally, the sample was fractionated with HPLC and 
1D or 2D electrophoresis followed by MALDI-MS and MS-MS. The image 
analysis of the gels demonstrated a quite impressive number of protein spots, 
but albumin and IgG were still quite abundant. Whereas easily obtainable body 
fluids such as blood, urine, saliva, or tears are samples of first choice for human 
proteomic studies, more specialized samples are frequently used to evaluate 
the condition of a given organ system. It is implied that a sample taken closer 
to the diseased organ will show changes in protein composition that are more 
closely related to the disease than those occurring in blood or urine. 
Recently, the proteomics of bronchoalveolar lavage fluid (BALF) was 
reviewed [131,132]. Bronchoalveolar lavage samples the epithelial lining of the 
lung and is frequently analyzed in cases of severe respiratory diseases (e.g. 
chronic obstructive pulmonary disease, severe asthma, pulmonary fibrosis). 
BALF consists of a soluble part often used for biomarker analysis and cells 
derived from lung tissue or blood (alveolar macrophages, lymphocytes, 
neutrophils, and eosinophils). It is noteworthy that most proteins found in 
BALF correspond to abundant plasma proteins, indicating “plasma leakage” 
into the alveolar space owing to the lavage procedure. A map of the BALF 
proteome showed up to 1400 different proteins on a 2D gel [131], with some 
proteins at higher concentrations than in serum or plasma. These proteins are 
likely directly derived from the lung. Removing albumin as the most abundant 
protein in BALF by RAM chromatography allows one to process larger 
volumes and thus to detect lower abundance components (Figure 10). 
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Figure 10. Sample preparation of bronchoalveolar lavage fluid (BALF) by restricted access material 
(RAM) chromatography. The upper panel shows the reversed-phase HPLC analysis of 10 μL BALF 
(major peak is albumin), and the lower panel shows the analysis of 1 mL BALF after sample 
preparation (Dr. Begona Barroso, unpublished data). 
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3. The Linkage to Separation Methods and Mass Spectrometry 
The analysis of complex proteomes requires that dedicated and effective 
sample preparation be followed by high-resolution separation to reduce 
complexity to a level that can be handled by MS in terms of protein or peptide 
ionization, identification, and quantification. A wide range of separation 
methods has been applied to proteins and peptides, and it is beyond the scope 
of this chapter to review them all. The main purpose of the ensuing sections is 
to highlight how sample preparation of body fluids affects the downstream 
separation procedures and MS. To this end, two of the major separation 
methods will be highlighted, notably 2D electrophoresis for whole proteins 
and HPLC for the low-molecular-weight fraction of proteins and peptides or 
for protein digests. 
 
3.1. 2D Gel Electrophoresis of Proteins in Body Fluids 
The presence of a few high-abundance proteins in most body fluids poses a 
problem for 2D electrophoresis. 2D gels have a limited loading capacity of 
some hundred micrograms of total protein, which makes the detection of 
medium- to low-abundance proteins difficult if not impossible unless the 
sample is prefractionated. Considering that albumin in serum represents 40 
mg/mL of the 80 mg/mL total protein concentration and that established 
tumor markers circulate at concentrations of a few ng/mL or even less, it is 
clear that applying, for example, 500 μg of total protein to a gel (corresponding 
to approximately 6 μL of serum) will yield only about 10 pg (approximately 
0.12 fmol for a protein of 50 kDa) of a given tumor marker in the original 
sample. Even assuming a recovery of 100%, this is clearly below the detection 
level of any protein staining technique and definitely an amount that cannot be 
identified by in-gel digestion and MS. Without any enrichment or 
prefractionation, 2D electrophoresis will not be able to reveal  proteins at 
concentrations much below the μg/mL range, an area that is largely occupied 
by well-known plasma or serum proteins that are likely not relevant as disease-
specific biomarkers (Figure 3) [8,133]. 
One way to enhance the capacity of 2D electrophoresis to detect proteins at 
lower concentrations is to remove high-abundance proteins selectively.  An 
affinity column developed to deplete the six most abundant proteins from 
serum resulted in a reduction in total protein by about a factor of 10 [50]. The 
effect of this removal step on 2D electrophoresis can be appreciated in Fig. 7, 
which shows that after depletion a range of proteins become visible. However, 
increasing the loading capacity by a factor of 10 is not sufficient to  reach into 
the ng/mL concentration range for complex body fluids like serum. 
Another strategy to cover more of the low-abundance proteins is to enrich 
some of them specifically. This is naturally at the expense of losing the 
overview over the proteome and thus potentially missing relevant markers. 
Enrichment depends critically on the selection of appropriate ligands in Introduction 
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combination with stationary phases of low nonspecific protein binding. Both 
requirements are not easily met but it is often the elimination of nonspecific 
binding that poses the greatest problems. As an example of the effect of 
nonspecific binding, Figure 9 shows the binding kinetics of a metalloprotease 
to controlled porosity glass beads (with or without silanization to render the 
surface more hydrophilic) and to the silanized beads containing an 
immobilized metalloprotease inhibitor. 
Prefractionation of the sample is another option to reduce complexity prior 
to 2D electrophoresis, at the expense, however, of having to run multiple gels 
for a single sample. This is often not a viable option owing to the work-
intensive nature of 2D gels. An alternative is to select narrow pH ranges to 
visualize only that part of the proteome that does not coincide with the high-
abundance proteins. Unfortunately, most serum proteins have similar 
isoelectric points between pH 5 and 6 (see  Figure 7), making fractionation 
difficult. More recently, prefractionation by preparative in-solution isoelectric 
focusing has emerged as a first step in body fluid analysis prior to 2D 
electrophoresis and also chromatography [134]. This approach has the 
advantage that proteins are fractionated based on a clear-cut physicochemical 
parameter, their isoelectric point, but multiple fractions still need to be 
analyzed, meaning that an efficient, preferably automated method should be 
used downstream [135]. The possibilities of prefractionating [136] proteins in 
depleted serum/plasma on a newly developed “Macroporous Reversed-Phase 
C18 High-Recovery Protein Fractionation HPLC column (mRP)” prior 
digestion and analysis (Agilent, www.agilent.com/chem, Agilent technologies 
publication 5989-250EN) will be described in chapter VI.  
 
3.2. LC-MS of Proteins and Peptides in Body Fluids 
Based on the above discussion, it is obvious that 2D electrophoresis is not 
the method of choice for analyzing large series of clinical samples in quest of 
new disease-specific markers. Consequently, other methods have been sought 
to reduce the workload of 2D gels, methods that make use of automated 
equipment. In addition to the already described direct combination of sample 
preparation on protein chips or magnetic beads with MS, there is increasing 
interest in the combination of online sample preparation with LC (LC-MS). In 
the following two examples, a focus on the low-molecular weight part of the 
body fluid proteome (also referred to as the peptidome) and the shotgun 
proteomics approach requiring proteolytic digestion will be highlighted. 
Indeed, there are many possibilities of integrating sample preparation with the 
ensuing separation, but these two approaches may serve as examples. 
 
3.2.1. Peptidomics 
Dividing the proteome of body fluids into a high- and a low-molecular 
weight fraction (the so-called peptidome [14,137-140]) is an approach to detect Chapter I 
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lower abundance small proteins and peptides. Although it is restricted to a 
certain molecular weight range, the peptidome contains extensive information 
about processes in the organism that may be relevant for diagnosis and follow-
up of therapy. This is a deliberate choice of sample pretreatment, eliminating 
most of the high-abundance serum or plasma proteins. An additional 
advantage of focusing on the molecular weight region below 15 to 20 kDa is 
that these molecules are more easily separated and recovered by reversed-
phase HPLC (RP-HPLC), which is the preferred method for coupling to MS. 
There are a number of techniques that allow elimination of the fraction of 
the proteome above approximately 20 kDa, such as ultrafiltration, precipitation 
with acids or organic solvents or the combination of ultrafiltration with 
adsorption chromatography (e.g., RAM chromatography) [15,16]. Full 
integration of all analytical steps in an automated system is often desirable for 
biofluid analysis in a clinical or biomedical environment to increase 
throughput, reduce the need for skilled personnel, and increase 
reproducibility. Furthermore, documentation is often facilitated by using an 
integrated, fully automated analytical system. Combining the “unit operations” 
of sample pretreatment, separation, and detection in the case of peptidomics 
was achieved in a system described by Wagner et al. [17]  and further 
developed by Machtejevas et al. [18]. Figure 11 shows the instrumental setup 
combining selection of the peptidome from human hemofiltrate by RAM 
chromatography followed by prefractionation on a strong cation exchanger 
and finally separation by RP-HPLC. 
Although this setup was not coupled online to a mass spectrometer, 
analysis of selected fractions after RP-HPLC by MALDI-TOF-MS showed that 
complexity of the original hemofiltrate had been reduced to such a level that 
most of the fractions contained one major peptide or small protein (Figures 12 
and 13). Introduction 
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Figure 11. Schematic diagram of an online comprehensive 2D HPLC system including an 
integrated sample preparation step by restricted access chromatography. Strong cation-exchange 
HPLC is used in the first dimension (IEX) followed by rapid reversed-phase (RP) HPLC on four 
nonporous particle-packed columns working in parallel. Reproduced with permission from 
Machtejevas E, John H,Wagner K, et al. Automated multi-dimensional liquid chromatography: 
sample preparation and identification of peptides from human blood filtrate. J Chromatogr B 
2004;803:121–130. Chapter I 
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Figure 12. Selected reversed-phase chromatograms from human hemofiltrate processed through 
the integrated, multidimensional chromatography system shown in Fig. 11. Numbered and 
marked peak fractions 1 to 10 were selected for MS analysis. Reproduced with permission from 
Machtejevas E, John H, Wagner K, et al. Automated multi-dimensional liquid chromatography: 
sample preparation and identification of peptides from human blood filtrate. J Chromatogr B 
2004;803:121–130. 
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Figure13. MALDI-TOF mass spectra of selected peaks from the reversed-phase HPLC fractions 
shown in Fig. 12. Spectra (A), (B), (C), and (D) correspond to peak fractions 4, 7, 8, and 9, 
respectively. Measurement was performed in the linear mode with positive ionization using a 
matrix of α-cyano-4-hydroxycinnamic acid mixed with fucose. The peak at m/z  =3914.4 is an 
internal standard. Reproduced with permission from Machtejevas E, John H, Wagner K, et al. 
Automated multi-dimensional liquid chromatography: sample preparation and identification of 
peptides from human blood filtrate. J Chromatogr B 2004;803:121–130. 
 
3.2.2. Shotgun Proteomics 
Applying HPLC separation to the high-molecular-weight region of the 
proteome requires prior proteolytic digestion, since most complex proteins are 
not stable under the denaturing conditions of RP-HPLC and are thus not 
quantitatively recovered. In addition, it is not possible to identify proteins 
based on their molecular weight only, and fragmentation of large proteins is 
impossible in most commonly employed mass spectrometers. 
This has led to the shotgun proteomics approach, whereby the entire 
proteome is first digested with trypsin followed by one- or two-dimensional 
chromatographic separations of the peptides [20-23]. Most of the observations 
about high-abundance proteins masking those of lower abundance that were Chapter I 
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made with respect to 2D electrophoresis also apply to the shotgun method. 
This is partially because of the limited loading capacity of the chromatographic 
columns, especially when nanoLC-MS (loadability in the ng–μg range) is the 
final analytical step. Removing high-abundance proteins by affinity 
chromatography prior to digestion is one way of increasing the loading of 
medium- and low-abundance proteins. The effect of depletion of albumin on 
the detection of a tryptic peptide derived from α1-antitrypsin, whose 
concentration in serum is about 20-fold lower, shows the clear improvement 
even for a protein that is still considered to belong to the high-abundance class 
(Fig. 6). Depleting high-abundance proteins and notably albumin can also have 
drawbacks, however, as albumin is known to bind and carry numerous 
compounds including small proteins and peptides that may be co-depleted. 
Zhou et al. [37] showed, for example, that albumin binds some 210 proteins 
and peptides, which could be identified in the albumin-containing fraction 
after depletion. In some of our own studies, we observed that a small protein 
added as an internal standard (horse heart Cytochrome C) at pmol/μL 
concentrations was co-depleted to leave about 25% [61] of the original amount 
when the six most abundant proteins were removed by affinity 
chromatography. It is important to note that although depletion removes some 
other proteins and peptides, this seems to be rather reproducible, at least when 
judged from the results with horse heart Cytochrome C (the relative standard 
deviation of peak areas without normalization is 10–30%) and our recent data 
with a large series of serum samples from prostate cancer patients [28]. 
The enormously complex mixture generated by shotgun proteomics 
usually requires multiple separation dimensions prior to MS. This has inspired 
researchers to develop novel ways of performing “coupled column” HPLC   
multidimensional protein identification technology (MudPIT) [21]  or the 
integrated setup outlined in Fig. 11. Because analysis of individual fractions 
from earlier dimensions in such a multidimensional HPLC approach requires 
12 to 24 h per sample, more efficient and rapid separation methods are under 
development. One of them is based on reducing the particle diameter of the 
chromatographic materials to 1-2 μm, which results in rather high 
backpressures that can only be delivered by special HPLC equipment [141-
144]. Other approaches are based on monolithic materials that support very 
high linear flow rates at pressures amenable to common HPLC equipment 
[24,145-149] or the use of pellicular stationary phases also at elevated 
temperatures [150-153]. These developments show that in addition to the major 
advances in MS, which have made proteomics as we know it today possible, 
there is also considerable activity in the fields of sample preparation and 
separation methodology. It is only through integration of these unit operations 
into an analytical strategy that the challenges of body fluid analysis can be 
tackled and possibly the entire dynamic range covered. Much remains to be 
done. Introduction 
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4. Conclusions 
Proteomics of body fluids is a rapidly expanding field driven by the search 
for better biomarkers for disease diagnosis, follow-up on therapy and 
evaluation of the response of patients to newly developed pharmaceuticals. 
The analysis of body fluids has a long tradition in clinical chemistry and serves 
to support decision making by clinicians in many respects. Because of recent 
methodological developments in separation science, MS, and bioinformatics, 
there has been a surge of efforts to apply them to biomarker discovery, often 
focusing on biomarker patterns rather than individual molecules. Sample 
preparation, the indispensable and very critical first step in an analytical 
method, has attracted less attention, and its relevance is often underestimated. 
As outlined in this chapter, the approach to sample preparation is an important 
decision of strategic relevance for the ensuing analyses. It is therefore pivotal to 
weigh the pros and cons of each approach in light of the final goal. We hope 
that the overview given in this chapter will guide the reader in this complex 
methodological field.  
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Chapter I.III  
 
Label-Free Proteomics of Serum 
 
N.I. Govorukhina, P. Horvatovich and R. Bischoff 
Book chapter in: Functional Proteomics, the Humana Press (Totowa, New 
Jersey, USA), in press (2007). 
 
1. Introduction 
 
The comparative analysis of serum samples from patients and healthy 
controls requires highly standardized operating procedures that produce 
reproducible data [1]. The generated data need to be processed in a manner to 
bring the significant, disease-related differences in protein or peptide profiles 
forward and to reduce non-related noise [2]. Processed data have to be 
analyzed in a statistically rigorous fashion and subjected to both statistical and 
biological validation. 
In this chapter we present a protocol to perform proteomics of serum 
samples obtained from cancer patients but the protocol is generic enough to be 
also applicable to sera from patients with other diseases. This is obviously just 
one way of proceeding and there are quite a number of other approaches, some 
of which can be found in this series. In order to enhance the concentration 
sensitivity of this method, we remove high-abundance proteins by 
immunoaffinity chromatography. We have recently shown that this can be 
done efficiently and with high repeatability [3,4]. The subsequent trypsin 
digestion step and reversed-phase HPLC-MS analysis are performed in a 
reproducible manner and controlled with standard samples at regular 
intervals. Concentration sensitivity of this method is app. 0.5 μM for the added 
Cytochrome C. In order to enhance concentration sensitivity further, it is 
optional to include an additional protein separation step. We describe the use 
of a recently developed reversed-phase material that can be run at 80°C [5].  
Although we touch upon data processing and statistical analysis, we 
cannot go into the methodological details due to limited space. We refer the 
reader to the cited references as well as to a dedicated book in this series 
focusing on bioinformatics. 
 
2. Materials  
 
2.1. Depletion of the 6 most abundant proteins  on a Multiple Affinity 
Removal column 
1. Store serum samples at -80ºC in aliquots. 
2. Buffer A (# 5185-5987, Agilent, Palo Alto, California, USA). Introduction 
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3. Buffer B (#5185-5988, Agilent,  Palo Alto, California, USA). 
4. 0.22 µm spin filters (Part # 5185-5990, Agilent).  
5. Multiple Affinity Removal column (Agilent, 4.6 x 50 mm, Part # 5185-5984 
Palo Alto, California, USA). 
 
2.2. SDS-PAGE  
1. All chemicals for Polyacrylamide gel were from BIO-RAD (Bio-Rad, 
www.biorad.com) 
2. PageRuler TM Prestained Protein Ladder (Fermentas, #SM0671)  
3. Coomassie Brilliant Blue R concentrate (Sigma, www.sigmaaldrich.com). 
 
2.3. HPLC-MS 
1. Atlantis™ dC 18 (1.0 x 150 mm, 3 μm) column for cap-LC-MS, (Waters, 
Milford, Massachusetts, USA, www.waters.com). 
2. Atlantis™ dC 18 in-line trap column for cap-LC-MS (Waters, Milford, 
Massachusetts, USA, www.waters.com). 
3. Chip for chip-LC-MS with a 40 nl trap column (75 µm × 11 mm) and a 75 µm 
× 43 mm analytical column both containing C-18SB-ZX 5 µm chromatographic 
material (Cat. # G4240-62001, Agilent, Palo Alto, California, USA). The chip is 
equipped with a nanoelectrospray tip of 2 mm length with conical shape: 100 
µm OD × 8 µm ID. 
4. Micro BCATM protein assay reagent kit  (www.piercenet.com). 
5. Sequencing-grade modified trypsin (Promega, Cat# V5111, U.S.A.). 
6. Acetonitrile HPLC-S (ACN) gradient-grade was from (Biosolve, 
Valkenswaard, The Netherlands). 
7. Formic acid, FA, 98-100% pro analysis (Cat# 1.00264.1000., Merck, 
Darmstadt, Germany). 
8. Ultra-pure water (conductivity: 18.2 MΩ), Maxima System (Elga Labwater, 
Ede, The Netherlands). 
 
2.4. Pre-fractionation of depleted serum on an mRP-C18 Macroporous 
Reversed-Phase column  
1. Macroporous Reversed-Phase mRP-C18 column (Agilent, 4.6 x 50mm, Part # 
5188-5231 Palo Alto, California, USA). 
2. Trifluoroacetic Acid, TFA, sequencing grade (# 28902, Pierce). 
3. Ultra-pure water (conductivity: 18.2 MΩ), Maxima System (Elga Labwater, 
Ede, The Netherlands). 
4. Urea (#084K0063, Sigma, www.sigmaaldrich.com) 
5. Glacial acetic acid (Cat#1.00063.1000, Merck, Darmstadt, Germany) 
6. Solvent A for mRP column (97% water/0.1% TFA) 
7. Solvent B for mRP column (97% AcN/0.1% TFA) 
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3. Methods 
3.1. Preparation of Samples 
 
1. Mix 20 μL of crude serum with 80 µL of buffer A (Agilent). Filter through 
0.22 µm spin filters at 13000g and 4˚C for 10 min to remove particulates.  
2. Inject 80 µL (80% of the total amount of diluted crude serum) on a Multiple 
Affinity Removal column for depletion according to the manufacturer’s 
instructions (with detection at 280 nm using the following timetable: 0-9 min, 
100% buffer A (0.25 mL/min); 9.0-9.1 min, linear gradient 0-100 B % (1 
mL/min), 9.1-12.5 min, 100% buffer B (1 mL/min); 12.5-12.6 min, linear 
gradient 100-0% buffer B (1 mL/min); 12.6-20  min, 100% buffer A (1 mL/min). 
Removal of abundant proteins, as described above, was performed on a 
LaChrom HPLC System (Merck Hitachi, www.merck.com) or on an AKTA 
FPLC system (GE Healthcare). 
3. Collect the flow-through fraction (depleted serum collected between 2-6 min) 
of a total volume of appr. 1 mL.  
4. Determine protein concentrations with the Micro BCATM protein assay 
reagent kit (www.piercenet.com) and calculate for an average protein 
molecular weight of 50 kDa. Use BSA as the calibration standard. 
5. Digest 100 µL (~10% of the total amount, which corresponds to ~8 µg or 160 
pmol of total protein) of depleted serum with trypsin (1:20 wt/wt enzyme to 
substrate) at 37oC overnight with shaking at 400 rpm. 
 
3.2. SDS-PAGE  
1. SDS PAGE was  performed in a Mini-Protein III cell (Bio-Rad, 
www.biorad.com) using 12%  gels with 0.1% SDS according to the 
manufacturer’s instructions. 
2. Boil samples with sample buffer containing 0.02 M DTT for 1 min, cool down 
and apply directly to the gel. 
3. Perform staining with Coomassie Brilliant Blue R concentrate (Sigma, 
www.sigmaaldrich.com) diluted and used as instructed by the manufacturer. 
 
3.3. HPLC-MS 
3.3.1. Capillary- and chip-LC-MS 
1. All LC-MS analyses were performed on an Agilent 1100 capillary (cap) 
HPLC system coupled on-line to an SL ion-trap mass spectrometer 
(www.home.agilent.com). In the case of cap-LC-MS, the instrument was 
equipped with an Atlantis™ dC 18 (1.0 x 150 mm, 3 μm) column that was 
protected by an Atlantis™ dC 18 in-line trap column. 40 µL of the pretreated 
(depleted and digested) serum corresponding to ~8 µg or 160 pmol of total 
protein digest (calculation based on a 50kDa protein) were injected. An 
autosampler (cat. # G1367A) equipped with a 100 µL injection loop was used 
for cap-LC-MS. For chip-LC-MS the same mass spectrometer was used but Introduction 
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equipped with a microfluidics (chip-cube) interface (cat. # G4240A) including a 
chip microfluidic device. The injected sample amount was 0.25 µg (3.4 - 5.1 µL; 
5 pmol) of depleted, trypsin-digested serum, 10-times diluted with 0.1% aq. 
FA. Injections were performed with an autosampler (Agilent, cat. n° G1389A) 
equipped with an injection loop of 8 µL (this includes also the dead volume up 
to the trapping column). In both case, the autosampler was temperature-
controlled using a cooler (cat. # G1330A) maintaining the samples at 4°C. 
The HPLC system for cap-LC-MS had the following additional modules: 
capillary pump (cat. #, G1376A), solvent degasser (cat. #, G1379A), UV detector 
(cat. # G1314A) and column holder (cat. #, G1316A). The sample was injected 
and washed in the back-flush mode for 30 min (0.1% aq. FA and 3% acetonitrile 
at a flow-rate of 50 µL/min). Peptides were eluted in a linear gradient from 0 to 
70% (0.5%/min) acetonitrile with 0.1% formic acid at a flow-rate of 20 µL/min. 
After each injection the in-line trap and the analytical column were 
equilibrated with eluent A for 20 min prior to the next injection. 
The chip-LC-MS system contained the following additional modules: 
nanopump (cat. n° G2226A), capillary loading pump and solvent degasser. The 
sample was injected and washed in the back-flush mode for 4 min (0.1% aq. 
FA, 2 µL/min) and then the on-chip trapping column was switched in-line 
with the analytical column on the microfluidics device. For these separations, 
the same eluents A and B as for the cap-LC-MS system were used at a flow-rate 
of 0.3 µL/min. After elution for 6 minutes with eluent A, a linear gradient from 
0 to 50% eluent B at 0.5 %/min followed by a step gradient from 50 to 70% at 1 
%/min of eluent B was run. 70% eluent B was maintained for 10 min. After 
each injection, the in-line trap and the analytical column were equilibrated with 
eluent A for 20 min at 2 and 0.3 µL/min, respectively. 
2. In the MS acquisition parameters only the ionization voltage and the use 
of nebulizer gas were different between the two systems (1800-2000 V of 
ionization voltage and no use of nebulizer gas for chip-LC-MS; 16.0 psi N2 
nebulizer gas and 3500 V of ionization voltage for cap-LC-MS). The following 
general settings were used for mass spectrometry during LC-MS: drying gas: 
6.0 L/min N2, skimmer: 40.0 V, cap. exit: 158.5 V, Oct. 1: 12.0V, Oct. 2: 2.48 V, 
Oct. RF: 150 Vpp (Voltage, Peak Power Point), Lens 1: -5.0 V, Lens 2: -60.0 V, 
Trap drive: 53.3, To: 325o, Scan resolution: enhanced (5500 m/z per second scan 
speed). Target mass: 600. Scan range: 100-1500 m/z. Spectra were saved in 
centroid mode. LC-MS chromatographic data were analyzed with Bruker 
Data Analysis software, version 2.1 (Build 37). 
 
3.3. Data Processing 
The original Bruker Daltonics LC-MS data files were converted into ASCII-
format with the Bruker data analysis software. For further data analysis Matlab 
(version 7.2.0.232 (R2006a), Mathworks, Natick, Massachusetts, USA) and the 
PLS toolbox (version 3.5.2, Eigenvector Research Inc., Wenatchee, Washington, Chapter I 
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USA) were used. Centroid data were smoothed and reduced using a 
normalized two-dimensional Gaussian filter with rounding of the nominal 
m/z ratios to 1 m/z (the original data had a resolution of 0.1 m/z). After 
meshing the data files of all chromatograms, they were time-aligned to a 
reference data file using Correlation Optimized Warping (COW) based on 
Total Ion Currents (TICs) constructed from signals in the range 100-1500 m/z. 
A modified M-N rule was applied for peak detection by first calculating a 
median local baseline using a sliding window technique separately for each 
m/z trace. A median window size of 1200 data points, corresponding to 20.84 
min for chip-LC-MS and 20.17 min for cap-LC-MS, was used with a moving 
rate of 10 points and a minimum median value of 200 counts. According to the 
M-N rule, a threshold of M-times the local baseline was used and a peak was 
assigned if, within one m/z trace, the signal exceeded this threshold for at least 
N consecutive points. For each detected peak the m/z value, the mean 
retention times of the three highest measured intensities (within the same peak 
reduced by the local baseline) were stored in a peak list created for every 
chromatogram. 
In order to combine the peak lists from different samples with each other, 
one-dimensional peak matching was achieved by using the sliding window 
technique, in which the same m/z traces were evaluated for peaks that are 
proximate in time (step size 0.1 min; search window 1.0 min; maximal accepted 
standard deviation for all retention times within a group of matched peaks was 
0.75 min). Missing peak locations were filled with extracted local signals 
reduced with the local baseline at a given m/z retention time location. The 
generated peak matrix, created from the peak lists of the individual samples, 
consisted of a peak(row)-sample(column)-intensity(value) matrix. This peak 
matrix was used for multivariate statistical analysis. 
A Nearest Shrunken Centroid (NSC) supervised classification algorithm in 
conjunction with leave-one-out cross-validation (LOOCV) was applied to select 
the most discriminating compounds. The selected compounds were then 
subjected to autoscaled Principal Component Analysis (PCA) and visualized 
using biplots of the first two principal components. All data processing and 
statistical analyses were done on a personal computer equipped with a dual 
core +3800 MHz AMD 64 X2 processor equipped with 4 GB of RAM. Figure 1 
shows an example of data obtained by chip- and capillary-LC-MS. 
 
3.4. Pre-fractionation of depleted serum by reversed-phase HPLC on an mRP 
column at 80°C 
1. Add to ~300μg (about 300μL) of depleted serum 0.48 g urea and 13μL of 
glacial acetic acid, according to the manufacturer’s instructions 
(www.agilent.com/chem/bioreagents).  
2. Add solvent A to a final volume of 1mL and inject the total volume with a 
1mL loop onto the column. Introduction 
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3. Fractionate at 80 o C (pH <5.0) at a flow rate of 0.75mL/min with UV 
detection at 280nm. 
4. Run gradient from 3 to 30% B in 6 min, to 55% solvent B in 40 min and up to 
100% in 53 min. 
5. Collect fractions of 0.75mL (see Figure 2a). 
6. Compare fractions after pre-fractionation by SDS-PAGE (in our case pair-
wise before and after medical treatment for each patient) (see Figure 2b). 
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Figure 1. Raw LC-MS data of depleted and trypsin-digested serum analyzed by chip- (a)  or 
capillary LC-MS (b) represented as “heat map”. The horizontal axis represents the m/z values in 
amu and the vertical axis shows the retention time in min. Peak intensity is coded as indicated 
(white: high; black: low). Panels (c) and (d) show the same data in the conventional representation 
as Total Ion Chromatograms (TICs). The dashed lines depict the calculated baseline. Data were 
collected in centroid mode and meshed using a data reduction of 1:10. 
 Chapter I 
  55
0.0
5.0
10.0
15.0
20.0
25.0
mAU
15.0 20.0 25.0 30.0 35.0 ml
11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
15.0 20.0 25.0 30.0 35.0 ml
11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
Fractions: 31A 31B MW kDa 30A 30B
170
130
100
70
55
40
35
25
170
130
100
70
55
40
35
25
31A 31B MW kDa 30A 30B 31A 31B MW kDa 30A 30B
170
130
100
70
55
40
35
25
170
130
100
70
55
40
35
25
0.0
5.0
10.0
15.0
20.0
25.0
mAU
15.0 20.0 25.0 30.0 35.0 ml
11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
15.0 20.0 25.0 30.0 35.0 ml
11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
Fractions: 31A 31B MW kDa 30A 30B
170
130
100
70
55
40
35
25
170
130
100
70
55
40
35
25
31A 31B MW kDa 30A 30B 31A 31B MW kDa 30A 30B
170
130
100
70
55
40
35
25
170
130
100
70
55
40
35
25
 
Figure 2. (a) 300 μg of depleted serum were pre-fractionated on an mRP column at 80oC (example 
of a sample from a cervical cancer patient before treatment). (b) 12% SDS-PAGE of serum from a 
cervical cancer patient before “A” and after “B” medical treatment. 30A and 31A: fractions 30 and 
31 from the mRP column of patient serum before medical treatment; 30B and 31B: fractions 30 and 
31 of the serum from the same patient after treatment. Note the clear difference at about 35 kDa in 
fraction 30.  
 
 
4. Notes 
Prefractionating proteins in depleted serum/plasma on a newly developed 
“Macroporous Reversed-Phase C18 High-Recovery Protein Fractionation 
HPLC column (mRP)” prior to digestion is reproducible and enables high 
resolution to be achieved. High protein recoveries allow the complexity of the 
sample to be significantly reduced. Robustness and high recovery mRP 
fractionation makes higher-quality protein identification by coupled LC-MS 
methods [5]. Based on our experiences and the work of Martosella et al. [5], 
elevated mRP column temperature (80 degrees C) is a very critical operational 
parameter, while poor control of the temperature could result in poor 
reproducibility and bad chromatographic resolution. 
The performance of the described methodology was evaluated by 
comparing the ability of cap- and chip-LC-MS to find discriminating features. 
For this purpose, 5 serum samples, spiked with 21 pmol of horse heart 
C y t o c h r o m e  C  i n  2  µ L  s e r u m ,  w e r e  a n a l y z e d  n e x t  t o  5  n o n - s p i k e d  s e r u m  
samples. Due to losses during immunoaffinity depletion of high-abundance 
proteins, the actual amount of Cytochrome C that was analyzed was 4.2 pmol 
[3], corresponding to about 3% (molar) of the total protein content. The raw 
data obtained were subjected to data processing as described [6], followed by 
supervised classification and selection of discriminating features using the 
Nearest Shrunken Centroid (NSC) algorithm [7]. The shrinkage parameter was 
optimized using a “leave one out” cross validation (LOOCV), strategy with the 
aim of reaching the lowest cross validation error. Although we applied a rather 
low threshold (M = 2, N = 5) for peak picking, which introduced more noise in 
the peak list, a large domain of shrinkage showed no cross-validation error 
(0.90-29.51 for chip- and 0.61-16.80 for cap-LC-MS, Figures 3a and b, 
(b)  (a) Introduction 
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respectively), indicating a robust classification model. Evaluating the 16 most 
discriminating features selected at shrinkages of 10 and 8.5 for chip- and cap-
LC-MS, respectively, resulted in 6 different peptides. Six peptides selected from 
the chip-LC-MS and 5 of the 6 peptides selected from the cap-LC-MS data 
corresponded to in-silico predicted tryptic peptides of horse heart Cytochrome 
C. Figure 3 shows that correct discrimination between spiked versus non-
spiked serum samples was easily possible based on the selected peaks (Figures 
3c and d). PCA analysis of the selected features (Figures 3e and f) revealed that 
almost all variability in the data can be explained by Principal Component 1 
(99% for chip- and 98% for cap-LC-MS). Visualization of the Extracted Ion 
Chromatograms (EICs) of some of the selected peaks (Figure 4) confirmed that 
highly discriminating peaks had been correctly found within the complex 
mixture of digested serum proteins. Figure 4 shows also the generally good 
time alignment using COW. 
The results show that the integration of nanoLC into microfluidic devices 
enables quantitative profiling studies to find protein expression differences 
using  ∼30 times less sample with higher separation efficiency compared to 
capillary LC. Chapter I 
  57
 
 
Figure 3. Representation of the “leave-one out” cross-validation (LOOCV) error and the number of 
selected variables as a function of the shrinkage for chip-LC-MS (a) and cap-LC-MS (b). The 
selected variables, where the shrinkage domain has no cross-validation error, are indicated with 
arrows. For these domains, the selected variables enabled a perfect separation of the two classes 
(see panels (e) and (f)). PCA plots using all peaks obtained with M = 2, N = 5 for chip-LC-MS (c) 
and cap-LC-MS (d), (14091 for chip-LC-MS and 11256 for cap-LC-MS) did, however, not allow 
discrimination between the classes. In the figures PC 1 and PC 2 refer to the Principal Component 
axis 1 and 2. 
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Figure. 4. Examples of Extracted Ion Chromatograms (EICs) of NSC-selected peaks corresponding 
to tryptic fragments of horse heart Cytochrom C from datasets obtained with chip-LC-MS (left) and 
cap-LC-MS (right). The green upper traces were obtained from spiked, the blue lower traces were 
obtained from non-spiked samples. Chapter I 
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Chapter I.IV 
Outline of the thesis 
 
Blood (plasma or serum) and urine can be easily sampled from patients 
and or healthy volunteers and are therefore often the first choice when trying 
to discover novel biomarkers or biomarker patterns to diagnose cancer and 
other diseases. There are, however, drawbacks in using a blood plasma or 
serum such as the masking  of low-abundance by high-abundance proteins and 
the possible effect of sampling and sample handling procedures (e.g. different 
times and conditions for blood clotting). A review of the current techniques 
dealing with blood proteomics in blood is given in Chapter I.I. Practical details 
of the protocol used for analyzing blood serum is given in Chapter I.III. 
The LC-MS method to analyze serum is presented in Chapter II. Two 
sample preparation methods were tested in terms of their efficiency to deplete 
high-abundance serum proteins and how they affect the repeatability of the 
LC–MS analysis. The first method comprised depletion of human serum 
albumin (HSA) on a column that contained dye ligand and immunoglobulin G 
(IgG) on an immobilized protein support followed by tryptic digestion, 
fractionation by cation-exchange chromatography, trapping on a C18 column 
and reversed-phase LC–MS. The second method included depletion of the six 
most abundant serum proteins based on multiple immunoaffinity 
chromatography followed by tryptic digestion, trapping on a C18 column and 
reversed-phase LC–MS. 
Chapter III describes an application of a miniaturized, microfluidics-based 
LC-MS system (chip-LC-MS). It is shown that chip-LC-MS has at least twice the 
resolution of the standard capillary LC-MS method described in Chapter II. 
Two protocols were compared side-by-side. As a control, some samples were 
spiked with horse heart Cytochrome C. Further statistical analysis allowed 
discrimination between control and spiked samples. 
Since blood is a multifunctional, complex  physiological fluid, its state and 
composition will change under the influence of external factors. In Chapter IV 
the influence of clotting time on protein composition of serum samples was 
studied. It appeared that variation in clotting time between 1 and 8 hours had 
only a minor effect on the overall serum composition. However, the 
concentration of fibrinopeptides varied significantly, as expected, since they 
are directly involved in the clotting process. 
Chapter V describes a more comprehensive approach to evaluate the 
influence of various pre-analytical parameters on the serum proteome. We 
applied a factorial design to assess the importance of seven factors, including 
the level of hemolysis, the clotting time, and storage conditions. 
Chapter VI describes the analysis of serum samples from cervical cancer 
patients before and after treatment using the methodology mentioned above, 
followed by data processing and statistical data analysis. While we did not Chapter I 
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discover major changes in the serum proteome using this method, some 
changes in proteins composition were found in samples taken before and after 
medical treatment, the significance of which are being further investigated. It is 
thus demonstrated that the described methods are applicable to highly 
complex body fluids such as serum and that further studies into the relevance 
of the discovered changes of the serum proteome are warranted. 
 Chapter II 
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Chapter II. 
 
Analysis of human serum by liquid chromatography–mass 
spectrometry: Improved sample preparation and data analysis  
 
 
N.I. Govorukhina, T.H. Reijmers, S.O. Nyangoma, A.G.J. van der Zee, R.C. 
Jansen and R. Bischoff 
 Published in Journal of Chromatography A, v.1120, 142-150 (2006). 
 
Abstract 
Discovery of biomarkers is a fast developing field in proteomics research. 
Liquid chromatography coupled on line to mass spectrometry (LC–MS) has 
become a powerful method for the sensitive detection, quantification and 
identification of proteins and peptides in biological fluids like serum. 
However, the presence of highly abundant proteins often masks those of lower 
abundance and thus generally prevents their detection and identification in 
proteomics studies. To perform future comparative analyses of samples from a 
serum bank of cervical cancer patients in a longitudinal and cross-sectional 
manner, methodology based on the depletion of high-abundance proteins 
followed by tryptic digestion and LC–MS has been developed. Two sample 
preparation methods were tested in terms of their efficiency to deplete high-
abundance serum proteins and how they affect the repeatability of the LC–MS 
data sets. The first method comprised depletion of human serum albumin 
(HSA) on a column that contained dye ligand and immunoglobulin G (IgG) on 
an immobilized protein support followed by tryptic digestion, fractionation by 
cation-exchange chromatography, trapping on a C18 column and reversed-
phase LC–MS. The second method included depletion of the six most abundant 
serum proteins based on multiple immunoaffinity chromatography followed 
by tryptic digestion, trapping on a C18 column and reversed-phase LC–MS. 
Repeatability of the overall procedures was evaluated in terms of retention 
time and peak area for a selected number of endogenous peptides showing that Analysis of human serum by LC-MS: Improved sample preparation and data analysis 
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the second method, besides being less time consuming, gave more repeatable 
results (retention time: <0.1% RSD; peak area: <30% RSD). Application of an 
LC–MS component detection algorithm followed by principal component 
analysis (PCA) enabled discrimination of serum samples that were spiked with 
horse heart Cytochrome C from non-spiked serum and the detection of a 
concentration trend, which correlated to the amount of spiked horse heart 
Cytochrome C to a level of 5 pmol Cytochrome C in 2 μL original serum.  
 
1. Introduction  
Various methods have been applied in recent years for the discovery of 
biomarkers or biomarker patterns of major human diseases, especially for 
various types of cancer [1-13]. Surface-enhanced laser desorption ionization 
mass spectrometry (SELDI-MS), which combines on-chip sample preparation 
with mass spectrometric analysis, has become a popular method [14], although 
more recent results question the viability of this approach [15,16]. Liquid 
chromatography coupled on line to mass spectrometry (LC–MS) is one of the 
most widely used analytical methods with applications going beyond 
proteomics and biomarker discovery. It has the advantage of combining 
powerful separation by one- or multi-dimensional chromatography with the 
exquisite selectivity and sensitivity of modern mass spectrometers. The 
complexity of a typical LC–MS data set reaches 108 data points per sample at a 
resolution of 0.1 amu in the m/z domain and a chromatographic run time of 
approximately 2  h (7000 data points). It is thus pivotal to apply data pre-
processing algorithms to reduce data complexity and multivariate statistics to 
reduce dimensionality to be able to compare data sets obtained from 
longitudinal or cross-sectional patient studies comprising significantly less 
samples than the number of original variables in the data.  
Sample preparation is an often underestimated problem in comparative 
biomarker analysis. Notably in serum there are a few highly abundant proteins 
that will prevent detection of many minor proteins present in the sample. Since 
it is unlikely that high-abundance proteins like albumin or transferrin will be 
biomarkers for specific diseases, it is necessary for biomarker discovery 
methodology to detect and quantify proteins present at lower concentrations. 
One way to reduce serum complexity is chromatographic removal of the most 
abundant proteins. In human serum, the most abundant proteins are albumin 
and γ-globulins. Earlier [17], we tested different depletion strategies to reduce 
the level of abundant proteins based on either specific antibodies, dye ligands 
(for albumin) [18] or Protein A and G (for γ-globulins) [19] and [20]. Other 
approaches based, for example, on ultrafiltration showed lower selectivity for 
these target proteins but allowed on the other hand to concentrate the sample 
[21]. Co-depletion of proteins and peptides is a concern when employing such 
depletion strategies [22].  Chapter II 
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LC–MS is particularly adapted to the separation and detection of peptides. 
This has triggered development of the so-called “shotgun” proteomics 
approach [23]. Contrary to proteomics based on two-dimensional 
polyacrylamide gel electrophoresis (2D-PAGE), where the proteins are 
separated prior to tryptic digestion, trypsin digestion precedes the separation 
step. The shotgun approach results therefore in extremely complex mixtures of 
peptides presenting a challenge to any separation methodology. Very high 
efficiency separation systems have recently been applied to this problem, 
allowing identification of a wide range of proteins in plasma or serum [13]. A 
new approach developed recently combines the use of immunoaffinity 
depletion with reversed-phase separation of whole proteins at elevated 
temperatures to reduce sample complexity prior to identification of proteins in 
human serum [24]. This approach allowed, for example, to identify hepatocyte 
growth factor, which is present at a level of 20 ng/mL.  
In this study, we combined efficient depletion of high-abundance proteins 
with LC–MS-based shotgun proteomics followed by data pre-processing to 
select information-rich chromatographic traces based on the CODA algorithm 
[25]. This was followed by multivariate statistical analysis of the selected traces 
by principal component analysis (PCA) to evaluate the performance of the 
method to discriminate samples. Initially we tested two approaches for the 
preparation of human serum for LC–MS analysis. Removal of abundant 
proteins was performed by dye ligand or antibody-based multiple-affinity 
chromatography, which eliminates the six most abundant serum proteins. In 
the case of dye ligand chromatography, a two-dimensional chromatographic 
system was employed consisting of strong cation exchange followed by 
reversed-phase HPLC. Proteins remaining after the multiple-affinity removal 
step were directly digested and analyzed by reversed-phase LC–MS. The 
performance of each approach was assessed in terms of repeatability of 
retention times and peak areas for a selected number of endogenous peptides 
showing that the repeatability of the second method was superior. The 
discriminatory power of this method was assessed by adding decreasing 
amounts of horse heart Cytochrome C to the original serum proving that a 
concentration trend was correctly represented in the first principal component 
after non-supervised data pre-processing and PCA down to a lower level of 
50 pmol Cytochrome C in 20 μL serum. 
 
2. Experimental  
Serum samples were obtained from the Department of Gynecological 
Oncology (University Medical Center Groningen, The Netherlands) and stored 
at  −80  °C in aliquots. All intermediate fractions were stored at −20 °C.  To 
develop and optimize the analytical procedure, serum from a single cervical 
cancer patient with a squamous cell carcinoma antigen-1 (SCCA-1) [26] level of 
2.2 ng/mL (determined by ELISA) was used. Analysis of human serum by LC-MS: Improved sample preparation and data analysis 
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2.1. Sample preparation of human serum  
2.1.1. Method 1 
Two hundred and forty microliters of diluted crude serum (60 μL of crude 
serum mixed with 180 μL of 20 mM NaH2PO4 pH 7.0) were depleted on a 1 mL 
Bio-Rad Aurum Serum Protein (www.biorad.com) column according to the 
manufacturer's instructions. Protein concentrations were determined with the 
Micro BCA™ Protein assay reagent kit (www.piercenet.com) and calculated for 
an average protein molecular weight of 50  kDa. BSA was used as the 
calibration standard.  
An equivalent of 100 μg total protein of depleted serum were digested with 
trypsin (1:20, w/w enzyme to substrate) at 37 °C overnight (sequencing grade 
modified trypsin from Promega, Cat# V5111, USA). One hundred micrograms 
of digested, depleted serum were fractionated by strong cation exchange HPLC 
(Poly  SEA  2.0 mm × 150 mm,  5 μm, 300  Å column, Michrom BioResources, 
Auburn, CA, USA) operated at 0.3 mL/min on a Beckman Gold HPLC system 
(www.beckman.com). The salt gradient ranged from 0 to 1 M KCl with a slope 
of 10  mM/min. The mobile phase comprised two buffers: A: 5  mM 
KH2PO4/H3PO4 pH 3, 25% acetonitrile and B: 5 mM KH2PO4/H3PO4 pH 3, 25% 
acetonitrile, 1  M KCl. The following fractions were collected: #1 (0–50  mM) 
KCl, 17–21 min, #2 (50–100 mM) KCl, 22–26 min, #3 (100–150 mM) KCl, 27–
31 min and #4 (150–200 mM) KCl, 32–36 min. Samples were concentrated by 
vacuum centrifugation (Speed Vac, Univapo 150H, UniEquip, Martinsried, 
Germany) to approximately 1 mL to remove acetonitrile and fractions #3 and 
#4 were pooled together because of their low concentration of peptides. The 
concentrated fractions were passed through a Macro Trap 200 hydrophilic C18 
silica cartridge (ODS-AQ; 3  mm  ×  8  mm; Michrom, USA) for desalting and 
further concentration by loading at 0.3 mL/min followed by a column wash 
with 2 mL of 5% acetonitrile, 0.1% formic acid in H2O. Peptides were eluted 
with 0.5  mL 70% acetonitrile, 0.1% formic acid at a flow rate of 1  mL/min. 
Acetonitrile was evaporated by vacuum centrifugation (Speed Vac) and the 
final volume was adjusted to 150 μL. Pure acetonitrile and pure formic acid 
were added to reach final concentrations of 5% acetonitrile and 0.1% formic 
acid, respectively. All LC–MS analyses were performed on an Agilent 1100 
capillary HPLC system coupled on-line to an SL ion-trap 
(www.home.agilent.com) equipped with an Atlantis™ dC 18 
(1.0 mm × 150 mm, 3 μm) column (www.waters.com). Forty microliters of the 
pretreated fractions corresponding to  8 μg or 160 pmol of total protein digest 
(calculation based on a 50 kDa protein) were injected. Peptides were eluted in a 
linear gradient from 0 to 70% (0.5%/min) acetonitrile with 0.1% formic acid at a 
flow rate of 20 μL/min. 
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2.1.2. Method 2 
Eighty microliters (80% of the total amount of diluted crude serum (20 μL 
of crude serum mixed with 80 μL of buffer A (Agilent)) were depleted on a 
Multiple Affinity Removal column (Agilent, 4.6  mm  ×  50  mm, Part # 5185–
5984) according to the manufacturer's instructions.The flow-through fraction 
(depleted serum collected between 2 and 6  min) of a total volume of 
approximately 1 mL was collected. Protein concentrations were determined as 
in Method 1. One hundred microliters ( 10% of the total amount, which 
corresponded to ~7 μg or 140 pmol of total protein considering a molecular 
weight of 50 kDa) of depleted serum were digested with trypsin (1:20, w/w 
enzyme to substrate) under the same conditions as described in Method 1. All 
LC–MS analyses were performed on the identical LC–MS system (Agilent 1100 
capillary HPLC; SL ion-trap mass spectrometer) except that an in-line trap 
column was used (Atlantis™ dC 18, 3  μm,  2.1 mm × 20 mm  Guard  column 
(www.waters.com)). One hundred microliters depleted and digested serum 
were injected and washed in the back-flush mode for 40 min (0.1% aq. formic 
acid and 3% acetonitrile at a flow rate of 50 μL/min) and eluted on-line to the 
analytical column (Atlantis™ dC 18, 1.0  mm  ×  150  mm, 3  μm column 
(www.waters.com)). Gradient conditions were identical to Method 1. 
 
2.2. Polyacrylamide gel electrophoresis (SDS–PAGE) 
SDS–PAGE was performed in a Mini-Protein III cell (Bio-Rad, 
www.biorad.com) using 12% gels with 0.1% SDS according to the 
manufacturer's instructions. Staining was performed with Coomassie Brilliant 
Blue R concentrate (Sigma, www.sigmaaldrich.com) diluted and used as 
prescribed by the manufacturer. 
 
2.3. Mass spectrometry 
The following conditions were used for mass spectrometry during LC–MS. 
Nebulizer gas: 16.0 psi N2, drying gas: 6.0 L/min N2, skimmer: 40.0 V, cap. exit: 
158.5 V, Oct. 1: 12.0 V, Oct. 2: 2.48 V, Oct. RF: 150 Vpp (Voltage, Peak Power 
Point), Lens 1 : −5.0 V,  Lens  2:  −60.0  V, Trap drive: 53.3, T°: 325°, Scan 
resolution: Enhanced, 5500 m/z per second scan speed. Target mass: 600. Scan 
range: 100–1500  m/z. Spectra were saved in centroid mode. LC–MS 
c h r o m a t o g r a p h i c  d a t a  w e r e  a n a l y z e d  w i t h  B r u k e r  D a t a  A n a l y s i s  s o f t w a r e ,  
version 2.1 (Build 37). 
 
2.4. Repeatability study 
A serum sample from a cervical cancer patient was treated six times with 
Method 1 and five times with Method 2. In Method 2 crude sample of the same 
patient was also spiked with horse heart Cytochrome C (Sigma, 
www.sigmaaldrich.com) before depletion (210 pmol Cytochrome C per 20 μL 
of original serum) and the procedure repeated four times. Analysis of human serum by LC-MS: Improved sample preparation and data analysis 
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2.5. Standard addition of Cytochrome C 
Horse heart Cytochrome C was added to 20 μL of the original serum over a 
range of 25 pmol–1.26 nmol, of which 10% were subjected to the final LC–MS 
analysis to evaluate the discriminatory capacity of Method 2. Cytochrome C 
was alternatively digested with trypsin and added in the same amounts to 
depleted and trypsinized serum (2 μL equivalent) prior to LC–MS to evaluate 
whether the depletion procedure affected the recovery of Cytochrome C. 
 
2.6. Data analysis 
2.6.1. Data pre-processing 
The original Bruker Daltonics LC–MS data files were converted into ASCII-
format with the Bruker Data Analysis software. The original m/z ratios 
(0.1  amu resolution) were combined into 1  amu bins by rounding the m/z 
ratios off to the closest integer values. This reduced the amount of data by 
almost a factor 10 but, more importantly, avoided misclassification of m/z 
traces due to the fact that centroid sampling of the original mass spectra 
introduced a slight error that could lead to misalignment of m/z traces. In 
order to classify the individual m/z traces with respect to their “information 
content”, the component detection algorithm (CODA) developed by Windig et 
al. was applied [25]. This algorithm compares the raw chromatograms with 
their smoothed (using a moving average) and standardized versions. The 
difference between the raw and smoothed chromatogram is small for high-
quality chromatograms (and the “CODA quality score” with a value ranging 
between 0 and 1, is high), while the opposite is true for chromatograms 
containing mainly background noise and/or spikes. By setting a threshold the 
user can define down to which level of quality m/z traces will be considered 
for the subsequent statistical analysis. In our study mass traces with a quality 
value higher than 0.98 were retained for further analysis meaning that only 
about 45 very-high-quality chromatograms were considered. The total ion 
current (TIC) was calculated from all mass traces or from the CODA-selected 
high-quality ones. The latter represented rather well the main characteristics of 
the original TIC, while background noise was essentially eliminated. 
Information of the peaks present in this rather conservative class of mass traces 
turned out to be sufficient for the detection of interpretable patterns in the data, 
for example, separation of spiked from non-spiked samples. 
 
2.6.2. Multivariate statistical analysis 
To perform multivariate statistical data analysis of multiple LC–MS 
samples, information present in the union set of all selected high-quality mass 
traces was used. For each high-quality mass trace in the union set of mass 
traces, the peak with the highest intensity was obtained and entered in a peak 
list. This peak list was further analyzed using principal component analysis. Chapter II 
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PCA is a widely used statistical technique that enables the search for and 
visualization of patterns present in highly multivariate datasets [27]. In this 
study mainly biplots were used to analyze the available LC–MS peak lists. All 
statistical data analysis calculations were performed in the MATLAB 
programming environment (version 3.5.1, release 13). 
 
2.7. Protein identification 
1D nanoLC–ESI–MS–MS analysis was performed on an integrated nanoLC 
system (Agilent) comprising a binar y  g r a d i e n t  p u m p  w i t h  a  c o o l e d  
autosampler, an auxilary pump for loading and washing the trap column, a 
column switching module configured for trap plus analytical capillary column, 
and a Q-Star XL API mass spectrometer (Applied Biosystems, MDS Sciex, 
Framingham, USA) fitted with nano-LC sprayer and operated under Analyst 
QS 1.1 control. Injected samples were first trapped and desalted isocratically on 
an LC-Packings PepMap C18  μ-Precolumn Cartridge (5  μm, 300  μm 
I.D. ×  1 mm; Dionex, Sunnyvale, CA, USA) for 5  min with 0.1% formic acid 
delivered by the auxillary pump at 10 μL/min after which the peptides were 
eluted from the trap column and separated on an analytical C18 capillary 
column (5 cm × 75 μm, Atlantis) connected in-line to the mass spectrometer, at 
250 nL/min using a 90 min gradient of 5–50% acetonitrile in 0.1% formic acid.  
The QStar XL mass spectrometer was operated in information-dependent 
acquisition (IDA) mode. In MS mode, ions were screened from m/z 300 to 1500, 
and MS–MS spectra were acquired from m/z 50 to 2000 (pulsing mode on). In 
standard acquisition mode, each acquisition cycle was comprised of a 1s MS 
and a 1s MS–MS scan. In IDA mode, the four most intense peaks were selected 
and MS–MS spectra acquired when their intensities exceeded 30 counts. In 
product ion mode, MS–MS spectra were acquired for selected precursor ions 
(m/z 619.2, 694.4, 753.5, 682.5 and 909.6) without threshold restriction. 
Acquired MS–MS spectra were searched against the SwissProt/Trembl 
database with a mass tolerance of 1.1 Da for the precursor and 0.15 Da for the 
obtained fragment ions. A hit was considered significant when the score 
exceeded 2.0, which corresponds to a confidence interval of more than 99%. 
 
3. Results 
3.1. Preparation of human serum for LC–MS analysis 
Depletion of high-abundance proteins is one way to enhance the capability 
of proteomic methods to detect subtle changes in the protein profile of human 
serum. Previously we reported on the efficacy of several depletion columns to 
remove albumin and γ-globulins [17]. Method 1 (Figure 1), used here as a first 
approach, is partially based on a previously published protocol, which was 
extended and optimized in the current work. Method 1 relies on dye-ligand 
affinity chromatography to remove albumin and Protein A to remove IgG. Analysis of human serum by LC-MS: Improved sample preparation and data analysis 
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The subsequent steps comprise trypsin digestion and strong cation 
exchange chromatography (SCX) to fractionate the sample prior to LC–MS 
analysis. This method was repeated six-times in order to evaluate the overall 
repeatability. To this end 10 endogenous peptides from three cation-exchange 
fractions that covered the entire retention time range of eluting peptides in 
serum were selected and their respective extracted ion chromatograms 
integrated. While repeatability in terms of retention times was satisfactory 
(RSD  <  0.8%), peak areas differed over a wide range (RSD between 12 and 
160%) (see Table 1). 
 
Figure. 1. Schematic description of two methods for sample preparation and analysis of human 
serum. The main differences between the methods are that Method 1 uses dye ligand affinity 
chromatography and Protein A for depletion of albumin and IgG (Aurum column, BioRad) while 
Method 2 employs a multiple affinity removal column (Agilent) based on a mixture of antibodies 
and Protein A. Method 1 includes a strong cation-exchange prefractionation step, while this step 
was omitted in Method 2.  
 
We argued that the low repeatability with respect to peak area of some 
peptides was due to the cation-exchange prefractionation step, since fraction 
collection from a highly complex chromatogram of partially resolved peaks can 
easily lead to arbitrary cutting of component peaks and thus to major 
quantitative differences. This effect can be depicted in Figure 2A showing six 
repetitions of the final LC–MS analysis using Method 1 clearly indicating two 
groups of three chromatograms. In order to overcome this limitation, we 
improved the efficiency of the depletion step by employing a multiple-affinity 
removal column (removes albumin, IgG, IgA, transferrin, haptoglobin, and α1-
antitrypsin) and eliminating the cation-exchange chromatography step (Figure 
1, Method 2). Visual inspection of the chromatograms showed already that this 
approach was superior in terms of repeatability (Figure 2B). Chapter II 
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Neither retention times nor peak areas were normalized. In bold (Table 1): 
Peaks detected in both methods (m/z 619.2 and 694.4: doubly charged ions of 
peptides [DLATVYVDVDVLK and VSFLSALEEYTK, respectively] from 
apolipoprotein A (accession number (P02647, SwissProt/Trembl); m/z 682.5: 
triply charged ion of [LLLQQVSLPELPGEYSMK] and m/z 753.5: doubly 
charged ion of [AAQVTIQSSGTFSSK] from alpha-2-macroglobulin precursor 
(P01023);  m/z 909.6: doubly charged ion of [SNLDEDIIAEENIVSR] from 
human complement C3 precursor (P01024). 
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Figure. 2.  LC–MS analyses of trypsin-digested serum samples prepared by Method 1 (A) or 
Method 2 (B). Six repetitions of fraction 2 of the strong cation-exchange HPLC pre-fractionation 
step (Method 1) are shown in comparison with five repetitions of Method 2. 
 
 
 
Figure. 3.  SDS–PAGE analysis of human serum prior to (lane 5) and after depletion using the 
multiple affinity removal column (lanes 1–4) or dye ligand/Protein A affinity chromatography 
(lane 6). Albumin is labelled with an asterisk.  Analysis of human serum by LC-MS: Improved sample preparation and data analysis 
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Table 1.Repeatability of Method 1 (six repetitions) and Method 2 (five 
repetitions) (see Figure 2) in terms of retention time and peak area for a 
selected number of endogenous peptides 
 
m/z  Average RT (min)  %RT dev.  Average area  % Area dev. 
Method 1. CEX fraction 1 
 772.1  100.72  0.25  4.9 × 106 36.8 
 472.2  106.20  0.23  3.0 × 107 85.5 
 552.9  108.95  0.79  9.7 × 105 104.8 
 713.8  111.62  0.24  5.4 × 107 50.0 
 682.5  115.25  0.26  7.3 × 106 157.5 
Method 1. CEX fraction 2 
 619.2  99.75  0.05  2.1 × 107 24.0 
 694.4  103.95  0.08  4.1 × 107 11.9 
 753.5  111.62  0.10  9.9 × 107 113.2 
 909.6  114.37  0.12  2.5 × 106 94.1 
Method 1. CEX fraction 3 
 525.1  99.34  0.50  2.2 × 107 73.8 
Method 2. 
 756.7  109.40  0.06  4.5 × 107 13.1 
 753.5  110.78  0.04  3.3 × 107 13.7 
 909.6  113.54  0.08  3.8 × 106 27.5 
 682.5  114.20  0  8.3 × 107 14.1 
 619.2  99.90  0.05  4.4 × 107 20.1 
 694.4  104.20  0.04  2.4 × 107 9.1 
 
 Chapter II 
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An overview of the efficiency of depletion by both methods was obtained 
by SDS–PAGE showing that Method 2 (multiple depletion) was more efficient 
in depleting high-abundant serum proteins (Figure. 3). 
This is in agreement with recently published data using 2D gel 
electrophoresis [28]. While Method 1 removed approximately 70% of total 
serum protein, Method 2 removed 90–95% according to determination of the 
total protein content after depletion. This allowed an increased loading 
capacity of the remaining digested proteins of 10–20-fold on the reversed-
phase column. 
 
3.2. Repeatability 
As indicated in Figure 2, Method 2 resulted in a better repeatability in 
terms of retention times (Method 1: <0.8% RSD; Method 2: <0.1% RSD). This 
may be due to the use of an in-line trap column for sample clean-up and 
focusing. It is noteworthy that retention time differences of five repetitive LC–
MS runs ranged from 0 to 6 s in the case of Method 2 without any alignment of 
the chromatograms. Importantly, Method 2 proved also to be significantly 
more repeatable with respect to the observed peak areas for identical, selected 
endogenous peptide peaks (Method 1: 12–160% RSD; Method 2: 10–30% RSD). 
This was particularly for those peptides that showed large standard deviations 
with Method 1 (Table 1). This may be attributed to the significantly reduced 
number of sample preparation steps and in particular elimination of the 
fraction collection step by strong cation-exchange HPLC. 
To estimate the repeatability of the developed methods on a more global 
scale, CODA was applied to all measured replicates. So instead of limiting 
ourselves to 6–10 univariate repeatability measures, all CODA-selected mass 
traces were used to compare the methods. Figure 4 displays the calculated 
CODA quality scores for the different mass traces of the replicates prepared 
according to sample preparation Method 1 (top) or Method 2 (bottom). 
Since the image plots of the first, second and third SCX fraction gave 
similar results, only the quality values of the second fraction are visualized. 
While for Method 2 the quality values of the different replicates are higher and 
very similar over the whole m/z range, Method 1 shows far less repeatable 
quality values. Replicates 2, 3 and 6 (Method 1) differ significantly from 
replicates 1, 4 and 5 (see also Figure 2). This result is confirmed after 
application of PCA to the peak lists generated from the high quality mass 
traces (CODA score > 0.98) selected by CODA. In the scores plot (not shown 
here) the replicates separate into two groups: a group containing replicates 2, 3 
and 6 and a group with replicates 1, 4 and 5. Such analytical variability may 
interfere with detecting patterns of samples when analyzing patient sera or 
indicate false clusters. Analysis of human serum by LC-MS: Improved sample preparation and data analysis 
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Figure. 4. Image plots showing the colour-coded CODA quality scores of the different mass traces 
(m/z 100–1500). High-quality values are red (in web version) and low-,quality values are blue (in 
web version). The image plot at the top displays quality values for the 6 replicates (the second 
fraction is displayed) using Method 1 (see Figure 2A). The image plot at the bottom shows the 
quality values of 5 replicates measured using sample preparation Method 2 (see Figure 2B).  
 
3.3. Data analysis 
In view of trying to discover differences in the abundance of peptides 
amongst samples from cancer patients at various stages of disease, it is pivotal 
that baseline variations are kept to a minimum due to methodological 
variability. Thus, Method 2 was chosen for further work. In an effort to 
evaluate the discriminatory capacity of the analytical and data analysis 
methodology, 210 pmol of horse heart Cytochrome C were added to 20 μL of 
the original serum sample and analyzed with Method 2 as described above. 
LC–MS data was acquired for in total four replicate samples spiked with 
Cytochrome C and five non-spiked replicates. Peak lists for all 9 LC–MS data 
files were obtained after application of the binning algorithm and usage of 
CODA. Figure 5 summarizes the results of PCA of the union peak list. The 
biplot shows besides the scores of the nine samples (4 spiked samples = red Chapter II 
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diamonds, five normal samples = blue squares) also the loadings of the high 
quality mass traces (45 mass traces = green triangles) that were used for the 
statistical analysis. In Figure 5A the spiked samples are clearly separated from 
the normal (non-spiked) samples. Especially m/z traces 483, 748 and 965 
contribute significantly to the discrimination of the spiked from the normal 
samples (Figure 5B). All of these m/z values are related to tryptic peptides of 
Cytochrome C (the m/z values of 483 and 965 correspond to doubly and singly 
charged ions of the same peptide). 
 
 
 
Figure 5. (A) Principal component analysis (PCA) biplot of trypsin digested, depleted human 
serum samples with 210 pmol spiked horse heart Cytochrome C in 20 μL serum (red diamonds) 
and without Cytochrome C (blue squares) after selection of high quality mass traces with CODA 
using a threshold of 0.98. Note that the recovery of Cytochrome C after depletion is only 20–25% 
(see Table 2). The used high quality mass traces are indicated by the green triangles. (B) Enlarged 
part of the boxed area in (A) showing that peaks at m/z 483, 965 and 748 contribute strongly to the 
discrimination between spiked and non-spiked. All of these peaks are derived from Cytochrome C. 
 
Since depletion of high-abundance proteins, notably albumin, has been 
reported to lead to co-depletion of other proteins, peptides and metabolites 
that are bound to albumin [21,22], we investigated the recovery of the added 
Cytochrome C from 20  μL serum of a cervical cancer patient (same patient 
serum as used before) after depletion. For comparison, an equal amount of a 
tryptic digest of Cytochrome C was added to the depleted and digested sample 
just prior to LC–MS analysis. Both analyses were repeated nine-times and the 
average peak areas for five selected m/z traces from peptides related to horse 
heart Cytochrome C were compared. A comparison of peak areas of 
Cytochrome C added to the original serum or added just prior to LC–MS 
analysis, revealed that 19–27% of spiked Cytochrome C were recovered 
following multiple affinity removal of high-abundance proteins (Table 2). 
Recoveries on the same order were also found when 10–63  pmol of 
Cytochrome C were spiked into 20 μL serum. The repeatability of the peak 
areas of spiked Cytochrome C was between 12 and 26% RSD (not shown) and Analysis of human serum by LC-MS: Improved sample preparation and data analysis 
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thus within the same range as relative standard deviations for other 
endogenous peptide peaks (see Table 1). Repeatability of the initial depletion 
step itself was assessed to be better than 5% RSD in terms of peak area of the 
flow-through fraction of the multiple affinity removal column. 
 
Table 2. Recovery of horse heart Cytochrome C (Method 2) added to human 
serum prior to depletion (210  pmol in 20  μL serum) of high-abundance 
proteins using the multiple affinity removal column (Agilent; depletes 
albumin, IgG, IgA, transferrin, haptoglobin, and α1-antitrypsin) based on 
extracted ion chromatograms (results based on 9 independent experiments 
with and without addition of Cytochrome C) 
 
m/z   Peak area   Recovery %  RSD % (n = 9)  
302.7 1233449  19.1  6.1 
604.4 12538882  27.3  8.6 
482.8 27618370  26.0  10.8 
748.4 39544944  26.4  7.0 
1495.7  504101 20.3  7.5 
    Average recovery 23.8  Average RSD 8.0 
 
To investigate whether loss of Cytochrome C was due to direct binding to 
the affinity column or mediated through binding to high-abundance proteins, 
similar amounts of Cytochrome C were dissolved in Buffer A and applied to 
the multiple affinity removal column. Practically all Cytochrome C was 
recovered showing clearly that binding to high-abundance proteins, most 
likely albumin, was responsible for the loss. Therefore, the actual amounts of 
Cytochrome C applied to LC–MS analysis in the comparative spiking studies 
shown in Figure 5 were about five times lower than the amount originally 
added to the serum sample. These results confirmed the observation that high-
abundance proteins may act as “molecular sponges”, which bind and transport 
low molecular weight proteins or peptides, an effect that needs to be corrected 
for when using spiked internal standards.  
In an effort to evaluate whether Method 2 in combination with CODA and 
PCA could detect a trend in concentration of a protein in serum, different 
amounts of horse heart Cytochrome C (25  pmol–1.26  nmol) were added to 
20 μL of the original serum sample before multiple depletion and 10% of the 
tryptic digest was subjected to LC–MS as described above. In Figure 6 Chapter II 
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multivariate statistical data analysis (PCA) results are displayed of LC–MS 
datasets treated with CODA to generate peak lists based on high-quality mass 
traces (CODA score  >  0.98). These results show that principal component 1 
(PC1), which describes about 89% of the variability in the data, follows the 
concentration trend generated by the added Cytochrome C down to a level of 
5 pmol in the equivalent of 2 μL serum (recalculated for an injection of 10% of 
the original sample). Variability reflected in PC2 (approximately 7%) is not 
correlated with the concentration of Cytochrome C. The serum sample 
containing 2.5 pmol follows the trend described by PC1 but is separated from 
the other samples mainly in PC2 most likely due to variability introduced by 
the analytical procedure. PCA analysis showed again that traces at m/z 483 
and 748, corresponding to peptides derived from Cytochrome C, contributed 
most significantly to the observed trend (see Figure 6). Method 2 combined 
with m/z trace selection by CODA and PCA thus correctly identified 2 m/z 
values that correlated with the observed trend in PC1 and the introduced 
concentrations of Cytochrome C added to the serum. 
 
 
 
Figure 6. Principal component analysis (PCA) biplot of human serum samples spiked with 
increasing amounts of horse heart Cytochrome C (25, 50, 100, 210, 610 and 1260 pmol in 20 μL 
original serum, recalculated for an injected amount corresponding to 10% of the original 2µL). 
Peaks (m/z values) used for PCA (selected by CODA) are shown as red triangles. Peaks with m/z 
483 and 749 contribute strongly to the observed trend in PC1. Both peaks are derived from 
Cytochrome C.  
 Analysis of human serum by LC-MS: Improved sample preparation and data analysis 
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In order to evaluate whether there is a good correlation between the detected 
m/z traces and the amount of added Cytochrome C, a linear correlation 
analysis was performed showing that the peak areas of the extracted ion 
chromatograms at 483 and 748 amu correlated well with the added amounts 
over the studied concentration range (R2 = 0.97–0.99). 
 
4. Discussion 
A procedure for the depletion of high-abundance proteins from human 
serum for subsequent analysis by shotgun proteomics using LC–MS has been 
described. The overall procedure showed a repeatability of 10–30% for peak 
area and better than 0.1% for retention times without the use of internal 
standards or alignment of the chromatograms. Data were pre-processed using 
CODA at a quality score threshold of 0.98 that selects about 45 of the most 
“information rich” m/z traces. This allowed the reconstruction of a TIC  which 
is highly similar to the original raw data, though, with drastically reduced 
background noise. PCA of pre-processed LC–MS datasets obtained after 
spiking different amounts of horse heart Cytochrome C into the original serum 
(range 25 pmol–1.26 nmol in 20 μL serum) revealed the trend in Cytochrome C 
concentrations in Principal Component 1, which described 89% of the 
variability in the data. Determination of recoveries for spiked Cytochrome C 
after depletion using a multiple affinity removal column depleting albumin, 
IgG, IgA, transferrin, haptoglobin, and α1-antitrypsin showed that only 20–25% 
of the added protein were recovered and that this loss was due to the presence 
of high-abundance proteins and not to direct binding to the affinity column. 
The effect of protein co-depletion needs therefore to be taken into account 
when adding internal standards to serum and likely also to other complex 
biological samples. Our data indicate that internal standardization using added 
marker peptides is a viable alternative to stable-isotope labeling for 
quantitative, comparative proteomics but that care needs to be taken to account 
for limited recoveries. Operating according to a strictly standardized procedure 
is mandatory. Other groups have also shown that reliable quantitative results 
in shotgun proteomics of complex peptide mixtures can be obtained based on 
reproducible peak areas [29,30]. However, repeatability may still be improved 
using the so-called “Global Internal Standard” strategy based on stable-isotope 
labeled samples [31], an approach that is under investigation.  
While our approach shows the feasibility of combining an LC–MS-based 
method including depletion of high-abundance proteins and trypsin digestion 
with data pre-processing and multivariate statistics to discover trends in 
concentrations of proteins in complex mixtures like serum, the concentration 
sensitivity is not sufficient to reach into the range of known tumor markers 
(ng/mL range). Improvements will therefore have to be made in sample 
preparation with the goal of being able to treat a larger volume of serum. Our 
analysis eventually used only 2 μL of the original serum sample, while it is Chapter II 
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possible to obtain 1mL without difficulty. Due to the high remaining protein 
content even after depletion (approximately 4–5 mg/mL), it is pivotal to start 
with a “preparative” separation method and to analyze the prefractionated 
sample. We are presently investigating prefractionation strategies at the 
protein level prior to tryptic digestion to reach a better concentration 
sensitivity. The described method is currently being applied to comparative 
cross-sectional and longitudinal studies with samples from healthy subjects 
and cervical cancer patients at different stages of disease to evaluate its 
suitability to classify different groups of patients. 
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Abstract 
The discovery of biomarkers in easily accessible body fluids such as serum 
is one of the most challenging topics in proteomics, requiring highly efficient 
separation and detection methodologies. Here we present the application of a 
microfluidics-based LC-MS system (chip-LC-MS) to the label-free profiling of 
immunodepleted, trypsin-digested serum in comparison to conventional 
capillary LC-MS (cap-LC-MS). Both systems proved to have a repeatability of 
~20% relative standard deviation (RSD) for peak area, all sample preparation 
steps included, while repeatability of the LC-MS part by itself was less than 
10% RSD for the chip-LC-MS system. Importantly, the chip-LC-MS system had 
a two fold higher resolution in the LC dimension and resulted in a lower 
average charge state of the tryptic peptide ions generated in the electrospray 
ionization (ESI) interface when compared to cap-LC-MS.  
In order to characterize both systems for their capability to find 
discriminating peptides in trypsin-digested serum samples, five out of ten 
individually prepared, identical sera were spiked with horse heart Cytochrome 
C. A comprehensive data processing methodology was applied, including two-
dimensional smoothing, resolution reduction, peak picking, time alignment 
and matching of the individual peak lists to create an aligned peak matrix 
amenable for statistical analysis. Statistical analysis by supervised classification 
and variable selection showed that both LC-MS systems could discriminate the Chip-LC-MS for label-free profiling of human serum 
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two sample groups. However, the chip-LC-MS system allowed the assignment 
of 55% of the overall signal to selected peaks, whereas this was only 32% for 
the cap-LC-MS system. 
 
1. Introduction 
Biomarker discovery through proteomics requires an intricate 
collaboration between medical, analytical and data sciences [1]. From an 
analytical point of view, it is a complex procedure and success is dependent on 
accurate quantification and the precise assignment of properties, such as 
retention time and m/z ratio, to individual molecules in highly diverse 
samples, while maintaining a comprehensive view of their compositions. Most 
biomarker discovery studies use easily accessible body fluids like urine, 
plasma or serum as starting materials. These samples are, however, extremely 
complex and cover a wide concentration range, which for serum can reach 10-
12 orders of magnitude [2]. 
Fast analytical screening methods such as surface enhanced laser 
desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS), 
which combines on-chip sample preparation with mass spectrometric analysis, 
are fr eq uen t l y used in  b i o m arker re se arch  [ 3] , a lt h o ugh  so m e r ecen t  result s  
question the reliability of this approach [4,5]. Present analytical research is 
trying to meet the challenge of more precise quantification and the coverage of 
a wider concentration range. The accuracy of relative quantification may be 
improved by stable-isotope labeling techniques, which have the advantage that 
the labeled proteins are mixed and subjected to the same sample preparation 
procedure and final LC-MS analysis, thus compensating for the variance 
occurring during these analytical steps. For in vitro cell culture experiments, 
amino acids labeled with different stable-isotopes (SILAC) are introduced 
through metabolic labeling [6,7], a procedure that is not applicable to most 
clinical samples such as body fluids. Chemical labeling provides an alternative 
option to introduce stable-isotopes into proteins. ICAT™ and iTRAQ™ are 
examples of two widely used reagents that react with thiol- or primary amine 
functionalities [8-10]. 
Label-free proteomics is frequently applied in biomarker research, since 
large numbers of samples need to be analyzed, increasing the cost of stable-
isotope labeling. For label-free profiling, it is preferable to first use the MS-
mode over the more commonly employed different information-dependent 
MS/MS techniques. Profiling in MS-mode results in more accurate 
quantification of minor peaks, because present-day mass analyzers are not fast 
enough to measure all the components of a complex mixture during 
information-dependent MS/MS routines. In cases where the sample is first 
digested with trypsin followed by reverse-phase HPLC coupled on-line to 
mass spectrometry (LC-MS) (the so-called “shotgun” approach [11-13]), nano-
LC systems with columns of 50-100 µm inner diameter (ID) are standard for Chapter III 
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protein identification [14]. However, they have rarely been employed in large-
scale biomarker discovery studies, due to their lack of robustness and poor 
repeatability over long time periods. Because of these shortcomings, nano-LC-
MS has found its main application in situations where only a few runs need to 
be compared, such as for protein identification from minute sample amounts. 
As a result, most biomarker discovery studies use columns of 0.3 to 1 mm ID 
(flow rates of 1-50 µL/min) for the label-free profiling of complex biological 
fluids [11,16]. 
The reliability of nano-LC-MS systems may be improved by integrating the 
trap and separating columns in a microfludics device (chip-LC-MS) [17], thus 
avoiding connections of varying dead volumes and the risk of leakage. Such 
devices also allow the integration of the electrical contact point into the chip, 
thereby avoiding the need for metal-coated spray needles which have limited 
long-term stability. In the present study, we show that chip-LC-MS compares 
favorably with a previously used capillary LC-MS (cap-LC-MS) system (1 mm 
ID column) [16] in terms of repeatability for both retention time and peak area. 
Human serum samples, depleted of the six most abundant proteins using a 
commercially available affinity column followed by trypsin digestion, were 
used to evaluate the chip-LC-MS system. The discrimination power of the 
system was compared with the cap-LC-MS system by adding horse heart 
Cytochrome C to the serum. The data generated by chip-LC-MS were treated in 
a comprehensive manner through automatic data processing and statistical 
analysis, revealing that chip-LC-MS is well suited for comparative, label-free 
profiling of highly complex samples. Moreover discrimination between 
samples of variable compositions was possible. Chip-LC-MS for label-free profiling of human serum 
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2. Experimental 
2.1. Chemicals 
Acetonitrile HPLC-S (ACN) gradient grade was from Biosolve 
(Valkenswaard, The Netherlands), formic acid (FA) 98-100% pro analysis was a 
product of Merck (Darmstadt, Germany) and ultra-pure water (conductivity: 
18.2 MΩ) was obtained from a Maxima System (Elga Labwater, Ede, The 
Netherlands). Equine heart Cytochrome C was from Fluka (cat n° 30397, 
primary accession number in Swiss Prot database P00004, Buchs, Switzerland). 
The Cytochrome C standard protein solution with a concentration of 42 
nmol/mL was stored at -20 ºC and prepared in 0.1% aqueous formic acid (FA). 
Buffers A and B used for immunoaffinity depletion were products of Agilent 
(cat nº 5185-5987 and 5185-5988, Palo Alto, California, USA). 
 
2.2. Sample Preparation 
Serum samples were obtained from the Department of Gynecological 
Oncology (University Medical Center, Groningen, The Netherlands) and stored 
at  −80°C in aliquots. All intermediate fractions were stored at −20°C. To 
develop and optimize the analytical procedure, serum from one cervical cancer 
patient was used. 
20 µL of serum were mixed with 80 µL of Buffer A and 80 µL of the diluted 
serum were depleted on a Multiple Affinity Removal column (Agilent, 4.6 
mm×50 mm, cat. n° 5185–5984; 1 mL/min flow rate) on an Akta FPLC system 
with cooled autosampler (4°C) and fraction collector according to the 
manufacturer’s instructions [20]. The flow-through fraction of a total volume of 
~1 mL was collected. Protein concentrations were determined with the Micro 
BCA™ protein assay reagent kit (Pierce, cat. n° 23235, Illinois, USA) and 
calculated for an average protein molecular weight of 50 kDa. BSA supplied 
with the reagent kit was used as calibration standard. 330 µL(~33% of the total 
amount) of depleted serum were digested with trypsin (1:20, w/w enzyme to 
substrate) at 37°C overnight (sequencing grade modified trypsin from 
Promega, cat. n° V5111, Madison, Wisconsin, USA). When Cytochrome C was 
spiked into serum, its recovery was shown to be 23.8±8.0% after the depletion 
[16]. 
 
2.3. HPLC-MS 
2.3.1. Cap-LC-MS 
Two HPLC-MS systems (Agilent) were used for analysis of the depleted, 
trypsin-digested serum. One was equipped with a conventional capillary 
column, the second with a chip-cube interface. Using the conventional capillary 
system, 7 µg (15-20 µL) (equivalent to 140 pmol of total protein assuming a 
molecular weight of 50 kDa) of protein were analyzed with an Agilent 1100 
series HPLC system containing an Atlantis™ dC 18 in-line trap column 
(Waters, Milford, Massachusetts, USA, 3 µm, 2.1 mm × 20 mm guard column, Chapter III 
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cat. n° 186001381) embedded in a Universal Sentry Guard Holder assembly 
(Waters, cat. n° 186000262) and an analytical capillary column of the same 
material (Waters, 1.0 mm × 150 mm, 3 µm, cat. n° 186001283) coupled on-line to 
an MSD-Trap-SL ion-trap mass spectrometer (cat. n° G2445A). The 
autosampler (cat. n° G1367A) was equipped with a 100 µL injection loop and a 
thermostated cooler (cat. n° G1330A) maintaining the samples at 4°C. The 
HPLC system had the following additional modules: capillary pump (cat. n°, 
G1376A), solvent degasser (cat. n°, G1379A), UV detector (cat. n° G1314A) and 
column holder (cat. n°, G1316A). The sample was injected and washed in the 
back-flush mode for 30 min (0.1% aq. FA and 3% acetonitrile at a flow-rate of 
50 µL/min). For elution of the retained peptides to the analytical column, 
eluent A (0.1% aq. FA) and B (acetonitrile with 0.1% FA) were used at a flow 
rate of 20 µL/min as follows: eluent A (15 min); linear gradient from 0 to 50% 
eluent B at 0.5%/min and then from 50 to 70% at 1%/min. The column was 
finally washed with 70% eluent B for 10 minutes. After each injection, the in-
line trap and the analytical column were equilibrated with eluent A for 20 min 
prior to the next injection. 
 
2.3.2. Chip-LC-MS 
The nano-LC-MS system was equipped with a microfluidics (chip-cube) 
interface (cat. n° G4240A) including a chip (cat. n° G4240-62001) with a 40 nL 
trap column (75 µm × 11 mm) and a 75 µm × 43 mm analytical column both 
containing C-18SB-ZX 5 µm chromatographic material. The interface contains a 
nanoelectrospray tip (2 mm length with conical shape: 100 µm OD × 8 µm ID) 
and was coupled on-line to an MSD-Trap-SL ion-trap mass spectrometer. The 
injected sample was 0.25 µg (3.39-5.05  µL) (5 pmol) of depleted, trypsin-
digested serum diluted ten fold with 0.1% aq. FA. Injections were performed 
with an autosampler (Agilent, cat. n° G1389A) equipped with an injection loop 
of 8 µl (this includes the dead volume up to the trapping column) and a 
thermostated cooler maintaining the samples in the autosampler at 4°C during 
the analysis. The interface was connected to an Agilent 1100 series HPLC 
system containing the following additional modules: nanopump (cat. n° 
G2226A), capillary pump and solvent degasser. The sample was injected and 
washed in the back-flush mode for 4 min (0.1% aq. FA, 2 µL/min) and then the 
trapping column was switched in-line with the analytical column. For these 
separations the same eluents A and B as for the cap-LC-MS system were used 
at a flow rate of 0.3 µL/min. After elution for 6 minutes with eluent A, a linear 
gradient from 0 to 50% eluent B at 0.5 %/min followed by a gradient from 50 to 
70% at 1 %/min of eluent B was run. 70% eluent B was maintained for 10 min. 
After each injection the in-line trap and the analytical column were 
equilibrated with eluent A for 20 min at 2 and 0.3 µL/min, respectively. 
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2.3.3. Mass spectrometry settings 
The following settings were common for both systems for ESI and mass 
analysis on the LC/MSD-Trap-SL mass spectrometer: Drying gas: 6.0 L/min 
N2, Skimmer: 40 V, Cap. exit: 136.0 V, Oct. 1: 12.0 V, Oct. 2: 1.74 V, Oct. RF: 
150.0 V, Lens 1: -5.0 V, Lens 2: -60.0 V, Trap drive: 53.3, T°: 325 °C, Scan 
resolution: enhanced, 5500 m/z per second scan speed, ICC target: 30 000, max. 
accumulation time: 15 000 µs. Scan range: 100-1500 m/z. Each scan was filtered 
by a Gaussian acquisition filter (width 0.1 m/z). Rolling average: average of 2 
spectra. Spectra were saved in profile mode. For cap-LC-MS, a nitrogen 
nebulizer gas pressure of 2.0 psi and an ionization voltage of 3500V were used. 
For the chip-LC-MS, the ionization voltage ranged between 1800 and 2000V. 
 
2.4. Data analysis and multivariate statistics 
2.4.1. Data analysis for method evaluation 
LC-MS data were first analyzed with the data analysis software of the 
LC/MSD Trap, version 3.3 (build 146) (Bruker Daltonics, Bremen, Germany). 
 
2.4.2. Data (pre-)processing 
For (pre-)processing and multivariate statistical analysis of the original 
Bruker Daltonics HPLC-MS data, the files were converted into ASCII-format 
with the Bruker data analysis software and saved in centroid mode. For further 
data analysis Matlab (version 7.2.0.232 (R2006a), Mathworks, Natick, 
Massachusetts, USA) and the PLS toolbox (version 3.5.2, Eigenvector Research 
Inc., Wenatchee, Washington, USA) were used. 
Centroid data were smoothed and reduced using a normalized two-
dimensional Gaussian filter, with rounding of the nominal m/z ratios to 1 m/z 
(the original data had a resolution of 0.1 m/z). In the retention time dimension, 
no data reduction was performed. This meshing procedure reduced the 
number of available data points by roughly a factor 10 and corrected for 
shifting m/z values as a result of different loadings of the ion-trap during 
elution of abundant peptides, a phenomenon that is common for ion-trap mass 
spectrometers [21,22]. After meshing the data files of all the chromatograms, 
they were time-aligned (warped) to a reference data file using Correlation 
Optimized Warping (COW) [23] based on TICs constructed from signals in the 
range 100-1500 m/z. 
A modified M-N rule was applied for peak detection by first calculating a 
median local baseline using the sliding window technique separately for each 
m/z trace. A median window size of 1200 data points, corresponding to 20.84 
min for chip-LC-MS and 20.17 min for cap-LC-MS, was used with a moving 
rate of 10 points and a minimum median value of 200 counts. According to the 
M-N rule, a threshold of M times the local baseline was used, and a peak was 
assigned if the signal exceeded this threshold for at least N consecutive points 
within one m/z trace [24]. For each detected peak, the m/z value and the mean Chapter III 
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retention times of the three highest measured intensities within the same peak 
reduced by the local baseline were stored in a peak list created for every 
chromatogram. 
We used a similar approach as Radulovic et al. [24] to obtain optimal 
settings for M and N. Different values for M (1.5-4) and N (4-8) were applied to 
two blank LC-MS runs and two LC-MS runs of depleted, trypsin-digested 
serum samples. At the settings used, the ratio between the number of peaks 
(between 5 and 100 min for the chip-LC-MS and 60-155 min for the cap-LC-MS 
runs) in the samples relative to the blank chromatograms was highest, and a 
minimal number of peaks were extracted from the noise in the blank 
chromatogram (M = 2 and N = 5 in our case). 
In order to combine the peak lists from different samples with each other, 
one-dimensional peak matching was achieved by using the sliding window 
technique, in which the same m/z traces were evaluated for peaks that are 
proximate in time (step size 0.1 min; search window 1.0 min; maximal accepted 
standard deviation for all retention times within a group of matched peaks was 
0.75 min). Missing peak allocation was performed by extracting the 
background-subtracted local signal of the given m/z trace at the given 
retention time. The generated peak matrix, created from the peak lists of the 
individual samples, consisted of a peak(row)-sample(column)-intensity(value) 
matrix. This peak matrix was used for multivariate statistical analysis. All data 
preprocessing work was done on a personal computer equipped with a dual 
core +3800 MHz AMD 64 X2 processor equipped with 4 GB of RAM. 
 
2.4.3. Classification and multivariate statistical methods 
To select the most discriminating peaks between spiked and non-spiked 
serum samples, the Nearest Shrunken Centroid (NSC) classification algorithm 
was applied [25,26]. NSC regularizes data whereby class-specific centroids are 
“shrunk” toward the overall (non-class-specific) centroid, which has the effect 
of eliminating the influence of the most weakly discriminating peaks, thereby 
reducing the risk to overfit the data [27]. This algorithm selects those peaks that 
are most relevant for the discrimination of the predefined classes. NSC is used 
in conjunction with leave-one-out cross-validation (LOOCV) to find the 
shrinkage value that gives the minimal LOOCV error [28]. In LOOCV, one 
observation per class is iteratively omitted from the data set that is used to 
construct the classification model, which is then used to classify the omitted 
observation. The selected peaks at the highest shrinkage value giving the 
lowest LOOCV error were employed for construction of the final classification 
model. The selected peaks were then subjected to autoscaled Principal 
Component Analysis (PCA) and visualized using biplots of the first two 
principal components [29]. 
 
 Chip-LC-MS for label-free profiling of human serum 
90 
3. Results and discussion 
3.1. Qualitative comparison of chip-LC-MS and cap-LC-MS 
3.1.1. Background ions 
Figure 1 shows a heat map of LC-MS data obtained with chip-LC-MS and 
cap-LC-MS at different stages of data processing. This figure conveys some of 
the similarities and differences of the data generated by the two methods when 
analyzing the same depleted, trypsin-digested serum sample. 
A remarkable feature of the chip-LC-MS data is that clear, straight lines at 
constant m/z values can be observed (Figure 1a). The majority of these peaks 
belongs to 3 types of ion series corresponding to a family of ubiquitous air 
contaminants, the polydimethylcyclosiloxanes. The ion series with rounded 
m/z values of 371.5, 445.5, 519.5, 593.5, 667.5, 741.5 and 815.5 after data 
reduction corresponding originally to 371.8, 445.4, 519.2, 593.1, 667.0, 741.0 and 
814.9 can be assigned to an oligomer with 4-10 monomers, respectively [30]. 
The ions with rounded m/z values of 355.5 and 429.5 (originally 355.6 and 
429.4) correspond to polydimethylcyclosiloxanes that lost one methyl group, 
due to fragmentation occurring during ion transfer between the capillary and 
the skimmer lens [31]. The ion series with rounded m/z values of 461.5, 536.5, 
610.5 and 683.5 (originally 462.3, 536.2, 610.1 and 684.1) are ammonia adducts 
of the corresponding polydimethylcyclosiloxanes. Beside these ions, the 
phthalate anhydride cation gave also raise to an intense background peak with 
a rounded m/z value of 150.5 (149.7), the ion at 279.5 (279.8) corresponds to the 
plasticizer di-n-butyl-phthalate, and the ion at 371.5 m/z (371.8) to another 
plasticizer (di-(2-ethylhexyl)-adipate) [32]. It has been shown that the intensity 
of some of these ions can be significantly reduced using an ESI source that is 
pressurized with nitrogen supplemented with clean artificial air as used with 
other nano-LC-MS systems [30 ] .  H o w e v e r ,  i t  i s  a l s o  p o s s i b l e  t o  r e m o v e  t h e 
signals corresponding to these ions during data pre-processing by calculating 
the local medium background with the sliding window technique (see Figures 
1c and 1e). Figure 1c shows the signal obtained from the raw data after 
background subtraction while Figure 1e shows the subtracted background 
clearly indicating that the vertical lines were recognized as background signals. 
For samples analysed with the cap-LC-MS system no such contaminants were 
observed. Chapter III 
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Figure 1. Visualization of LC-MS data at different stages of data pre-processing of depleted and 
trypsin-digested serum analyses obtained by chip-LC-MS and cap-LC-MS. Smoothed data 
obtained with chip-LC-MS (a) and cap-LC-MS (b) after application of a Gaussian filter with data 
reduction of 1:10 of the centroided raw data. LC-MS data after applying an M-N rule (for M = 2, N 
= 5) for peak detection for chip- (c) and cap-LC-MS (d). Representation of the local median baseline 
obtained with chip-LC-MS (e) and cap-LC-MS (f) by applying a sliding window technique (window 
size 1200 points, minimum value 200 points, moving step size of 10 points). 
 
Background ions from the polydimethylcyclosiloxanes might serve as 
indicators of ion suppression effects due to the eluting peptides. This would 
indicate that such effects might also affect co-eluting peptides, thus influencing Chip-LC-MS for label-free profiling of human serum 
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quantification. However, no such effects were observed in the case of chip-LC-
MS at retention times where significant amounts of peptides elute. Several 
papers reported ion suppression of hydrophobic, non-charged, weakly surface-
active compounds at comparatively high flow rates (2-100 µL/min), while ion 
suppression was absent at lower nL/min flow rates (5-50 nL/min) [33-35]. It 
has been shown that surface-active compounds or compounds charged before 
the electrospray process are enriched at the droplet surface, while compounds 
having the opposite properties are located in the bulk of the droplets [33-35]. 
Oligosaccharides and glycoproteins are therefore poorly ionized and less well 
detected by cap-LC-MS with ESI ionisation than in the nano-ESI regime [33,36]. 
The flow rate of 300 nL/min applied in chip-LC-MS is in the intermediate 
range between regular ion spray and nanospray and still not optimal to avoid 
ion suppression. Running the chromatographic separation at a flow rate of 10 
nL/min, at which ion suppression ceases, thus requires further miniaturization 
[34]. 
 
3.1.2. Charge state 
The average charge state of peptides in the chromatogram of the chip-LC-
MS run is lower than for cap–LC-MS. This can be observed in Figures 1a-d, 
where most of the peptide ions are in the range between 400-800 m/z for cap-
LC-MS and between 500-1000 for chip-LC-MS. Furthermore, for chip-LC-MS 
the peaks show a wider spread in the m/z dimension, which makes better use 
of the available mass range of the ion-trap mass analyzer. The lower average 
charge state cannot be explained simply by the lower voltage used in case of 
the chip interface (~1800 V) as compared to the regular ion spray interface 
(3500V), which uses N2 as nebulizer gas. As the distance between the end of the 
sprayer needle and the counter electrode is shorter for the chip interface (3.5 
mm) than for the regular ion spray interface (15 mm), this results in calculated 
electric field strengths of 0.514 V/m for the chip and 0.233 V/m for the regular 
ion spray. Most likely the higher average charge state observed for cap-LC-MS 
is partially due to the triboelectric effect generated by the nebulizer gas and the 
liquid droplets. This phenomenon has been used to produce ions at high 
velocity (100 m/sec) with pneumatic assistance, without the use of an external 
electric field [37]. However, since the flow rates in the applied ion spray 
interface are lower, this phenomenon may just lead to the observed shift in 
charge state. Another effect that may contribute to the observed shift is the 
higher occurrence of electrical discharge at the higher electric field strength in 
the chip-LC-MS interface, which results in the production of electrons. The 
combination of these electrons with the positively charged droplets would also 
lead to the observed reduction of the average charge state [38]. Further 
investigations are needed to clarify the underlying physical mechanisms. 
To give an overall assessment of the degree of charge-state reduction, the 
baseline was calculated using a sliding window technique in the m/z Chapter III 
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dimension. The observed ellipsoid-shaped area with an elevated baseline is 
caused by peaks that are non-resolved by the LC-MS system and that cannot be 
discriminated from the background by data pre-processing (Figures 1e-f). This 
background is completely absent in blank chromatograms, indicating that it is 
related to the overall resolution of the LC-MS system (data not shown). The 
centers of these regions reflect the average charge state of the ionized peptides, 
which is ~630 m/z for cap-LC-MS and ~815 m/z for chip-LC-MS. 
 
3.1.3. Chromatographic Resolution 
Since both methods make use of the same ion-trap mass analyzer, there 
was no difference in resolution in the m/z dimension. However, we observed 
an improved resolution in the retention time dimension for the chip-LC-MS 
module, despite the shorter column length. The mean full-width-at-half-
maximum (FWHM) for peaks was 0.32±0.05 min for chip-LC-MS and 0.62±0.07 
min for cap-LC-MS based on 10 randomly chosen peaks. The better 
chromatographic performance of the chip-LC-MS system is difficult to explain. 
A trapping column for sample injection in-line coupled to the analytical 
column was used in both systems but with a different type of C18 reverse-
phase chromatographic material (Atlantis™ dC 18 3 µm for the cap-LC-MS and 
C-18SB-ZX 5 µm for the chip-LC-MS; for details see Material and Methods). 
The considerable difference in column length, diameter, and applied flow rate 
also influenced the observed resolution. The gradient parameter ( ()
2
c
G
Ld
F t
Q = , 
where tG is the gradient time in min, F the flow rate in mL/min, L the column 
length in cm and dc the column internal diameter in cm) introduced by Snyder 
[15] has an effect on resolution. These values were 13.33 and 124.03 for the cap-
LC-MS and chip-LC-MS respectively. This large difference may explain the 
observed increase in resolution for the chip-LC-MS system. 
The overall peak capacity of an LC-MS system is determined by the 
resolution of the mass analyzer and the LC system. Due to improved 
chromatographic resolution, the overall peak capacity for the chip-LC-MS 
s y s t e m  d o u b l e d  c o m p a r e d  t o  c a p - L C - M S .  T h i s  c a p a c i t y  i s  a l s o  b e t t e r  u s e d  
because of the wider spread of signals in the m/z dimension, which enabled 
better repartition and separation of the compounds. This means that taking a 
100 min gradient time and an m/z range of 1400 for both system into account, 
the calculated uniform peak capacity of the cap-LC-MS system is 11980 and 
23211 for the chip-LC-MS system (calculated by using the measured FWHM 
values in the retention time dimension and an average 2.5–times m/z at the 
FWHM in the mass dimension allowing for 5% peak overlap while producing 
the tightest arrangement of the peaks). Concerning the effective resolution 
space (space where most of the peaks can be found) obtained for the studied Chip-LC-MS for label-free profiling of human serum 
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samples, the useful range is 95 min for both system and 400 versus 500 m/z for 
the cap- and chip-LC-MS, respectively, resulting in 3251 and 7875 of peaks. 
Figures 2a and 2b represent the TICs of the raw data and of the calculated 
baselines for chip- and cap-LC-MS. 
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Figure 2. TIC chromatogram of raw data and of the baseline obtained with chip-LC-MS (a) and cap-
LC-MS (b). TIC of the local median baseline obtained with the sliding window technique from the 
chromatogram of chip-LC-MS (blue) and cap-LC-MS (purple) (c). 
 
The part of the overall TIC signal that can be explained based on peaks 
selected by the M-N rule is 55% for chip-LC-MS and 32% for cap-LC-MS, 
indicating that a larger portion of the acquired data can be assigned to actual 
peaks in the case of the chip-LC interface using the same data pre-processing 
method. Visualization of the local baseline gives an indication of the 
distribution of the non-resolved peaks, which confirms that there is a lower 
amount of non-resolved peaks in the case of the chip-LC-MS system (Figures 
1e-f). Using rather conservative parameters for peak picking (M = 3 and N = 8), 
the number of extracted features was 4216 (between 60 – 155 min and 300 – 
1500 m/z) for cap-LC-MS and 11746 (between 5 – 100 min and 300 – 1500 m/z) 
for chip-LC-MS. Because of two-dimensional smoothing, data reduction, which 
combines isotopic peaks into a single peak distributed over several m/z traces, Chapter III 
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and with the presence of multiple charge states, 2-8 features in the peak list 
corresponded on average to one peptide. This gives the chip-LC-MS system the 
capacity to detect between 1468-5873 peptides while the cap-LC-MS system can 
detect between 527-2108 peptides in the studied sample. 
 
3.2. Repeatability and Quantification 
3.2.1. Repeatability 
Comparative biomarker studies rely on the repeatability of the analytical 
method. To test the repeatability of the overall method including sample 
preparation and LC-MS, 10 serum samples of the same patient were 
independently prepared by immunoaffinity depletion and trypsin digestion. 
All samples were analyzed by LC-MS on the same day. Six peptides from 3 
high-abundance proteins (apolipoprotein A-I [accession number: P02647, 
SwissProt/Trembl],  α-2-macroglobulin precursor [P01023], human 
complement C3 precursor [P01024]) with m/z values of 756.7, 753.5, 909.6, 
682.5, 619.2 and 694.4 m/z [16] were selected to test the analytical repeatability 
for both cap-LC-MS and chip-LC-MS. Manual integration of peak areas was 
first performed using extracted ion chromatograms (EICs) for m/z values 
taken at the maximum intensity of each selected peptide peak ±0.5 m/z, in 
order to account for shifts occurring in the ion-trap mass analyzer during peak 
elution. Retention time variation was small in both cases, although the cap-LC-
MS system showed a slightly higher standard deviation (SD) (mean value of 
0.29 min ± 0.15) than chip-LC-MS (mean value of 0.04 min ± 0.01). For peak 
area, practically the same relative standard deviation (RSD) was obtained for 
the cap-LC-MS and chip-LC-MS systems (21.87±7.60% and 21.73±7.51%, 
respectively) showing that the microfluidics-based chip-LC-MS system is 
equally well-suited for comparative label-free peptide profiling studies as the 
cap-LC-MS system, while requiring about 30 times less sample. The 
repeatability of ~20% in peak area is in agreement with an earlier study using a 
comparable cap-LC-MS system [16]. Repeatability of chip-LC-MS by itself 
showed that most of the analytical variability was due to the upstream sample 
preparation steps, since 5 repeated injections of the same sample on the same 
day resulted in a repeatability of 5.19±2.48% RSD in peak area. 
Despite the good retention time repeatability of cap-LC-MS and chip-LC-
MS, it is necessary to align the chromatograms to avoid incorrect peak 
matching between runs, especially in peak-rich regions. Since retention time 
shifts are minor and the TICs are highly similar, Correlation Optimized 
Warping (COW) [23] was used with success to reduce the RSD of the 6 peptide 
peaks to 0.07±0.03 min for cap-LC-MS and 0.02±0.01 min chip-LC-MS*. 
The peak area repeatability of both cap-LC-MS and chip-LC-MS was 
improved from 21.87±7.60% and 21.73±7.51%, respectively, to 19.79±7.72% and 
                                                 
* The ion 757 was omitted from the RSD calculations, since peak mismatching occurred. Chip-LC-MS for label-free profiling of human serum 
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14.52±3.91%* RSD by automated data pre-processing. Considering the chip-LC-
MS part only, repeatability improved from 5.19±2.48% to 3.50±0.96% for the 5 
repeated injections of the same sample. The increased repeatability is probably 
due to the fact that data reduction and Gaussian filtering smoothed out some of 
the variability of the mass detector. 
Assessing repeatability based on only 6 peaks does not give a 
comprehensive view of the variability of the LC-MS profiling system. 
Automatic data processing using a higher threshold (M = 3, N = 8) for peak 
picking to exclude the majority of noise enabled us to have a more global view. 
Figure 3 shows histograms of the RSD for the matched peak lists of datasets 
containing 10 analyses of separately prepared digested serum samples for the 
cap-LC-MS (blue trace) and the chip-LC-MS (red trace) systems. 
Evaluating only the chip-LC-MS system on its own with 5 repeated 
injections of the same sample (green trace) confirms that most of this variability 
is due to the sample preparation steps and not to the LC-MS part. It appears 
from these histograms that cap-LC-MS has a slightly higher maximum (mode)** 
RSD (24.29±0.35%) than chip-LC-MS (22.38±0.46%) for the data sets, including 
variability due to sample preparation. Variability in the data set obtained with 
chip-LC-MS, including only the variability of the LC-MS system, was again 
lower (8.33±0.35%). These results confirm the data obtained with the analysis 
of the 6 peptides and are in agreement with the reproducibility values obtained 
on a prototype of the chip-LC-MS microfluidic device [17]. 
The presented data processing method leads to loss of the fine structure of 
the mass dimension and thus to a lower overall resolution of the analytical 
platform because of data reduction from 0.1 to 1 m/z and two-dimensional 
Gaussian filtering. It is envisioned that processing without data reduction, 
using profile spectra combined with a more accurate peak picking algorithm 
with higher overlapping peak resolving capabilities, will increase the precision 
of the information extracted from the raw data. This is particularly relevant for 
low-abundance peaks and for peaks eluting in highly crowded areas. Work 
along these lines is underway. 
                                                 
** The maximum was obtained based on the fit of 3 Gaussian curves on the 
histogram excluding the plateau region of the data. Among the 3 Gaussian 
curves the maximum of the highest curve was taken. The presented standard 
deviation is the value obtained by curve fitting. Chapter III 
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Figure 3. Relative Standard Deviation of peaks obtained using an M-N rule with a higher threshold 
(M = 3, N = 8) for cap-LC-MS (red) and chip-LC-MS (blue) obtained from 10 serum samples from 
the same patient including the sample preparation steps and for chip-LC-MS (green) obtained from 
5 repetitive injections, representing thus only the variation of the LC-MS system. 
 
3.2.2. Multivariate  statistical  analysis 
In order to compare the ability of cap-LC-MS and chip-LC-MS to find 
discriminating features, 5 serum samples were spiked with 21 pmol of horse 
heart Cytochrome C for 2 µL serum. Due to losses during immunoaffinity 
depletion of high-abundance proteins, the actual amount of horse heart 
Cytochrome C after depletion was 4.2 pmol [16], corresponding to 3% of the 
total protein content. The obtained raw data were subjected to data processing 
as described above, followed by supervised classification and selection of 
discriminating features using the Nearest Shrunken Centroid (NSC) algorithm 
[25, 26]. The shrinkage parameter was optimized through “leave one out” cross 
validation (LOOCV). Initially a low threshold (M = 2, N = 5) was used for peak 
picking in order to see the ability of the classifier to find discriminating features 
in the presence of noise in the peak list. Figure 4 shows the LOOCV error and 
the number of selected variables plotted against the shrinkage for chip-LC-MS 
and cap-LC-MS.  
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Figure 4. Representation of the LOOCV error and the number of selected variables as function of 
the shrinkage obtained using an NSC-based variable selection and classification algorithm on the 
matched peak list after peak detection (M-N rule with M = 2, N = 5) for chip-LC-MS (a) and cap-
LC-MS (b). The selected variables, where the shrinkage domain has no cross-validation error, are 
highlighted with red arrows (0.90-29.51 shrinkage and 2540 to 2 selected variables for chip-LC-MS; 
0.61-16.80 shrinkage and 3496 to 2 selected variables for cap-LC-MS). For these domains, the 
selected variables enabled a perfect separation of the two classes of spiked and non-spiked 
samples. 
 
There is a large domain of shrinkage where the cross validation error was 0 
in both cases (0.90-29.51 for chip and 0.61-16.80 for cap-LC-MS), and where 
selecting variables at those shrinkage values resulted in a perfect classification. 
The most discriminating features are found at higher shrinkage values. 
Evaluating the 16 most discriminating features selected at shrinkages of 10 and 
8.5 for chip- and cap-LC-MS, which corresponded to 6 different peptide peaks, 
showed that all of these 6 peptides for the chip-LC-MS and 5 for the cap-LC-
MS peptides corresponded to in-silico predicted tryptic peptides of horse heart 
Cytochrome C (Table 1). 
The remaining features are most probably due to non-specific cleavages, 
because they show clear absence and presence in the corresponding spiked or 
non-spiked chromatograms. These features are also present in the standard 
tryptic digest of horse heart Cytochrome C. Figure 5 shows that correct 
discrimination between spiked and non-spiked serum is easily possible, based 
on the selected peaks (Figure 5c and d). 
Visualization of the EICs of some of the selected peaks (Figure 6) confirms 
that these peaks differ clearly between chromatograms obtained from spiked 
and non-spiked samples. Chapter III 
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Table 1. Main characteristics of the 16 most discriminating peaks selected by 
NSC at a shrinkage of 10 and 8.5 for chip-LC-MS and cap-LC-MS, respectively 
(see Figure 3). The peaks in bold contributed most to the discrimination 
between the spiked and non-spiked serum samples. 
 
Platform m/z 
Retention 
time [min] 
Charge 
state 
Miss 
cleavage 
Location  In-silico Peptide sequence 
605.5 26.29  1  0 56-60  GITWK 
584.5 43.00  2  0 28-38  TGPNLHGLFGR 
390.5 39.93  2  0 80-86  MIFAGIK 
391.5 39.93  2  0 80-86  MIFAGIK 
482.5 47.00  2  0 92-99  EDLIAYLK 
483.5 46.98  2  0 92-99  EDLIAYLK 
484.5 46.98  2  0 92-99  EDLIAYLK 
747.5 53.06  2  0 61-72  EETLMEYLENPK 
748.5 53.09  2  0 61-72  EETLMEYLENPK 
963.5 47.06  1  0 92-99  EDLIAYLK 
964.5 47.05  1  0 92-99  EDLIAYLK 
965.5 46.97  1  0 92-99  EDLIAYLK 
734.5 32.00  2  0 40-53  TGQAPGFTYTDANK 
735.5 32.00  2  0 40-53  TGQAPGFTYTDANK 
736.5 32.00  2  0 40-53  TGQAPGFTYTDANK 
Chip-LC-
MS 
737.5 32.06  2  0 40-53  TGQAPGFTYTDANK 
557.5 104.90  3  2  23-38  GGKHKTGPNLHGLFGR 
558.5 104.92  3  2  23-38  GGKHKTGPNLHGLFGR 
559.5 104.89  3  2  23-38  GGKHKTGPNLHGLFGR 
577.5 111.36         
578.5 111.35         
735.5 87.29  2  0 40-53  TGQAPGFTYTDANK 
736.5 87.31  2  0 40-53  TGQAPGFTYTDANK 
737.5 87.27  2  0 40-53  TGQAPGFTYTDANK 
747.5 111.36  2  0  61-72  EETLMEYLENPK 
748.5 111.39  2  0  61-72  EETLMEYLENPK 
749.5 111.43  2  0  61-72  EETLMEYLENPK 
750.5 111.35  2  0  61-72  EETLMEYLENPK 
965.5 104.94  1  0  92-99  EDLIAYLK 
451.5 96.84  3  1 89-99  TEREDLIAYLK 
576.5 111.42         
Cap–LC-
MS 
964.5 104.93  1  0  92-99  EDLIAYLK 
 Chip-LC-MS for label-free profiling of human serum 
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Figure 5. PCA plots using all peaks obtained with M = 2, N = 5 for chip-LC-MS (a) and cap-LC-MS 
(b), (14091 for chip-LC-MS and 11256 for cap-LC-MS) and PCA plots of 16 features selected by NSC 
from datasets obtained with chip-LC-MS (shrinkage value of 10.00) (c) and cap-LC-MS (shrinkage 
value of 8.50) (d). 
 
Among these variables, the peak at 484.5 m/z and 46.97 min (sequence 
EDLIAYLK) contributed most to the discrimination for chip-LC-MS and the 
peak at 559.5 m/z and 104.89 min (sequence GGKHKTGPNLHGLFGR) for 
cap-LC-MS. PCA analysis of the selected peaks (Figures 5c and d) shows that 
almost all variability in the data can be explained by Principal Component 1 
(99% for chip- and 98% for the cap-LC), however, chip-LC-MS used 28-times 
less sample (the analyzed sample amount was 140 pmol for cap- and 5 pmol 
for chip-LC). Distribution of the selected variables in the PCA biplots also 
shows that all selected variables have higher intensities in the spiked samples 
as expected. 
The necessity to apply NSC for variable selection prior to the final centroid 
classification is evident when using centroid classification with all variables, 
which did not result in any discrimination between spiked and non-spiked 
samples along PC1 and PC2 of the PCA plot using the complete peak list 
obtained by the M-N rule (Figures 5a and 5b). 
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Figure 6. Example of EICs of NSC-selected peaks corresponding to tryptic fragments of horse heart 
Cytochrome C from datasets obtained with chip-LC-MS (left) and cap-LC-MS (right). The upper 
traces were obtained from spiked, the lower traces were obtained from non spiked samples. 
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4. Conclusions and future perspectives 
We show that integration of a nano-HPLC (column ID=75 µm) system on a 
microfluidic chip directly connected to a mass spectrometer via an ESI interface 
results in repeatable analyses of highly complex samples such as trypsin-
digested human serum. Indeed, overall performance was equal or superior to a 
previously used cap-LC-MS system while requiring ~30-times less sample. The 
higher chromatographic resolution resulted in an increased peak capacity and 
an overall lower charge state was observed, which resulted in improved use of 
the available time × m/z space (see Figures 1c-d). The data processing 
methodology presented is able to remove background ions efficiently and the 
visualization of the local baseline gives an overview over the intensity, 
distribution and average charge state of the non resolved peaks of each system, 
which is a valuable tool for the evaluation and further optimization of the 
analytical system. The presented data processing and classification 
methodology was able to discriminate between spiked and non-spiked samples 
at 3% of the total protein content based on the acquired data, with slightly 
better performance for the chip-LC-MS system. 
The present analyses were performed with a quadrupole ion-trap mass 
analyzer and it is evident that use of the chip-LC interface with high resolution 
mass analyzers such as Time-Of-Flight, orbitrap- or Fourier Transform-Ion 
Cyclotron Resonance systems would further enhance the overall resolution. 
Replacing the particle-packed column on the chip with monolithic materials 
would, on the other hand, decrease the pressure and permit increased analysis 
speed. Faster analyses would in turn allow the analysis of prefractionated 
samples (e.g. after cation-exchange HPLC) with a higher throughput and thus 
to increase the dynamic range of the overall analysis. As the maximum 
pressure limit of the present chip is 150 bar, the development of a chip able to 
work at 300-1000 bar would allow the use of smaller diameter particles, which 
would in turn result in an increase in the resolution of the LC dimension. 
Further improvements along these lines should render microfluidics-based 
nano-LC-MS a highly useful tool for biomarker discovery. Chapter III 
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Abbreviations 
ACN Acetonitrile 
BSA Bovine  Serum  Albumin 
cap-LC-MS  HPLC-MS system using capillary column 
chip-LC-MS  nanoHPLC-MS system integrated on a microfluidic device 
COW  Correlation Optimized Warping 
EICs  Extracted ion chromatograms 
ESI Electrospray  Ionisation 
FA Formic  Acid 
FWHM  Full Width at Half Maximum 
HPLC  High Performance Liquid Chromatography 
ICAT  Isotope Coded Affinity Tag 
LOOCV  Leave One Out Cross Validation 
NSC Nearest  Shrunken  Centroids 
PCA  Principal Component Analysis 
PCX  Principal Component number X 
RSD  Relative Standard Deviation 
TIC  Total Ion Current Chip-LC-MS for label-free profiling of human serum 
104 
References 
[1]  Horvatovich P, Govorukhina NI, Bischoff R. Biomarker discovery by proteomics: 
challenges not only for the analytical chemist. Analyst 2006;131:1-6. 
[2]  Anderson NL, Anderson NG. The human plasma proteome: history, character, and 
diagnostic prospects. Mol. Cell. Proteomics 2002;1(11):845-867. 
[3]  Petricoin EF, Liotta LA. SELDI-TOF-based serum proteomic pattern diagnostics for early 
detection of cancer. Curr. Opin. Biotechnol. 2004;15:24-30. 
[4]  Diamandis EP. OvaCheck: Doubts Voiced Soon After Publication. Nature 
2004;430(7000):611. 
[5]  Diamandis EP. Proteomic Patterns to Identify Ovarian Cancer: 3 Years on. Expert. Rev. Mol 
Diagn. 2004;4:575-577. 
[6]  Ong SE, Kratchmarova I, Mann M. Properties of 13C-Substituted Arginine in Stable-Isotope 
Labeling by Amino Acids in Cell Culture (SILAC). J. Proteome Res. 2003;2(2):173-181. 
[7]  Ong SE, Foster LJ, Mann M. Mass spectrometric-based approaches in quantitative 
proteomics. Methods 2003;29(2):124-130. 
[8]  Gygi SP, Rist B, Gerber SA, Turecek F., et al., Quantitative analysis of complex protein 
mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999;17(10):994-999. 
[9]  Ross PL, Huang YN, Marchese JN, Williamson B., et al., Multiplexed protein quantitation in 
Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell 
Proteomics 2004;3(12):1154-1169. 
[10]  Leitner A, Lindner W. Current chemical tagging strategies for proteome analysis by mass 
spectrometry. J. Chromatogr. B. 2004;813(1-2):1-26. 
[11]  Higgs ER, Knierman DM, Gelfanova V, Butler PJ, Hale EJ. Comprehensive Label-Free 
Method for the Relative Quantification of Proteins from Biological Samples. J. Proteome 
Res. 2005;4(4):1442-1450. 
[12]  Washburn MP, Wolters D, Yates JR. Large-Scale Analysis of the Yeast Proteome by 
Multidimensional Protein Identification Technology. Nat. Biotechnol. 2001;9:242-247. 
[13]  Wolters DA, Washburn MP, Yates JR. An Automated Multidimensional Protein 
Identification Technology for Shotgun Proteomics. Anal. Chem. 2001;73:5683-5690. 
[14]  Meiring HD, van der Heeft E, ten Hove GJ, de Jong APJM. Maintaining fixed band spacing 
when changing column dimensions in gradient elution. J. Sep. Sci. 2002;25(9):557-568. 
[15]  Dolan JW, Snyder LR. Maintaining fixed band spacing when changing column dimensions 
in gradient elution. J. Chrom. A. 1998;799(1-2):21-34. 
[16]  Govorukhina NI, Reijmers TH, Nyangoma SO, van der Zee AGJ., et al., Analysis of human 
serum by liquid chromatography–mass spectrometry: Improved sample preparation and 
data analysis. J. Chromatogr. A. 2006;1120:142-150. 
[17]  Fortier MH, Bonneil E, Goodley P, Thibault P. Integrated Microfluidic Device for Mass 
Spectrometry-Based Proteomics and Its Application to Biomarker Discovery Programs. 
Anal. Chem. 2005;77:1631-1640. 
[ 1 8 ]   V o l l m e r  M ,  H ö r t h  P ,  R o z i n g  G ,  C o u t  Y., et al., Multi-dimensional HPLC/MS of the 
nucleolar proteome using HPLC-chip/MS. J. Sep. Sci. 2006;29:499-509. 
[19]  Martosella J, Zolotarjova N, Liu H, Nicol G, Boyes BE. Reversed-Phase High-Performance 
Liquid Chromatographic Prefractionation of Immunodepleted Human Serum Proteins to 
Enhance Mass Spectrometry Identification of Lower-Abundant Proteins. J. Prot. Res. 
2005;4(5):1522-1537. 
[20]  Dekker LJ, Bosman J, Burgers PC, van Rijswijk A., et al., Depletion of high-abundance 
proteins from serum by immunoaffinity chromatography: a MALDI-FTMS study. J. Chrom. 
B. 2007;847:65-69. 
[21]  Hao Ch, March ER. A survey of recent research activity in quadrupole ion-trap mass 
spectrometry. Int. J. Mass Spectrum. 2001;212:337–357. 
[22]  Wells JM, Plass WR, Patterson GE, Ouyang Zh. Chemical Mass Shifts in Ion-trap Mass 
Spectrometry: Experiments and Simulations. Anal. Chem. 1999;71:3405-3415. Chapter III 
  105
[23]  Tomasi G, van den Berg F, Andersson C. Correlation optimized warping and dynamic time 
warping as preprocessing methods for chromatographic Data. J. Chemometrics 2004;18:231-
241. 
[24]  Radulovic D, Jelveh S, Ryu S, Hamilton TG., et al.,  Informatics platform for global 
proteomic profiling and biomarker discovery using liquid chromatography-tandem mass 
spectrometry. Mol. Cell. Proteomics 2004;3:984-997. 
[25]  Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by 
shrunken centroids of gene expression. Proc. Natl. Acad. Sci. USA. 2002;99:6567-6572. 
[26]  Tibshirani R, Hastie T, Narasimhan B, Soltys S., et al., Sample classification from protein 
mass spectrometry, by 'peak probability contrasts'. Bioinformatics 2004;20:3034-3044. 
[27]  Listgarten J, Emili A. Statistical and computational methods for comparative proteomic 
profiling using liquid chromatography-tandem mass spectrometry. Mol. Cell. Proteomics 
2005;4:419-434. 
[28]  Wagner M, Naik D, Pothen A. Protocols for disease classification from mass spectrometry 
data. Proteomics 2003;3:1692-1698. 
[29]  Hilario M, Kalousis A, Muller M, Pellegrini C. Machine learning approaches to lung cancer 
prediction from mass spectra. Proteomics 2003;3:1716-1719. 
[30]  Schlosser A, Volkmer-Engert RJ. Volatile Polydimethylcyclosiloxanes in the Ambient 
Laboratory Air Identified As Source of Extreme Background Signals in Nanoelectrospray 
Mass Spectrometry. Mass Spectrom. 2003;38:523-525. 
[31]  Spiteller M, Spiteller G. Massenspektrensammlung von Lösungsmitteln, Verunreinigungen 
Säulenbelegmaterialien und einfachen aliphatischen Verbindungen, Springer Verlag, Wien, 
New York 1973. 
[32]  Guo X, Bruins PA, Covey RT. Characterization of typical chemical background 
interferences in atmospheric pressure ionization liquid chromatography-mass 
spectrometry. Rapid Commun. Mass Spectrom. 2006;20:3145–3150. 
[33]  Karas M, Bahr U, Dülcks T, Fresenius. Nano-electrospray ionization mass spectrometry: 
addressing analytical problems beyond routine. J. Anal. Chem. 2000;366:669–676. 
[ 3 4 ]   S c h m id t  A ,  K a r a s  M ,  D ü l c k s  T .  E f f e c t  o f  D i f f e re n t  S o l u t i o n  F l o w  R a t e s  o n  A n al y t e  I o n  
Signals in Nano-ESI MS, or: When does ESI turn into Nano-ESI? J. Am. Soc. Mass Spectrom. 
2003;14:492-500. 
[35]  Juraschek R, Dülcks T, Karas M J. Nanoelectrospray—More Than Just a Minimized-Flow 
Electrospray Ionization Source. Am. Soc. Mass Spectrom. 1999;10:300–308. 
[36]  Bahr U, Pfenninger A, Karas M, Stahl B. High-Sensitivity Analysis of Neutral 
Underivatized Oligosaccharides by Nanoelectrospray Mass Spectrometry. Anal. Chem. 
1997;69:4530-4535. 
[37]  Goodley CP, Fischer MS, Gourley LD. Self generating ion device for mass spectrometry of 
liquids. US patent 5559326A. 1996. 
[38]  Ebeling DD, Westphall SM, Scalf M, Smith ML. Corona Discharge in Charge Reduction 
Electrospray Mass Spectrometry. Anal. Chem. 2000;72:5158-5161.  Chapter IV 
  107
Chapter IV. 
 
Influence of clotting time on the protein composition of serum 
samples based on LC-MS data 
 
 
N.I. Govorukhina, M. de Vries, T.H. Reijmers, P. Horvatovich, A.G.J. van der 
Zee, and R. Bischoff 
Manuscript in preparation  
 
Abstract 
Many large banks of serum samples were acquired prior to the widespread 
use of proteomics in biomarker research. An important parameter that is often 
not exactly known is clotting time. We therefore investigated the influence of 
clotting time on the protein and peptide composition of serum by label-free 
and stable-isotope labeling techniques. The label-free analysis of trypsin-
digested serum showed that the overall pattern of LC-MS data is not affected 
by clotting times varying from 2 to 8h. However, univariate and multivariate 
statistical analyses revealed that proteins that are directly involved in blood 
clot formation, such as the clotting-derived fibrinopeptides, change 
significantly. This is most easily detected in the supernatant of acid-
precipitated, immunodepleted serum. Stable-isotope labeling techniques show 
that truncated or phosphorylated forms of Fibrinopeptides A and B increase or 
decrease depending on clotting time. These patterns can be easily recognized 
and should be taken into consideration when using serum sample collections 
of which the clotting time is not known. Leucine-rich alpha-2-glycoprotein 
(P02750) was down-regulated in all samples compared to the sample for which 
the clotting time was one hour based on iTRAQ labeling data. Influence of clotting time on the protein composition of serum samples based on LC-MS data 
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1. Introduction 
The discovery and validation of biomarkers for early diagnosis of disease 
at a stage where successful therapy is still possible is an important goal of 
modern biomedical research. To achieve this goal, high-resolution analytical 
techniques are applied to complex clinical samples, mostly body fluids. Serum 
is a body fluid that is representative of the composition of soluble proteins and 
peptides in blood and is thus a suitable starting material for biomarker 
discovery studies. Moreover, many existing large sample collections at major 
hospitals consist of serum that is stored frozen at -80°C. Since these collections 
may well contain important information about the health status of the 
corresponding patients and controls, especially when they have been followed 
over time, it is critical to evaluate under which conditions it is possible to 
compare samples from these collections with modern proteomics approaches. 
The generation of serum requires that blood be coagulated and that the 
cellular components as well as the blood clot be removed by centrifugation or 
filtration. It has notably been argued that the time and conditions under which 
blood is allowed to clot (clotting time) are important parameters that must be 
controlled and kept constant in order to compare protein and peptide profiles 
[1-5]. However, most existing sample collections have not been obtained with 
subsequent proteomics analyses in mind and clotting time has often not been 
rigorously controlled. Many of the studies evaluating the influence of pre-
analytical parameters on serum protein composition have been performed by 
Surface-Enhanced Laser Desorption Ionization Time-Of-Flight Mass 
Spectrometry (SELDI-TOF-MS) [4], a method that suffers from rather poor 
concentration sensitivity and that may be prone to mass spectrometric artifacts 
[6]. More sensitive approaches using enrichment of proteins and peptides on 
m a g n e t i c  b e a d  s e p a r a t o r s  o r  b y  L i q u i d  C h r o m a t o g r a p h y  ( L C )  f o l l o w e d  b y  
Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass 
Spectrometry (MALDI-TOF-MS) have also indicated that conditions of sample 
handling and preparation are critical [2,3,5,7,8]. Our previous studies and those 
of others have shown that the combination of LC with Electrospray-Ionization 
Mass Spectrometry (ESI-MS), abbreviated LC-MS, is suitable to analyze body 
fluids such as serum or urine [9,10]. The increasing number of applications of 
LC-MS and LC-MS/MS for the profiling of body fluids or the targeted 
detection of individual proteins underscores furthermore that this method is 
capable of achieving concentration sensitivities in the ng-pg/mL range [11-18]. 
In return, LC-MS provides highly complex data sets when used in the profiling 
mode (measurement of all detectable compounds in a sample) and it is thus not 
easy to assess the effect of a given pre-analytical parameter on the overall 
result. 
We describe here an approach to assess the effect of clotting time on LC-
MS profiles of serum obtained from a healthy volunteer by univariate and 
multivariate statistical analysis after data processing. In order to render serum Chapter IV 
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samples suitable to high-performance LC-MS analysis, proteins were digested 
with trypsin. Additionally, we investigated the supernatant of acid-
precipitated serum samples which are highly enriched in low-molecular 
weight proteins and peptides (the so-called Peptidome) [3,19-24]. For 
comparison of samples we used label-free as well as stable-isotope labeling 
(iTRAQTM) [25] approaches. 
 
2. Materials and Methods 
2.1. Description of samples 
Serum samples were prepared at the Department of Gynecological 
Oncology (University Medical Center Groningen, Groningen, The 
Netherlands) and stored at -80ºC in aliquots until analysis. All intermediate 
fractions that were obtained during sample preparation were stored at -20ºC. 
Glass tubes (Becton Dickinson, #367953), with a separation gel and micronized 
silica to accelerate clotting, were used for blood collection. Serum was obtained 
from a single healthy female volunteer, who consented to this study, after 
different clotting times (1, 2, 4, 6 and 8 h). Serum was prepared by letting the 
freshly collected blood coagulate at room temperature for 1, 2, 4, 6 or 8 h 
followed by centrifugation at room temperature for 10 min at 3000 rpm. 
 
2.2. Preparation of serum samples 
20 µL of serum were mixed with 80 µL of buffer A (Agilent, Santa Clara, 
California, USA) of which 80 µL were injected on a Multiple Affinity Removal 
column (Agilent, 4.6 × 50 mm, Part # 5185-5984) after filtration through a 0.22 
µm spin filter (Part # 5185-5990) at 13000 g and 4°C for 10 min to remove 
particulates. Removal of abundant proteins was performed on a LaChrom 
HPLC System (Merck Hitachi, www.merck.com) with detection at 280 nm 
using the following timetable: 0-9 min, 100% buffer A (0.25 mL/min); 9.0-9.1 
min, linear gradient 0-100 B % (1 mL/min), 9.1-12.5 min, 100% buffer B (1 
mL/min); 12.5-12.6 min, linear gradient 100-0% buffer B (1 mL/min); 12.6-20 
min, 100% buffer A (1 mL/min). The flow-through fraction (depleted serum 
collected between 2-6 min) of a total volume of appr. 1 mL was collected [9]. 
Each serum sample obtained after different clotting times (1, 2, 4, 6, 8 h) was 
depleted in duplicate. 
Protein concentrations were determined with the Micro BCATM Protein assay 
reagent kit (www.piercenet.com) and calculated for an average protein 
molecular weight of 50 kDa. BSA was used as the calibration standard. 
Depleted serum samples were digested with trypsin (sequencing grade 
modified trypsin, Promega, cat # V5111, USA) at an enzyme-to-substrate ratio 
of 1 : 20 overnight at 37°C with shaking at 400 rpm (Eppendorf Thermomixer) 
and 4% of the digest were subjected to capillary LC-MS analysis. 
 Influence of clotting time on the protein composition of serum samples based on LC-MS data 
110 
2.3. Standard addition of horse heart Cytochrome C 
Serum samples were spiked with 21 – 50 pmol of horse heart Cytochrome 
C (Sigma, www.sigmaaldrich.com, cat. # 9007-43-6) prior to immunodepletion 
(21 pmol (+) or 50 pmol (++)), of which 10% were subjected to the LC–MS 
analysis after trypsin digestion. Cytochrome C was alternatively digested with 
trypsin and added in the same amounts to depleted and trypsin-digested 
serum (1 h clotting time) prior to LC–MS (21 pmol (n+) or 50 pmol (n++)). 
 
2.4. Cap-LC-MS 
All LC-MS analyses were performed on an Agilent 1100 capillary HPLC 
system coupled on-line to an SL ion-trap mass spectrometer 
(www.home.agilent.com) equipped with an Atlantis™ dC 18 (1.0 × 150 mm, 3 
μm) column that was protected by an Atlantis™ dC 18 in-line trap column (3 
μm, 2.1 mm × 20 mm guard column). 40 µL of the pretreated (depleted and 
digested) fractions corresponding to ~8 µg or 160 pmol of total protein digest 
(calculated based on a 50 kDa protein) were injected. The autosampler (cat. # 
G1367A) was equipped with a 100 µL injection loop and a temperature-
controlled cooler (cat. # G1330A) maintaining the samples at 4°C. The HPLC 
system had the following additional components: capillary pump (cat. #, 
G1376A), solvent degasser (cat. #, G1379A), UV detector (cat. # G1314A) and 
column holder (cat. #, G1316A). The sample was injected and washed in the 
back-flush mode for 30 min (0.1% aq. formic acid (FA) and 3% acetonitrile 
(AcN) at a flow rate of 50 µL/min). Peptides were eluted in a linear gradient 
from 0 to 70% (0.5%/min) AcN containing 0.1% FA at a flow-rate of 20 
µL/min. After each injection, the in-line trap and the analytical column were 
equilibrated with eluent A (H2O/AcN/FA; 950:50:1) for 20 min prior to the 
next injection. 
The following settings were used for mass spectrometry during LC-MS. 
Nebulizer gas: 16.0 psi N2, drying gas: 6.0 L/min N2, skimmer: 40.0 V, 
ionisation voltage: 3500 V, cap. exit: 158.5 V, Oct. 1: 12.0V, Oct. 2: 2.48 V, Oct. 
RF: 150 Vpp (Voltage, Peak Power Point), Lens 1: -5.0 V, Lens 2: -60.0 V, Trap 
drive: 53.3, T: 325°C, Scan resolution: enhanced (5500 m/z per second scan 
speed). Target mass: 600. Scan range: 100-1500 m/z. Spectra were saved in 
centroid mode. LC-MS chromatographic data were analyzed with Bruker Data 
Analysis software, version 2.1 (Build 37) [9]. 
 
2.5. TCA precipitation of serum samples and MALDI-TOF-MS analysis 
TCA, dissolved in 40 µL ice-cold water, was added to 20 μL of the original 
serum samples to reach a final concentration of 5%. After 30 min on ice, 
samples were filtered through 0.22 µm spin filters (Part # 5185-5990, Agilent) at 
13000 g at 4°C for 10 min to remove particulates. Filtrates were used for further 
analysis. Chapter IV 
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For MALDI-TOF-MS analysis, 2 μL of the filtrates of the TCA precipitate were 
purified using C18 Stage tips (Proxeon, Odense, DK) according to the manufacturer’s 
instructions. Peptides were eluted in 2 μL of 5 mg/mL α-Cyano-4-hydroxycinnamic 
acid (CHCA) in 50% AcN/0.1%TFA and directly spotted on a stainless-steel MALDI 
target. Analysis was performed in the positive ionization mode using a Voyager DE Pro 
instrument (Applied Biosystems, Foster City, California, USA). Spectra were 
acquired in reflectron mode with delayed extraction. Mono-isotopic molecular 
masses were considered in the further analysis and the instrument was 
calibrated using singly-charged BSA tryptic fragments with the m/z values of 
927.49 Da and 2045.03 Da. 
 
2.6. iTRAQ labeling of depleted serum 
Changing of buffer and concentration of samples for iTRAQ labeling of 
depleted serum were done by ultrafiltration (Concentrators, Spin 5K MWCO, 4 
mL, Part no 51855991, Agilent) using 5 mL of 10% AcN with 0.1% TFA in 
water. Samples were evaporated to dryness in a CentriVapConcentrator 
(LABCONCO, Kansas City, Missouri, USA) before labeling. iTRAQ labeling 
was performed according to the manufacturer’s protocol [Applied Biosystems, 
iTRAQ™ Reagents Application Kit-Plasma (Amine-Modifying Labeling 
Reagents for Plasma Sample Applications)] with modification of the trypsin-to-
protein ratio (1:14 instead 1:5.75 w/w). Sequencing grade modified trypsin was 
from Promega. 
 
2.6.1. Strong Cation Exchange (SCE) fractionation 
In order to remove excess iTRAQ reagent and to simplify the ensuing 
reversed-phase nanoLC-MS-MS analysis, the peptide mixture was washed and 
fractionated using a strong-cation exchange column [PolyLCinc 4.6 × 200mm 
column, column volume: 3.3 mL (Columbia, Maryland, USA)] operated at 0.2 
mL/min (AKTA Purifier 10 with frac-900 fraction collector, GE Healthcare Bio-
Sciences AB, Uppsala, Sweden). The mobile phase was comprised of two 
buffers: A: 5 mM KH2PO4/H3PO4 pH 3, 25% AcN and B: 5 mM KH2PO4/H3PO4 
pH 3, 25% AcN, 1.0 M KCl. The KCl concentration was varied in three 
segments: 15%B [12 column volumes (CVs)], 50%B (3CVs), 100%B (5CVs), KCl 
(10 mM/min). The resulting 50 fractions (0.2 mL each) were pooled to obtain 
20 fractions based on intensity and dried in a CentriVapConcentrator prior to 
nanoLC-MS-MS analysis. 
 
2.6.2. Reversed-phase nanoLC-MS-MS 
Derivatized peptides (pooled SCE fractions) were dissolved in 50 μL 2% 
AcN/0.1% FA and analyzed by nanoLC-MS/MS on a hybrid quadrupole time-
of flight mass spectrometer (QSTAR® XL, Applied Biosystems) connected to an 
1100 nanoHPLC system (Agilent). 10 μL of the SCE fractions were loaded onto 
a 0.3 mm × 0.5 cm C18-PepMap trapping column (Dionex, Sunnyvale, Influence of clotting time on the protein composition of serum samples based on LC-MS data 
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California, USA) at a flow rate of 10 μL/min (2% AcN/ 0.1% FA). After 30 
minutes of washing, the trap column was switched and peptides were 
separated on a 75 μm × 15 cm C18 PepMap column (Dionex). Peptides were 
eluted at a flow rate of 300 nL/min using a 105 min gradient ranging from 
95%A to 50%A [A: H2O /AcN/FA (950:50:1), B: H2O /AcN/FA (50/950/1)]. 
The outlet of the column was connected to an on-line standard coated silica 
picotip with a 10 μm ID (NewObjective, Woburn, Massachusetts, USA). The 
typical ionspray voltage was 2200V. Data was acquired using an independent 
data acquisition (IDA) protocol where, for each cycle, the 3 most abundant 
multiply-charged peptides (2 to 4 charges) in the MS scan with m/z values 
between 350 and 1500 amu were selected for MS/MS. For precursor ion 
selection, a threshold of 30 counts was applied. Each precursor ion was 
selected twice and then dynamically excluded for the following 60 seconds. 
Protein identification and quantification was carried out using ProQuant 
software v1.1 (Applied Biosystems). The search was performed against the 
Uniprot/SwissProt knowledge database (V49, downloaded May 2005). The 
search parameters allowed a tolerance up to 0.15 Da for precursor ion selection 
and the obtained MS/MS fragments, one missed cleavage (trypsin), oxidation 
of methionine (variable modification) and cysteine modification with 
iodoacetamide (fixed modification). ProGroup Viewer software v1.0.2 from 
Applied Biosystem was used to identify proteins with at least 95% confidence. 
The results obtained from ProGroup Viewer were exported to Microsoft Excel 
for further analysis. 
 
2.7. iTRAQ labeling of TCA-precipitated serum supernatant 
20 μL of TCA-precipitated serum supernatant were evaporated to dryness 
in a CentriVapConcentrator (LABCONCO) before labeling. iTRAQ labeling 
was performed according to the manufacturer’s protocol with stable-isotopes 
[iTRAQ reagents with 114 (2 h) and 117 (6 h) isobaric tags] (see also section 2.6 
for details). The samples were analyzed by LC-MS-MS with collision 
parameters optimized for observing the reporter mass tags. 
 
2.8. NanoLC-MS-MS analysis of TCA-precipitated serum 
NanoLC-MS/MS was performed as described under 2.6.2 with some 
modifications. The supernatant of TCA-precipitated serum was diluted ten fold 
with 2% AcN/ 0.1%FA, and 8 µL of the diluted sample were loaded onto a 0.3 
mm × 0.5 cm C18-PepMap trapping column (Dionex) at a flow rate of 10 
µL/min (2%AcN/0.1% FA). After 3 min of washing, the trap column was 
switched towards nanoLC and peptides were separated on a 75 μm × 15 cm 
C18 PepMap column (Dionex). Peptides were eluted using a 57 min gradient 
ranging from 98%A to 50%A (A: H2O/AcN/FA; 950:50:1, B AcN/ H2O /FA; 
950:50:1). The column was connected to a spray capillary (10 µm tip) 
(NewObjective). The ion spray voltage applied was 2500 V. Data was acquired Chapter IV 
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using an independent data acquisition (IDA) protocol where, for each cycle, the 
most abundant, multiply charged peptides (2 to 4 charges) in the MS scan with 
m/z between 350 and 1500 were selected for MS/MS. A threshold of 30 counts 
was applied. Each peptide was selected twice and then dynamically excluded 
for 15 seconds. 
The resulting data was processed using Analyst QS 1.1/BioAnalyst software 
(Applied Biosystem) with MASCOT (Matrix Science, London, UK) used for 
protein/peptide identification : MS/MS search parameters: enzyme: none; 
variable modifications [deamidation (NQ), oxidation(M), Phospho (ST), 
pyroGlu (N-term E/Q), mono-isotopic, tolerance 0.2 Da]. The search was 
performed against the Uniprot/SwissProt knowledge database (V49, 
downloaded May 2005). 
 
3. Data analysis 
3.1. Computational environment 
For (pre-)processing and multivariate statistical analysis the original 
Bruker Daltonics label-free LC-MS data files were converted into ASCII-format 
with the Bruker Data Analysis software. For all other type of data and 
statistical analyses (e.g. one-way ANOVA), and visualization Matlab (version 
7.2.0.232 (R2006a), Mathworks, Natick, Massachusetts, USA) was used. 
Principal Component Analysis was performed using the PLS toolbox (version 
3.5.2, Eigenvector Research Inc., Wenatchee, Washington, USA) under Matlab 
environment. All data preprocessing work was done on a personal computer 
equipped with a +3600 MHz AMD processor and with 4 GB of RAM. 
 
3.2. Pre-processing and statistical analysis of label-free LC-MS data 
Centroid data were smoothed and reduced using a normalized two-
dimensional Gaussian filter, by rounding the nominal m/z ratios to 1 m/z (the 
original data had a resolution of 0.1 m/z). In the retention time dimension no 
data reduction was performed. This meshing procedure reduced the number of 
available data points by roughly a factor 10 and corrected for shifting m/z 
values as a result of different loadings of the ion-trap during elution of 
abundant peptides, a phenomenon that is common for ion-trap mass analyzers 
[26,27]. After meshing the data files, all chromatograms were time-aligned 
(warped) to a reference data file using Correlation Optimized Warping (COW) 
[28] based on TICs constructed from signals in the range 100-1500 m/z. 
A modified M-N rule was applied for peak detection by first calculating a local 
median baseline using the sliding window technique separately for each m/z 
trace. A median window size of 1200 data points, corresponding to 20.84 min, 
was used with a moving rate of 10 points and the minimum median value was 
set to 200 counts. According to the M-N rule, a threshold of M-times the local 
baseline was used and a peak was assigned if, within one m/z trace, the signal 
exceeded this threshold for at least N consecutive points [26]. For each detected Influence of clotting time on the protein composition of serum samples based on LC-MS data 
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peak the m/z value, the mean retention times of the three highest measured 
intensities within the same peak reduced by the local baseline value were 
stored in a peak list created for every chromatogram. We used a similar 
approach as Radulovic et al. [26] to obtain optimal settings for M and N. 
Different values for M (1.5-4) and N (4-8) were applied to two blank LC-MS 
runs and to two LC-MS runs of depleted, trypsin-digested serum samples. 
Settings were used at which the ratio between the number of peaks (between 
60-155 min) in the samples relative to the blank chromatograms was highest 
and at which a minimal number of peaks was extracted from the noise in the 
blank chromatogram (M = 2 and N = 5 in our case). 
In order to combine the peak lists from different samples, one-dimensional 
peak matching was applied using the sliding window technique, in which the 
same m/z traces were evaluated for peaks that are proximate in time (step size 
0.1 min; search window 1.0 min; maximal accepted standard deviation for all 
retention times within a group of matched peaks was 0.75 min). Missing peak 
allocation was performed by extracting the background subtracted local signal 
of the given m/z trace at the given retention time. The generated peak matrix, 
created from the peak lists of the individual samples, consisted of a peak(row)-
sample(column)-intensity(value) matrix. This peak matrix was used for 
multivariate statistical analysis. 
 
3.3. Analysis of iTRAQ data 
The ProQuant software was used to calculate the intensity of 3 reporter 
ions (m/z: 115, 116 and 117) and to divide them by the intensity of the 4th 
reporter ion (m/z: 114) for each measured compound. Systematic experimental 
error occurring during sample preparation and measurement were corrected 
by subtracting the median of the corresponding ion ratio series (115/114, 
116/114 and 117/114) for all compounds and adding one. 
The data from two experimental series were analyzed. The first series (Series 1) 
contained samples with 1 and 2 h of clotting time with each sample measured 
in duplicate. The second series (Series 2) contained samples with 2, 4, 6 and 8 h 
of clotting time each of them measured once. Data from Series 1 were 
normalized to one sample with 1 h clotting time and data in Series 2 were 
normalized to the 2 h clotting time sample, which was used as denominator in 
the calculation of ion ratios. The number of identified proteins (95% 
confidence; see section 2.6.2) was 129 for Series 1 and 96 for Series 2, 
respectively. 
Even after correction for experimental bias between different series of 
measurements as described above, there is fluctuation of the ion ratios within a 
single series. The aim of the further statistical analysis is to determine whether 
a difference in ion ratio is statistically significant relative to the measurement 
errors (expressed in terms of standard deviations). To this end, all ratios were 
transformed into decimal logarithms so that all ratios obtained from a single Chapter IV 
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sample (excluding clotting time-related abundance differences) will have 
normal distribution. We selected “reference series” to calculate the standard 
deviation (SD) characterizing a particular set of measurements. In this study 
the reference series for Series 1 (1 and 2h clotting time measured in duplicate) 
were the duplicate samples at 1 and 2h, since differences between them cannot 
be due to clotting time. For Series 2 (2, 4, 6 and 8h clotting time) we based our 
reference series on the assumption that there are few, if any, differences 
between 6 and 8h clotting time and that differences between these time points 
are largely due to experimental error. Ion ratios were plotted against the 
number of identified proteins (supporting information Fig. S1), Gaussian 
curves were fitted on the smoothed histograms (histogram between -1 and 1 
with 200 steps, smoothing using a Savitzky-Golay algorithm) and the standard 
deviations (SD) were determined. Proteins with log-transformed ion ratios 
differing by at least 3xSD (99.7% confidence) were considered significantly 
different from the random fluctuation calculated for the corresponding 
reference series. resulted in only one compound significantly different from the 
reference series. For Series 1 the mean of the 2 samples with 2 h of clotting time 
w a s  u s e d  t o  s e l e c t  p r o t e i n s  t h a t  d i f f e r e d  s i g n i f i c a n t l y  d i f f e r e n t  f r o m  t h e  
reference series. For Series 2 all proteins were included that showed a 
significant difference for at least one clotting time point. The log-transformed 
ratios of the selected proteins were used to visualize the clotting time-related 
differences (see Figure 7). 
 
3.4. Statistical Analysis 
For Principal Component Analysis (PCA) the processed data was mean-
centered and normalized with respect to the standard deviation. One-way 
ANOVA was used for univariate statistics. 
 
4. Results and discussion 
The preparation of serum is a complex biochemical process and may be 
difficult to control, since cellular metabolism and the activity of extracellular 
enzymes continues for many hours after the collection of blood [6,7]. Some 
authors have noted that clotting time affects the resulting serum proteome, and 
that these effects are most pronounced in the low-molecular-weight portion, 
the so-called peptidome [1,3]. 
It is likely that changes in serum occur due to varying clotting times but it is 
not clear to which extent such changes affect subsequent proteomics analyses. 
This is dependent on the employed analytical approach (e.g. shotgun 
proteomics versus peptidomics) as well as on the use of label-free versus 
stable-isotope labeling techniques. Finally this depends also on the 
concentration sensitivity of the employed methodology, since high-abundance 
proteins may be less prone to significant relative change than those of lower 
abundance. Since biomarker discovery generally uses a comparative study Influence of clotting time on the protein composition of serum samples based on LC-MS data 
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design, it will also depend on how large and reproducible group-specific 
differences in serum proteomes are relative to variation induced by pre-
analytical factors such as the clotting time. 
In order to study the effect of clotting time on both the serum proteome and the 
serum peptidome, we have used two complementary methodologies. The first 
was based on tryptic digestion of serum after depletion of the six most 
abundant serum proteins followed by LC-MS (proteome), and the second on 
acid precipitation of serum and analysis of the supernatant (peptidome). The 
effect of clotting time was assessed with label-free and stable-isotope labeling 
techniques. 
 
4.1. Label-free serum analysis after depletion and tryptic digestion 
Serum was prepared and analyzed by capillary-LC ion-trap mass 
spectrometry (LC-MS) as previously described [9]. The six most abundant 
proteins were depleted by immunoaffinity chromatography [29]. In order to 
compare the effect of clotting time relative to a known change in the serum 
proteome, horse heart Cytochrome C was added to one group of samples at a 
concentration of 8 or 20µM prior to depletion (the concentration after depletion 
is 5-times lower due to co-depletion of Cytochrome C). This method was 
previously shown to have a concentration sensitivity of appr. 0.5µM for the 
added Cytochrome C. Clotting times of 1, 2, 4, 6 and 8h were compared, in 
duplicate, by both univariate (ANOVA) and multivariate (PCA) statistical 
analyses after data processing. 
Using in-house-developed algorithms [10], a matched peak matrix was 
generated from the LC-MS data. This peak matrix contained 12659 aligned 
features that are defined in terms of retention time, m/z value and intensity. 
The LC-MS traces (Total Ion Chromatograms; TICs) of depleted, trypsin-
digested serum samples showed little if any visible differences (Figure 1). Chapter IV 
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Figure 1. LC-MS analysis of immunodepleted, trypsin-digested human serum. Comparison of 
Total Ion Chromatograms (TICs) of serum samples obtained after 1, 2, 4, 6 and 8 h of clotting time. 
 
 
Figure 2. Correlation map of peak lists from all LC-MS analyses of depleted, trypsin-digested 
serum obtained after different clotting times (1, 2, 4, 6 and 8 h) and spiked with horse heart 
Cytochrome C (21 pmol (+), 50 pmol (++)) before the depletion step or with a tryptic digest of 
Horse heart Cytochrome C (21 pmol (n+) and 50 pmol (n++)) before LC-MS analysis. Highest 
correlation (1.0) = white, lowest correlation (0.9) = black. All non-spiked samples were analyzed in 
duplicate (s1 and s2) while single measurements were performed on the spiked samples. Samples 
are grouped by similarity (note that spiking of Cytochrome C results in a clearly decreased 
correlation coefficient, which is further decreased when a tryptic digest of Cytochrome C is added 
directly prior to LC-MS analysis). Influence of clotting time on the protein composition of serum samples based on LC-MS data 
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A correlation map, comparing the peak lists of all LC-MS data files related to 
samples obtained after different clotting times (highest correlation (1.0) = 
white, lowest correlation (0.9) = black) confirmed this result by showing an 
overall high correlation (Figure 2). These results indicate the absence of major 
differences between serum samples with clotting times ranging from 1 to 8h 
analyzed by the described method. Contrary to this, the correlation map clearly 
separated the spiked (before depletion 21pmol (+) or 50pmol (++) and after 
depletion 21pmol (n+) and 50pmol (n++)) from the non-spiked samples, 
showing that the effect of spiking of Cytochrome C outweighs the effect of 
clotting time. 
 
(b) (a)
 
 
Figure 3. Principal Component Analysis (PCA) score plots of aligned peak matrixes obtained from 
LC-MS analysis of depleted, trypsin-digested serum after clotting times of 1, 2, 4, 6 and 8h. All 
analyses were performed in duplicate on different days (denominated as s1 and s2). Samples 
containing added horse heart Cytochrome C are labeled + (8 µM) or ++ (20 µM). In samples labeled 
n+ (8 µM) and n++ (20 µM) a tryptic digest of Cytochrome C was added directly prior to the LC-
MS analyses. a) PCA scores plot for non-spiked samples; b) PCA scores plot for spiked (red) and 
non-spiked (black) samples. 
 
The generated aligned peak matrix was subjected to Principal Component 
Analysis (PCA) and the calculated scores of PC1 and PC2 were visualized 
(Figure 3). Fig. 3a shows that there is no clear discrimination between samples 
with respect to clotting time. Differences between duplicate measurements (s1 
and s2) appear to be similar when compared to differences between samples 
obtained after different clotting times. This indicates that varying the clotting 
time between 1 and 8h does not lead to detectable differences with the 
described analytical method. On the contrary, Fig. 3b shows that adding 8µM 
of Cytochrome C (appr. 1.6µM after depletion) leads to a clear discrimination 
between “spiked” (red) and “non-spiked” (black) samples. These data indicate 
that variable clotting times do not prevent detection of a single protein at a 
concentration of about 1.5 µM or 50µg/mL (for a 50kDa protein) using the Chapter IV 
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described methodology. Proteins that are present at this concentration are, 
however, still considered “classical serum or plasma proteins” [30]. To find 
smaller local differences between samples that are the result of different 
clotting times supervised classification methods should be used instead of 
unsupervised multi-variate statistical methods. 
The obtained peak lists were further analyzed by univariate statistical 
analysis (ANOVA). In this way a p-value is calculated for each peak expressing 
the magnitude of the effect of a certain factor (clotting time or spiking with 
Cytochrome C). Table 1 lists several peaks showing significant differences (p-
values < 1.6 x 10-4) between the samples obtained at different clotting times and 
Figure 4 shows box plots for several of the listed peaks. While there is a fairly 
even distribution of p-values when considering clotting time only, there are 
more peaks with very low p-values in the case of added Cytochrome C (p-
values < 2.2 × 10-11; Table 2) indicating that addition of Cytochrome C clearly 
outweighs the effect of clotting time. 
The peaks shown in Table 1 were subjected to LC-MS-MS analysis and 
identified as corresponding to fragments of Fibrinogen alpha chain 
(FIBA_HUMAN (P02671); m/z = 733 and 809) or to Fibrinogen beta chain 
(FIBB_HUMAN (P02675); m/z = 1325) with a pyroglutamic acid at the N-
terminus (see Fig. S2-S4, supporting information for further details), while all 
peaks in Table 2 were derived from Cytochrome C. Extracted Ion 
Chromatograms (EICs) of discriminative peaks corresponding to fragments of 
Fibrinogen alpha chain (m/z: 733, 91.22 min and m/z: 809, 93.42 min) at 1, 2, 4, 
6 and 8 h of clotting times are presented in Figure S5 (supporting information). 
 
(b) (a)
 
Figure 4. Box plots of the intensity values of two fibrinogen-derived peptide peaks that change 
significantly with clotting time (see Table 1). Peptides were identified as fragments of Fibrinogen 
alpha chain [(a) DSGEGDFLAEGGGVR; (b) ADpSGEGDFLAEGGGVR); FIBA_HUMAN (P02671)] 
(see Fig. S2 and S3, supporting information). 
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The peaks which correspond to p-values below 1.6 × 10-4 with respect to 
clotting time are listed in Table 1 and those with respect to Cytochrome C 
addition (p-values below 2.2 × 10-11) in Table 2. 
 
Table 1. Peaks detected in serum that are significantly affected by clotting times 
ranging from 1 to 8h. Calculations are based on a comparison of intensities by 
one-way ANOVA. 
 
p-value    m/z  Retention time (min)  Peptide sequence 
2.6 10-7      733 1   91.09   DSGEGDFLAEGGGVR 
1.1 10-4    1325 2   103.87   QGVNDNEEGFFS 
1.6 10-4      809    93.42    ADSGEGDFLAEGGGVR 
1 isotopic peaks at m/z 732 (p = 1.4 x 10-4) and 734 (p = 6.2 x 10-8) show also significant 
differences. 
2 the isotopic peak at m/z 1324 shows also a significant difference (p = 2.8 x 10-4). 
 
Table 2. Peaks detected in serum that are significantly affected by the addition 
of horse heart Cytochrome C (8µM prior to depletion) independent of clotting 
times ranging from 1 to 8h. Calculations are based on a comparison of 
intensities by one-way ANOVA. 
 
m/z 
measured1 
m/z 
expected 
charge 
state 
retention 
time (min) 
p-value Cytochrome  C  sequence 
634 634,4  +1  76.14  <1.00e-015  IFVQK 
453 454,3  +2  92.18  1.74e-014  MIFAGIKK 
966 964,5  +1  98.67  9.16e-014  EDLIAYLK 
559 559,3  +3  99.22  9.51e-014  GGKHKTGPNLHGLFGR 
452 450,9  +3  92.22  2.30e-013  TEREDLIAYLK 
749 748,3  +2  104.36  4.57e-013  EETLMEYLENPK 
782 781,4  +2  95.24  4.61e-013  HKTGPNLHGLFGRK 
798 799,9  +2  103.19  7.82e-012  KTGQAPGFTYTDANK 
1169 1168,6  +1  91.82  1.60e-011  TGPNLHGLFGR 
1 after meshing to integer values 
 
4.2. Detailed analysis of Fibrinopeptides after TCA precipitation 
The analysis of depleted and trypsin-digested serum indicated that 
fibrinogen-related peptides were affec t e d  b y  c l o t t i n g  t i m e ,  a s  m i g h t  b e  
expected. We therefore examined the effect of clotting time on the overall 
serum peptidome in more detail. TCA precipitation after 2 and 6 hours clotting 
time was used to enrich the low molecular weight fraction and the resulting 
supernatant was analyzed by MALDI-TOF-MS to gain an overview of the 
peptide patterns (Figure 5). Chapter IV 
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A small set of prominent peptide peaks was observed. The spectrum was 
dominated by a peak at m/z 1465.8, which was identified as an N-terminally 
truncated form of Fibrinopeptide A (FPA) (DSGEGDFLAEGGGVR, doubly-
charged ion of m/z 733.8 (supporting information, Fig. S2, Table S1)) by LC-
MS/MS. This peptide was also shown to be most significantly affected by 
clotting time based on the univariate statistical analysis of the LC-MS data (see 
Table 1). A minor signal for intact FPA (ADSGEGDFLAEGGGVR) at m/z 
1536.6 was also observed. Database-search of the LC-MS/MS data showed that 
the majority of the observed signals using this approach were derived from 
FPA (Table S1). Interestingly, two post-translational modifications of FPA were 
seen in the MALDI spectrum. Peaks at m/z 1545.7 and 1616.8 correspond to 
the phosphorylated forms DpSGEGDFLAEGGGVR (doubly-charged ion m/z 
773.4) and ADpSGEGDFLAEGGGVR (doubly-charged ion m/z 808.8) as 
confirmed by LC-MS/MS (supporting information, Fig. S3,S4)). The MALDI 
spectrum showed also two less well-resolved peaks at m/z 1524,5 and m/z 
1453 (Figure 5C). These peaks represented metastable ions due to the formation 
of dehydro-alanine (loss of phosphoric acid from the phosphorylated serine 
during flight to the detector). Besides FPA-related peptides, partial sequences 
of Fibrinopeptide B (FPB) were also identified. 
In order to gain further insight into the ratios of FPA- and FPB-related 
peptides at 2 and 6h clotting time, supernatants after TCA precipitation were 
labeled with stable-isotopes (iTRAQ reagents with 114 (2h) and 117 (6h) 
isobaric tags). The samples were analyzed by LC-MS-MS with collision 
parameters optimized for observing the reporter mass tags. Database search of 
the MS/MS data sets allowed the identification of a greater variety of peptides 
than in the original, targeted analyses. Fragments of FPA and FPB were readily 
identified but quantification was problematic, due to the fact that the software 
(proQuantTM 1.1) is designed for tryptic peptides and not for naturally 
occurring peptides with non-tryptic cleavage sites. Extracted ion traces related 
to Fibrinopeptides from the data base search were therefore inspected 
manually. As an examples, the MS/MS spectra of the iTRAQ-labeled peptides 
ADpSGEGDFLAEGGGVR and FLAEGGGV are shown in Figure 6. In the 
insert the iTRAQ reporter ions indicate that the amount of this peptide is 
reduced by a factor 1.75 between 2 and 6h clotting time (Figure 6A), whereas 
another iTRAQ-labeled FPA peptide (FLAEGGGV; m/z 447 doubly-charged 
ion) showed a 2.8-fold increase over this time period (Figure 6B). An overview 
of all identified peptides is given in Table S2 (supporting information). 
These experiments show that a number of peptides derived from 
Fibrinogen changed in abundance with respect to clotting time and that these 
peptides can be easily detected in the so-called peptidome due to their 
relatively high-abundance. Influence of clotting time on the protein composition of serum samples based on LC-MS data 
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Figure 5. MALDI-TOF-MS spectrum of the supernatant of TCA-precipitated serum after 2 (A) and 
6h (B) clotting time. The major peak at 1465.8 corresponds to an N-terminally truncated form of 
Fibrinopeptide A (FPA) and the minor peak at 1536.8 (Fig. 5C) corresponds to full-length FPA. 
These forms of FPA were also observed as serine-phosphorylated forms (m/z 1545.7 and m/z 
1616.8). (C) Metastable ions at m/z 1453 and 1524,5 (labeled with * in panel (C)) indicate the 
presence of dehydro-alanine due to decay of the metastable phosphoserine residue during MALDI-
TOF-MS analysis. Chapter IV 
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Figure 6. MS/MS spectrum of the iTRAQ-labeled, phosphorylated Fibrinopeptide A (FPA) 
(ADpSGEGDFLAEGGGVR) (a). The insert shows the relative abundance of this peptide at 2h [114 
mass tag] and 6h [117 mass tag] clotting time (ratio 2h/6h = 1.75). MS/MS spectrum of iTRAQ-
labeled truncated FPA (FLAEGGGV; m/z 447.3 doubly-charged ion) which increases by 2.8-fold 
between 2 [mass tag 114] and 6h [mass tag 117] clotting time (b). Influence of clotting time on the protein composition of serum samples based on LC-MS data 
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4.3. Multiplexed analysis of trypsin-digested serum 
Since the concentration sensitivity of the label-free analytical method 
described in section 4.1 reaches only about 0.5µM, it was of interest to apply a 
two-dimensional HPLC method with stable-isotope labeling to obtain a more 
comprehensive view of the effect of clotting time on the serum proteome. The 
initial experimental design consisted of varying clotting time between 2, 4, 6 
and 8 h followed by immunodepletion of the six most abundant proteins. 
Proteins were furthermore reduced and alkylated and digested with trypsin 
prior to derivatization with a different isobaric tag for each clotting time [114 
(2h), 115 (4h), 116 (6h) and 117 (8h)]. The combined samples (50 µg each) were 
fractionated by Strong Cation-Exchange HPLC (SCX; 20 fractions) prior to 
reversed-phase nanoLC-MS-MS analysis. The LC-MS-MS data were used for 
relative quantification and identification of proteins. 96 proteins were 
identified with a confidence higher than 95% and quantified relative to each 
other using the reporter mass tags in the MS/MS spectra of selected multiply-
charged ions. Examples of spectra produced after iTRAQ labeling are shown 
(supporting information, Figure S6). 
All the data files were analyzed separately using the ProQuant software. 
This software package is able to quantify the reporter ions and to calculate the 
ratio relatively to a preset denominator, in this case the 2h clotting time point 
(mass tag 114). A bias (multiplication factor) was applied in order to correct for 
systematic differences in the iTRAQ ratios due to experimental errors related to 
sample preparation (e.g. combining the different reaction mixtures; small 
differences in dilutions). The software calculates this bias and corrects the 
ratios assuming that the majority of proteins does not differ in response to 
clotting time and that the median iTRAQ ratio should be 1. In the experiment 
used the mean bias applied was 1 for the 114 (2h) signal (was set to 1), 1.09 for 
115 (4h), 1.34 for 116 (6h) and 1.14 (8h) for 117. 
Visualization of the obtained ratios for the 96 identified proteins (Figure 
7a) showed that 10 proteins have significant differences in ratios relative to the 
2h clotting time point (Figure 7a). Three of them (Complement component C8 
alpha chain precursor (P07357), Hepatocyte growth factor activator precursor 
(HGF activator) (Q04756), Ig kappa chain C region (P01834)) were increased 
and seven (Insulin-like growth factor II precursor (IGF-II) (Somatomedin A) 
(P01344), Leucine-rich alpha-2-glycoprotein precursor (LRG) (P02750), 
Complement factor H-related protein 1 precursor (FHR-1) (H factor-like 
protein 1) (H-factor-like 1) (Q03591), Serum amyloid P-component precursor 
(SAP) (9.5S alpha-1-glycoprotein) ((P02743), Coagulation factor IX (P00740), 
Complement factor H-related protein 2 precursor (P36980) and Apolipoprotein 
C-IV precursor (P55056)) were decreased. All mentioned proteins were 
increased or decreased relative to the reference series (see Materials and 
Methods; section 3.3) with a confidence above 99.7%. However, none of the 
mentioned proteins was more than +/- 50% increased or decreased. Chapter IV 
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Figure 7. Compound showing significant difference in sample having clotting time of 2, 4, 6 and 8 
hours (a) and clotting time 1 and 2 hours (in duplicate) (b) using iTRAQ quantification. The 
number on the figures are corresponding to the following proteins: (a): 1: SAMP_HUMAN 
(P02743) 2: FA9_HUMAN (P00740), 3: FHR2_HUMAN (P36980), 4: APOC4_HUMAN (P55056), 5: 
CO8A_HUMAN (P07357), 6: HGFA_HUMAN (Q04756), 7: KAC_HUMAN (P01834), 8: 
IGF2_HUMAN (P01344), 9: A2GL_HUMAN (P02750), 10: FHR1_HUMAN (Q03591); (b): 1: 
APOC1_HUMAN (P02654), 2: FIBA_HUMAN (P02671), 3: SC1_HUMAN (Q08554), 4: 
APOF_HUMAN (Q13790), 5: A2GL_HUMAN (P02750), 6: ALBU_HUMAN (P02768), 7: 
EPC2_HUMAN (Q52LR7), 8: HV3P_HUMAN (P01777). 
 
Since it was not possible, at the time, to include more then 4 different 
clotting time points in one iTRAQ experiment, we compared the effects of 
shorter clotting times [1h (mass tags 114, 115) and 2 h (mass tags 116, 117)] in 
separate duplicate experiments. The analysis resulted in the identification of 
129 proteins at the 95% confidence level. Based on an analogous analysis of the 
obtained data, eight proteins were shown to differ between serum samples 
with 1h as compared to 2h clotting time (Fig. 7b). Human serum albumin 
precursor (P02768), Fibrinogen alpha chain (P02671), Desmocollin-1 (Q08554) 
and Ig heavy chain V-III region TEI (P01777) were increased in concentration 
(up to +70%) and Apolipoprotein C-I (P02654), Apolipoprotein F (Q13790), 
Leucine-rich alpha-2-glycoprotein (P02750) and Enhancer of polycomb 
homolog 2 (Q52LR7) were decreased by at least 100%. Overall it appears that 
changes to the serum proteome are more drastic between 1 and 2 h clotting 
time and that the serum proteome “stabilizes” after 2 h. 
Fibrinogen alpha chain (P02671), from which Fibrinopeptide A is cleaved 
off during blood clotting, was up-regulated after 2h clotting time compared to 
1h but this difference was not significant at a confidence level of 99.7%. 
Fibrinogen alpha chain is involved in blood clotting and Fibrinopeptide A is 
the product of Fibrinogen cleavage during coagulation. Since we did not 
observed further changes in the relative abundance of this peptide after 2h 
clotting time, it is likely that coagulation was completed (Figure 7b). 
Coagulation factor IX (P00740), consisting of Coagulation factor IXa light 
chain and Coagulation factor IXa heavy chain, was down-regulated after two Influence of clotting time on the protein composition of serum samples based on LC-MS data 
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hours clotting compare to 4, 6 and 8 hours but only in -0.1/-0.2 times which fall 
into the the normal measurement fluctuation. Leucine-rich alpha-2-
glycoprotein (P02750) was down-regulated in all samples compared to one 
hour clotting sample. Leucine-rich alpha-2-glycoprotein is known as marker 
for granulocytic differentiation [31] which is involved in formation of platelets. 
Platelets are components of blood coagulation and activate the final step in the 
process of blood coagulation, thus Leucine-rich alpha-2-glycoprotein related to 
blood coagulation cascade. 
Our studies with immunodepleted, trypsin-digested serum indicate that 
the serum proteome is rather stable once clotting has proceeded for at least 2h. 
Univariate statistical comparisons of the processed LC-MS data showed that 
fibrinogen-derived peptides change significantly with clotting time (p-values 
1.6 x 10-4 to 7 × 10-8) but that most other peptides remain stable in their 
intensities (+/- 25%). A more detailed analysis of these peptides revealed that 
they form a family of truncated forms, some of which contain post-
translational modifications such as phospho-serine or pyroglutamic acid. 
Stable-isotope labeling combined with a two-dimensional chromatographic 
separation showed that 10 out of 96 identified proteins showed statistically 
significant differences between 2, 4, 6 and 8h clotting time. Our results indicate 
that serum stabilizes after 2h clotting under the described conditions, while 
shorter clotting times need to be more tightly controlled. This opens the 
possibility of using disease-relevant serum samples for biomarker discovery 
that would otherwise be very difficult to generate de novo. 
Other authors have observed that clotting time needs to be tightly 
controlled when focusing on the so-called peptidome, the low-molecular 
weight complement of the proteome [3,5]. This is confirmed by our results, 
which show that especially fibrinogen-related peptides vary greatly with 
clotting time. These fibrinopeptides form a family of related molecules that are 
N- or C-terminally truncated as well as phosphorylated or containing N-
terminal pyro-glutamic acid residues (see Table S2, supporting information). 
An increasing number of authors report that proteolytic degradation products 
o f  h i g h - a b u n d a n c e  p r o t e i n s  m a y  b e  r e l a t e d  t o  c a n c e r  a n d  m a y  t h u s  b e  o f  
interest as biomarkers [32,33]. This interesting observation was based on a 
rigorously controlled sample handling and preparation protocol, which may be 
difficult to implement in routine clinical diagnostic laboratories [8]. Some of 
these biomarker candidates were forms of Fibrinopeptides, which are also 
affected by clotting time. It will be interesting to follow the development of this 
field of biomarker research, since cancer development is often associated with 
changes in the balance between the proteolytic systems of the coagulation 
cascade, the fibrinolytic and the complement system. Villanueva et al. [33] 
assume that these major proteolytic systems provide the “founder peptides” 
that are subsequently further degraded by cancer-specific proteases. Chapter IV 
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Our study sheds additional light on the effect of clotting time on the 
composition of the serum proteome and peptidome. Biomarker discovery is 
relying on changes in protein or peptide abundance related to disease relative 
to unavoidable changes due to biological and analytical variations. Abundance 
ratios of some 100 identified proteins changed no more than 10 between 2 and 
8h clotting time while changes were 8 between 1 and 2h. Most analyzed 
proteins were not significantly affected by clotting time. While the expected 
changes in putative, disease-relevant biomarkers can not be predicted, it is 
possible to make a calculation as to how large the relative difference should be 
in order to be statistically significant. The kinetics of blood coagulation are 
affected by multiple factors related to the blood collection tubes (e.g. some 
tubes contain clotting activators) as well as to the medication a patient might be 
taking (e.g. use of anti-coagulants, chemotherapy). We did not study these 
parameters but it is clear that they must be taken into account in comparative 
biomarker discovery studies. The detected fibrinopeptides might be good 
indicators to assess the clotting conditions a posteriori and thus to define 
inclusion/exclusion criteria for serum samples in existing biobanks. The 
question whether serum or plasma should be the preferred blood derivative for 
a given study cannot be answered definitively. Both types of samples have 
their advantages and disadvantages and plasma has also been shown to be 
dependent on a number of parameters, notably the anti-coagulant [3]. Influence of clotting time on the protein composition of serum samples based on LC-MS data 
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Figure S1. Evaluation of iTRAQ data. The thin red and green are the smoothed logtransformed 
ratio of the references sets after correction with the median, and the bold corresponding lines are 
the Gaussian fit. The thin blue and purple curve is the ratios corresponding to set 1 and 2 in which 
significance peak ratios has to be determined. The arrows are indicating the log ratio of area 
considered as significant 3 SD (99.7%). Chapter IV 
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 +TOF Product (733.4): Experiment 4, 37.029 min from 8hrTCA_NoFilt.wiff
a=3.57102881815718470e-004, t0=-3.69373534563346770e+001
Max. 54.0 counts.
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Figure S2. MS-MS spectrum of a FPA fragment (DSGEGDFAEGGGGVR; m/z 733.4 , doubly 
charged) 
 
 +TOF Product (808.9): Experiment 2, 35.137 min from 8hrTCA_NoFilt.wiff
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Figure S3. MS/MS spectrum of a phosphorylated FPA fragment (ADpSGEGDFLAEGGGVR; m/z 
808.9, doubly-charged). Influence of clotting time on the protein composition of serum samples based on LC-MS data 
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 +TOF Product (773.4): Experiment 2, 34.954 min from 8hrTCA_NoFilt.wiff
a=3.57102881815718470e-004, t0=-3.69373534563346770e+001
Max. 42.0 counts.
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Figure S4. MS-MS spectrum of a phosphorylated FPA fragment m/z 773.4 (MM1464.8, 
DpSGEGDFLAEGGGVR, doubly charged) 
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Figure S5. Discriminative peaks [733 m/z, 91.22 min (a) and 809 mz and 93.42 min (b)] between 1 
(upper traces) and 2 (lower traces), 4, 6 and 8 h (lower traces) of clothing time. Chapter IV 
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  +TOF Product (838.0): Experiment 2, 80.347 min from iTRAQ2704_2H_25.w...
a=3.57028561719374580e-004, t0=-3.61682940257596780e+001
Max. 698.0 counts.
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+TOF Product (697.1): Experiment 4, 63.074 min from Sample 1 (Sample00...
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Figure S6.  Examples of iTRAQ data for 2, 4, 6 and 8h clotting time is given. ApoA1 (a) and 
Complement C3 precursor (b) identified. In inserts 114, 115, 116 and 117 ions showed. 
 
Mascot Paramaters; Database Swissprot, 
Type of search : MS/MS Ion Search  Influence of clotting time on the protein composition of serum samples based on LC-MS data 
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Enzyme : None 
Variable modifications : Q->p-E(N-term Q), E->p-E(N-term E), Oxidation(M), 
Phos (ST), Phos(Y)  
Mass values : Monoisotopic  
Protein Mass : Unrestricted  
Peptide Mass Tolerance : ± 0.2 Da  
Fragment Mass Tolerance: ± 0.2 Da  
Max Missed Cleavages : 1  
Instrument type : Default  
Data File Name : D:\mascot mgf files\8hrsTCA.mgf Number of queries : 145 
 
Query Observed  Mr(expt) Mr(calc) Delta Miss Score Rank Peptide 
 277  432.75    863.49   863.40   0.08   0   47    1   DFLAEGGGV 
 305  510.81   1019.60  1019.50   0.10   0   36    2   DFLAEGGGVR 
 307  525.79   1049.56  1049.47   0.10   0   23    1   EGDFLAEGGGV 
 310  539.32   1076.63  1076.52   0.10   0   47    1   GDFLAEGGGVR 
 314  554.30   1106.58  1106.49   0.09   0   28    1   GEGDFLAEGGGV 
 323  597.82   1193.63  1193.52   0.11    0   28    1  SGEGDFLAEGGGV 
 324  603.85   1205.68  1205.57   0.11    0   51    1  EGDFLAEGGGVR 
 340  655.34   1308.67  1308.55   0.12    0   24    1  DSGEGDFLAEGGGV 
 348  675.88   1349.74  1349.62   0.12    0   62    1  SGEGDFLAEGGGVR 
 366  730.85   1459.68  1459.55   0.13    0   20    3  ADSGEGDFLAEGGGV+Phos.(ST) 
 368  733.40   1464.78  1464.65   0.13    0   78    1  DSGEGDFLAEGGGVR 
 383  773.38   1544.75  1544.61   0.14    0  (72)   1  DSGEGDFLAEGGGVR+Phos.(ST) 
 389  808.90   1615.79  1615.65   0.14    0   74    1  ADSGEGDFLAEGGGVR+Phos.(ST) 
 
Query Observed  Mr(expt) Mr(calc) Delta Miss Score Rank Peptide 
 311  546.27   1090.52  1090.42   0.10   0   18    2  QGVNDNEEGF+Q->p-E(N-term Q) 
 328  619.81   1237.61  1237.49   0.12   0   23    2  QGVNDNEEGFF+Q->p-E(N-term Q) 
 341  663.33   1324.64  1324.52   0.12   0   20    4  QGVNDNEEGFFS+Q->p-E(N-term Q) 
 357  698.85   1395.69  1395.56   0.14   0   23    1  QGVNDNEEGFFSA+Q->p-E(N-term Q) 
 
Table 1. A list of identified peptides using TCA precipitation and LC-MS/MS 
by Mascot is shown. Top 2 from mascot hits. 
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1. FIBA_HUMAN Mass: 94914 Total score: 1044  Peptides matched: 29, 
(P02671) Fibrinogen alpha chain precursor [Contains: Fibrinopeptide A] 
 
Query Observed  Mr(expt) Mr(calc) Delta Miss Score Rank Peptide 
  23   433.29    432.28    432.25   0.04   0    9    3  GGGV+iTRAQ4p(N-term) 
 307   447.30    892.58    892.48   0.10   0   42    1  FLAEGGGV+iTRAQ4p(N-term) 
 477   504.82   1007.62   1007.50   0.11   0   53    1  DFLAEGGGV+iTRAQ4p(N-term) 
 508   519.81   1037.60   1037.43   0.17   0   43    1  SGEGDFLAEGG 
 517   525.36   1048.70   1048.58   0.12   0   39    1  FLAEGGGVR+iTRAQ4p(N-term) 
 528   533.33   1064.65   1064.53   0.12   0   91    1  GDFLAEGGGV+iTRAQ4p(N-term) 
 551   544.81   1087.60   1087.53   0.07   0   35    1  TGKTFPGFFS 
 556   548.33   1094.64   1094.50   0.14   0   42    1  EGDFLAEGGG+iTRAQ4p(N-term) 
 594   582.89   1163.76   1163.61   0.15   0   34    1  DFLAEGGGVR+iTRAQ4p(N-term) 
 600   594.86   1187.70   1187.56   0.15   0   27    1  EGDFLAEGGGVR+E->p-E(N-term E) 
 608   597.88   1193.74   1193.57   0.17   0   63    1  EGDFLAEGGGV+iTRAQ4p(N-term) 
 624   611.40   1220.78   1220.63   0.16   0   32    1  GDFLAEGGGVR+iTRAQ4p(N-term) 
 659   620.86   1239.70   1239.54   0.16   0   59    1  DSGEGDFLAEG+iTRAQ4p(N-term) 
 667   626.39   1250.76   1250.59   0.17   0   68    1  GEGDFLAEGGGV+iTRAQ4p(N-term) 
 702   649.38   1296.74   1296.56   0.18   0   54    1  DSGEGDFLAEGG+iTRAQ4p(N-term) 
 727   669.91   1337.80   1337.62   0.18   0   88    1  SGEGDFLAEGGGV+iTRAQ4p(N-term) 
 738   675.93   1349.84   1349.62   0.22   0   82    1  SGEGDFLAEGGGVR 
 782   469.96   1406.85   1406.69   0.16   0   47    1  GEGDFLAEGGGVR+iTRAQ4p(N-term) 
 802   727.43   1452.85   1452.65   0.20   0   73    1  DSGEGDFLAEGGGV+iTRAQ4p(N-term) 
 808   730.88   1459.75   1459.55   0.20   0   57    2  ADSGEGDFLAEGGGV+Phos (ST) 
 825   498.97   1493.90   1493.72   0.18   0  (59)   1  SGEGDFLAEGGGVR+iTRAQ4p(N-term) 
 832   767.42   1532.83   1532.62   0.21   0  (20)   2  DSGEGDFLAEGGGV+iTRAQ4p(N-term); Phos (ST) 
 834   773.42   1544.83   1544.61   0.22   0  (37)   1  DSGEGDFLAEGGGVR+Phos(ST) 
 846   533.16   1596.47   1596.59  -0.12   0    8    9  GSSGTGGTATWKPGSS+2 Phos(ST) 
 852   537.32   1608.95   1608.75   0.20   0   73    1  DSGEGDFLAEGGGVR+iTRAQ4p(N-term) 
 867   808.95   1615.88   1615.65   0.23   0   48    1  ADSGEGDFLAEGGGVR+Phos (ST) 
 918   561.01   1680.00   1679.79   0.21   0  (47)   1  ADSGEGDFLAEGGGVR+iTRAQ4p(N-term) 
 922   563.99   1688.94   1688.72   0.22   0  (32)   1  DSGEGDFLAEGGGVR+iTRAQ4p(N-term); Phos(ST) 
 960   587.67   1759.98   1759.75   0.23   0  (35)   1  ADSGEGDFLAEGGGVR+iTRAQ4p(N-term); Phos(ST) Influence of clotting time on the protein composition of serum samples based on LC-MS data 
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2. FIBB_HUMAN Mass: 55892 Total score: 466  Peptides matched: 13, (P02675) 
Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] 
 
Query Observed  Mr(expt) Mr(calc) Delta  Miss Score Rank Peptide 
 551  544.81   1087.60  1087.46   0.14   0    35    1  DNEEGFFS+iTRAQ4p(N-term) 
 587  580.33   1158.64  1158.50   0.15   0    24    1  DNEEGFFSA+iTRAQ4p(N-term) 
 611  601.83   1201.65  1201.50   0.15   0    43    1  NDNEEGFFS+iTRAQ4p(N-term) 
 618  607.86   1213.70  1213.54   0.16   0    46    1  VNDNEEGFF+iTRAQ4p(N-term) 
 653  619.83   1237.65  1237.49   0.16   0    43    1  QGVNDNEEGFF+Q->p-E(N-term Q) 
 675  636.37   1270.72  1270.56   0.16   0    53    1  GVNDNEEGFF+iTRAQ4p(N-term) 
 678  637.36   1272.71  1272.54   0.17   0    56    1  NDNEEGFFSA+iTRAQ4p(N-term) 
 720  663.35   1324.69  1324.52   0.16   0    58    1  QGVNDNEEGFFS+Q->p-E(N-term Q) 
 743  679.90   1357.78  1357.59   0.19   0    45    1  GVNDNEEGFFS+iTRAQ4p(N-term) 
 751  686.91   1371.80  1371.61   0.19   0    27    1  VNDNEEGFFSA+iTRAQ4p(N-term) 
 765  698.88   1395.75  1395.56   0.20   0    45    1  QGVNDNEEGFFSA+Q->p-E(N-term Q) 
 767  698.89   1395.77  1395.56   0.21   0   (30)   1  QGVNDNEEGFFSA+Q->p-E(N-term Q) 
 787  715.42   1428.82  1428.63   0.20   0    50    1  GVNDNEEGFFSA+iTRAQ4p(N-term) 
 
Table 2. Peptides in the supernatant identified after precipitation and itraq 
labeling by LCMSMS and subsequent SwissProt database search by the 
MASCOT algorithm.  
 
MASCOT parameters: Type of search: MS/MS Ion Search. 
Enzyme : None;Variable modifications: Q->E(N-term Q), E->p-E(N-term E), 
iTRAQ4p(N-term), iTRAQ4p(Y), Oxidation(M), Phos(ST), Phos(Y); Mass 
values: Monoisotopic; Protein Mass: Unrestricted; Peptide Mass Tolerance: ±0.3 
Da; Fragment Mass Tolerance: ±0.2 Da). 
 
MASCOT Search Parameters 
Type of search: MS/MS Ion Search 
Enzyme: None 
Variable modifications: Q->p-E (N-term Q), E->p-E (N-term E), iTRAQ4p(N-
term), iTRAQ4p (Y), Oxidation (M), Phospho (ST), Phospho (Y) 
Mass Monoisotopic 
Protein Mass: Unrestricted 
Peptide Mass Tolerance: ± 0.3 Da 
Fragment Mass Tolerance: ± 0.2 Da 
Max Missed Cleavages: 1 
Instrument type: Default 
Data File Name: D:\mascot mgf files\itraq_2_6hrs sup.mgf 
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Chapter V. 
 
Factorial design of serum protein profiling by LC-MS 
 
 
P. Horvatovich, N.I. Govorukhina, F. Suits, I.M. Westra, T.H. Reijmers, 
A.G.J. van der Zee, and R. Bischoff  
Manuscript in preparation  
 
1. Introduction 
Biomarker discovery requires complex procedures that involve close 
collaboration between medical, analytical and computational sciences (Figure 
1). Biofluids that are easily accessible, such as serum, are generally used for 
biomarker discovery, but they are extremely complex. During the process of 
biomarker discovery doctors working in medical sciences are responsible for 
diagnosis and patient classification, sample collection and storage as well as 
documentation. Scientists working in analytical science are responsible for 
sample preparation and analysis (e.g. by LC-MS), and must strive to minimize 
the variation introduced by these analytical steps. Scientists working in 
computational science process and analyze the generated data by extracting 
information related to the abundance of the various proteins and peptides in 
different samples and by using sophisticated statistical methods to find 
significant abundance differences between preclassified samples. Due to the 
complexity of the overall process, it is possible that certain experimental 
parameters may have an effect on the abundance of the measured protein and 
peptides thus affecting the outcome of the statistical analysis with the risk of 
creating false positives with respect to biomarker candidates or of missing 
potentially relevant candidates. It is thus important to determine the various 
factors, which affect the measured peptide profiles, in the case of trypsin-
digested serum. This will allow the experimentalist to keep close control over 
the most important factors and to relax the stringency of the experimental 
protocol for those factors, which have little effect on the outcome of the Factorial design of serum protein profiling by LC-MS 
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analyses. There are preanalytical factors that cannot be changed 
retrospectively, for example, when working with already existing biobanks 
(e.g. the hemolysis level) but that may well affect the protein composition. 
These factors may be used as entry criteria and can help to remove samples 
that do not meet these criteria prior to analysis with the added benefit that 
non–class-specific variance will be reduced. 
T o  a s s e s s  t h e  i m p o r t a n c e  o f  a  s e l e c t e d  n u m b e r  o f  f a c t o r s ,  w e  u s e d  a  
Factorial Design approach on serum samples that were depleted of the 6 most 
abundant proteins. As our analytical procedure by cap-LC-MS is rather time-
consuming, we prioritized seven factors that were analyzed at two levels each. 
The analyzed factors were:  
• type of blood collection tube (BD 367784, BD 368430, abrv.: Blo) 
• hemolysis level (low and high, abrv.: Hem) 
• clotting time (2 and 6 hours, abrv.: Clo) 
• number of freeze-thaw cycles (1 and 3 cycles, abrv.: Fre) 
• trypsin to protein ratio (1:20 and 1:100, abrv.: Try) 
• stopping of trypsin digestion with acid (yes and no, abrv.: Sto) 
• residence time in the autosampler (0 and 30 days, abrv.: Sta) at 4°C 
 
A full factorial design would requires 27=128 analyses and would give 
information on the main effect of each factor and on all interactions between 
different factors from the second till the seventh order. In order to reduce the 
total analysis time, we have chosen to perform a two-level fractional factorial 
design with resolution VI (a so-called 
3 7
VI 2
−  design). This design requires only 
16 analyses while resolution VI means that only the main effect of each factor 
can be evaluated directly, since these effects are not confounded by other 
effects or by two-factor interactions. Two-factor interactions are confounded in 
triads and thus in this design it is not possible to distinguish which of them is 
responsible for the measured effect. Higher order interactions between factors 
are generally negligible and thus confounding them with main and two-factor 
interactions will note affect the overall evaluation of our design. Table 1 
contains the main effect and two-factor confounding pattern of the 
3 7
VI 2
−  design 
as used in this study. In order to estimate the data variances not related to the 
studied factors we have performed 3 repetitions of one analysis leading to total 
of 19 analyses [1, 2]. 
Automatic processing of ion-trap LC-MS data resulted in 8 000 - 10 000 
aligned features or measured variables. The evaluation of this multivariate data 
set was done by eliminating one factor at a time to produce the average highest 
variance in the dataset. 
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Figure 1.  Schematic view of the collaborative environment of a biomarker discovery project. The 
final result may be affected by variable factors, as exemplified in red. 
 
Table 1. Main effect and two-factors confounding pattern of a 
3 7
VI 2
−  fractional 
factorial design as used in this study. 
 
Term  Confounded with  Confounded with 
Blo    
Hem    
Clo    
Fre    
Try    
Sto    
Sta    
Blo*Hem Clo*Try  Sto*Sta 
Blo*Clo Hem*Try  Fre*Sta 
Blo*Fre Clo*Sta  Try*Sto 
Blo*Try Hem*Clo  Fre*Sto 
Blo*Sto Hem*Sta  Fre*Try 
Blo*Sta Hem*Sto  Clo*Fre 
Hem*Fre Clo*Sto Try*Sta Factorial design of serum protein profiling by LC-MS 
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2. Methods 
2.1. Factorial design 
Different handling of serum samples can influence the resulting LC-MS 
data reflecting the peptide/protein composition of the samples. Based on 
previous experience with the analysis of serum samples we prioritized the 
following seven factors and defined the levels to be investigated: tubes for 
blood collection, high/low hemolysis level, different clotting times (2 or 6h), 
freeze-thaw cycles (1 or 3), digestion with trypsin at different enzyme to 
substrate ratios (1:20 or 1:100), stopping of trypsin digestion with acid or not, 
stability of the samples at 4oC prior to LC-MS analysis. Samples were analyzed 
according to the factorial design scheme given in Table 1. 
 
Table 2. 
3 7
VI 2
−  Fractional design pattern. 
 
Experiment 
name 
Run 
order 
Blood 
collection tube 
Hemolysis  Clotting 
time 
Freeze-thaw 
cycles 
Trypsin 
digestion 
Stopping 
trypsin 
Stability 
sample 
N1  11  BD368430  Low  2 hours  1 cycle  1:20  Yes  0 days 
N2  3  BD367784  Low  2 hours  1 cycle  1:100  Yes  30 days 
N3  9  BD368430  High  2 hours  1 cycle  1:100  No  0 days 
N4  17  BD367784  High  2 hours  1 cycle  1:20  No  30 days 
N5  18  BD368430  Low  6 hours  1 cycle  1:100  No  30 days 
N6  2  BD367784  Low  6 hours  1 cycle  1:20  No  0 days 
N7  10  BD368430  High  6 hours  1 cycle  1:20  Yes  30 days 
N8  16  BD367784  High  6 hours  1 cycle  1:100  Yes  0 days 
N9  8  BD368430  Low  2 hours  3 cycles  1:20  No  30 days 
N10  15  BD367784  Low  2 hours  3 cycles  1:100  No  0 days 
N11  13  BD368430  High  2 hours  3 cycles  1:100  Yes  30 days 
N12  7  BD367784  High  2 hours  3 cycles  1:20  Yes  0 days 
N13  12  BD368430  Low  6 hours  3 cycles  1:100  Yes  0 days 
N14  6  BD367784  Low  6 hours  3 cycles  1:20  Yes  30 days 
N15  5  BD368430  High  6 hours  3 cycles  1:20  No  0 days 
N16  19  BD367784  High  6 hours  3 cycles  1:100  No  30 days 
N17  14  BD368430  Low  2 hours  1 cycle  1:20  Yes  0 days 
N18  1  BD368430  Low  2 hours  1 cycle  1:20  Yes  0 days 
N19  4  BD368430  Low  2 hours  1 cycle  1:20  Yes  0 days 
 
The samples were injected into the LC-MS according to the order shown in 
column 2 “Run order”. 
 
2.1.1. Description of samples 
Serum samples were obtained from 2 healthy volunteers (Fact. Design #1, 
female and Fact. Design #2, male) and provided by the Department of 
Gynecological Oncology (University Medical Center Groningen, The 
Netherlands). They were stored at -80ºC in aliquots until analysis.  Chapter V 
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2.1.2. Blood collection tubes 
Two kinds of tubes were used for the collection of blood: BD368430 (a “red 
stopper clotting tube”, which is a glass tube with a siliconized inner wall used 
to avoid retention of red blood cell on the walls of the tube) and BD367784 (a 
“gel tube”, which is a glass tube with a separation gel and micronized silica to 
accelerate clotting). During centrifugation, the polymer gel moves up the inner 
wall of this tube forming a barrier between the supernatant (serum) and 
sediment (blood clot and cells)). These were selected, since they were both used 
at the University Medical Center Groningen, The Netherlands to acquire the 
available serum biobank from cervical cancer patients. 
 
2.1.3. Variation of clotting time 
Serum samples were allowed to clot for 2 or 6 hours at room temperature 
before centrifugation to obtain serum. 
 
2.1.4. Stability of trypsin-digested serum samples in the autosampler prior to 
LC-MS analysis 
Stability of the trypsin-digested serum samples was evaluated by keeping 
them for 30 days at 4ºC in the autosampler. Samples labeled “0 days samples” 
were injected directly after thawing (storage at -80ºC). 
 
2.1.5. Level of hemolysis 
To simulate a high level of hemolysis, a lysate of red blood cells was added 
to the serum prior to depletion. Red blood cells were collected according to the 
following protocol: 0.5 mL lysis buffer (NH4Cl 155 mmol/L, EDTA 
0.1mmol/L) was added to 0.5 mL fresh blood and centrifuged for 20 minutes at 
2000 rpm. 4 mL of lysis buffer was added to the pellet and incubated overnight 
at 4ºC. The next day the lysate was filtered through spin filters (0.22µm; # 5185-
5990, Agilent) at 13000 rpm. Aliquots of the filtrate were stored at -80ºC. 
The amount of lysed red blood cells that should be added to serum to 
mimic a high level of hemolysis was determined by the addition of different 
amounts (1, 3, 5, 7 and 10 µL) of red blood cell lysate to 20 µL serum that was 
immediately diluted with ice-cold water to a total volume of 60 µL followed by 
centrifugation at 13000 rpm for 30 min at 4ºC. Another 15 µL of ice-cold water 
were added to the supernatant and the absorbance was measured at 340, 380, 
415 and 450 nm (Biowave S2100 UV/Vis Diode Array Spectrophotometer 
(Biochrom Ltd, Cambridge, UK)). A calibration line with respect to hemoglobin 
(Hb) was obtained using the formula: Hb [g/L] = (167.2 * A415 – 83.6 * A340/380 – 
83.6 * A450) / 1000 [4]. The absorbance of a serum sample from the serum bank 
t h a t  a p p e a r e d  t o  b e  v e r y  r e d ,  i n d i c a t i n g  a  h i g h  l e v e l  o f  h e m o l y s i s ,  w a s  
measured and the amount (in µL) of red blood cells to reach the corresponding 
Hb level was calculated from the calibration curve.  To determine the 
concentration of hemoglobin that corresponded to a given volume of lysed red Factorial design of serum protein profiling by LC-MS 
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blood cells, a calibration curve of hemoglobin (Hemoglobin human, Sigma, 
#9008-02-0) was made. It was calculated that 4 µL red blood cell (containing 
6.68 µg hemoglobin) should be added before depletion to the serum to simulate 
a high level of hemolysis as observed in clinical samples from the biobank. 
 
2.1.6. Preparation of serum samples 
80 μL (80% of the total amount (20 μL of crude serum mixed with 80 µL of 
buffer A (Agilent)) of diluted crude serum was injected on a Multiple Affinity 
Removal column (Agilent, 4.6 x 50 mm, # 5185-5984) after filtration through 
0.22 µm spin filters (# 5185-5990) at 13000g and 4˚C for 10 min to remove 
particulates. The removal of abundant proteins was performed on a LaChrom 
HPLC System (Merck Hitachi, www.merck.com) with detection at 280 nm 
using the following timetable: 0-9 min, 100% buffer A (0.25 mL/min); 9.0-9.1 
min, linear gradient 0-100 B % (1 mL/min), 9.1-12.5 min, 100% buffer B (1 
mL/min);  12.5-12.6 min, linear gradient 100-0% buffer B (1 mL/min); 12.6-20  
min, 100% buffer A (1 mL/min). The flow-through fraction (depleted serum 
collected between 2-6 min) of a total volume of appr. 1 mL was collected [3].  
Protein concentrations were determined with the Micro BCA™  Protein 
assay reagent kit (www.piercenet.com) and calculated for an average protein 
molecular weight of 50 kDa. BSA was used as the calibration standard. 
 
2.1.7. Digestion of serum samples  
Trypsin (sequencing grade modified trypsin, Promega, # V5111, USA) in 
ratios 1:20 or 1:100 wt/wt (enzyme to total protein in depleted serum) was 
used for digestion at 37ºC at 450rpm (Eppendorf thermomixer, overnight). 
 
2.1.8. Stopping of trypsin digestion (according to Table 1) 
To stop the reaction with trypsin, formic acid was added after overnight 
digestion to reach a final concentration of 0.5% (v/v).  
 
2.1.9. Freeze-thaw cycles 
One or three freeze-thaw cycles (-80oC/room temperature) were include 
for comparative analysis (according to Table 1). 
 
2.2. Data processing 
For processing and multivariate statistical analysis of the original Bruker 
Daltonics HPLC-MS data, the files were converted into ASCII-format with the 
Bruker data analysis software LC/MSD Trap, version 3.3 (build 146) (Bruker 
Daltonics, Bremen, Germany) and saved in centroid mode. The time alignment 
algorithm was written in C++ using Microsoft Visual Studio [ver. 8.0.50727.762 
(SP.050-727-7600), Redmont, WA, USA]. For further data analysis, Matlab 
[version 7.4.0.287 (R2007a), Mathworks, Natick, Massachusetts, USA] was 
used. Chapter V 
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Centroid data were smoothed and reduced using a normalized two-
dimensional Gaussian filter, with rounding the nominal m/z ratios to 1 m/z 
(the original data had a resolution of 0.1 m/z). In the retention time dimension 
no data reduction was performed. This meshing procedure reduced the 
number of available data points by roughly a factor 10 and corrected for 
shifting m/z values as a result of different loadings of the ion-trap during 
elution of abundant peptides, a phenomenon that is common for ion-trap mass 
spectrometers [5,6]. After meshing the data files of all chromatograms, they 
were time-aligned (warped) to a reference data file using Correlation 
Optimized Warping (COW) [7] based on peak lists obtained from the 
chromatograms. This time alignment algorithm optimizes time shifts using the 
overlapping between the extracted peaks using 2-dimensional extent of the 
peaks (retention time and m/z value) in the two chromatograms. Thus all 
chromatograms were aligned to each other in a pair-wise manner starting with 
randomly selected chromatogram  as reference. The accuracy of correcting 
retention time shifts by time alignment was manually checked by visualization 
the 4 most intensive peaks for 10 equal time segments between 60-155 min 
before and after time alignment. 
A modified M-N rule was applied for peak detection on meshed data with 
data reduction 1:10 in m/z resulting rounded integer m/z in the mass spectra 
by first calculating a median local baseline using the sliding window technique 
separately for each rounded m/z trace. A median window size of 1200 data 
points, corresponding to 20.17 min, was used with a moving rate of 10 points 
and a minimum median value of 200 counts. According to the M-N rule, a 
threshold of M-times the local baseline was used and a peak was assigned if, 
within one m/z trace, the signal exceeded this threshold for at least N 
consecutive points [8]. For each detected peak the m/z value, the mean 
retention times of the three highest measured intensities within the same peak 
reduced by the local baseline were stored in a peak list created for every 
chromatogram. 
We used a similar approach as Radulovic et al. [8] to obtain optimal 
settings for M and N. Different values for M (1.5-4) and N (4-8) were applied to 
two blank LC-MS runs and two LC-MS runs of depleted, trypsin-digested 
serum samples. Settings were used at which the ratio between the number of 
peaks between 60 and 155 min in the samples relative to the blank 
chromatograms was highest and at which a minimal number of peaks was 
extracted from the noise in the blank chromatogram (M = 2 and N = 5 in our 
case). 
In order to combine the peak lists from different samples into a common 
peak matrix, one-dimensional peak matching was performed by using the 
sliding window technique, in which the same m/z traces were evaluated for 
peaks that are proximate in time (step size 0.1 min; search window 1.0 min; 
maximal accepted standard deviation for all retention times within a group of Factorial design of serum protein profiling by LC-MS 
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matched peaks 0.75 min). Missing peak allocation was performed by extracting 
the background subtracted local signal of the given m/z trace at the average 
retention time corresponded to the chromatograms where that peak was 
present. The generated peak matrix, created from the peak lists of the 
individual samples, consisted of a peak(row)-sample(column)-intensity(value) 
matrix. This peak matrix was used for analysis. All data preprocessing work 
was done on a personal computer equipped with a dual core +3800 MHz AMD 
64 X2 processor equipped with 4 GB of RAM. 
 
2.3. Statistical analysis 
Multiple Linear Regression was performed using the MODDE software 
(ver 7.0.0.1) from Umetrics (Kinnelon, NJ, USA) (Umetrics INC, USA, ver 
7.0.0.4). The evaluation of aligned peak matrices was performed using a 
stepwise method. First the aligned peak matrix was mean centered and 
normalized with respect to the standard variation for each peak (row) and thus 
relative standard deviation was obtained (RSD). Because of the small sample 
size and the high number of peaks (variables), occurrence of small standard 
deviations were avoided by adding 0.001. At each step the main factor effects 
were removed from the peak’s intensity by subtracting the corresponding 
mean factor-level . At a given step the factor resulting in the highest decrease in 
overall sum of the RSD (SRSD) was retained and eliminated from the 
remaining iterations. For the remaining steps the peak matrix corrected with 
the selected factor was used. Pearson correlation plots produced in Matlab 
were used to visualize the results. 
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3. Results 
Specific effect of the selected seven preanalytical parameters on LC-MS 
data was evaluated by integrating the peak areas of peptides belonging to 
high-abundant proteins (Apolipoprotein A, α-2-Macroglobulin precursor, 
human Complement C3 precursor with masses of 756.7, 909.6, 682.5, 753.5, 
619.2, 694.4). These protein-derived pepti d e s  h a v e  b e e n  s h o w n  b y  u s  t o  b e  
rather stable in quantity in serum samples [3] and may thus be considered to 
reflect major effects of preanalytical factors, if affected.  
In Figure 2 peak areas for these peptides are shown for serum from 
female (2a) and male blood (2b). The deviations of the mean retention time 
(RT) of endogenous standards were less than 0.8% confirming reproducibility 
of the LC-MS analyses. Variation in peak area ranged from approximately 40% 
a the peak derived from Apolipoprotein A (doubly charged peptide 
DLATVYVDVDVLK, m/z 619.2, accession number P02647) up to 130% for a 
peak derived from Alpha-2-macroglobulin precursor (doubly charged peptide 
AAQVTIQSSGTFSSK, accession number P01023); (m/z 753.5) for factorial 
design #1 (female serum) (Figure 2a) showing that the chosen preanalytical 
factors do have a significant effect even on peptides derived from high-
abundance proteins. 
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Figure 2. Six m/z values derived from high-abundance proteins remaining after depletion were 
analyzed to assess the overall effect of the selected seven preanalytical factors (see Table 2 for the 
factorial design) based on changes in peak areas of extracted ion chromatograms. a) female serum; 
b) male serum. Peptides with the same m/z values: 619,2; 694,4; 753,5 were eluted twice at different 
retention time. Standard deviations are calculated based on the peak area’s of the Selected Ion 
Chromatogram  of ±0.5 m/z values. 
 
In male samples (factorial design #2) the deviation of the mean RT of the 
same peptides was also less than 0.8%. Standard deviations of peak areas 
varied from approximately 75% for a peak m/z 756.7 up to 135% for the peak 
with m/z 753.5 from Alpha-2-macroglobulin precursor.  
In order to study the effects of the seven selected factors on these peptides, 
we applied a multiple linear regression model (Figure 3). The model showed 
that only one peptide was significantly affected by the studied factors in female 
serum (m/z 694.4, shown in red). 
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Figure 3. Peak areas of peptides derived from high-abundance proteins (see Table 3) were analyzed 
using a Multiple Linear Regression model. Data were obtained from two fractional factorial design 
studies (one in male and one in female serum). In the figure R2 refer to Residual Standard 
Deviation and is the fraction of variation of the response explained by model. Q2 refer to the 
predictive power of the model (Prediction Residual Sum of Squares) and is the fraction of variation 
of the response that can be predicted by the model. 
 
The peak area of the peptide derived from Apolipoprotein A (doubly 
charged ion of peptide VSFLSALEEYTK, accession number P02647, m/z 694.4) 
in female serum showed a linear correlation between the expected (as 
predicted by the model) and observed peak areas (Figure 4a). Analysis of the 
contribution of different factors showed that clotting time and the trypsin-to-
substrate ratio affected the measured peak area significantly (significance level 
of 95%) (Figure 4b). In male dataset the peak areas of the same peptide were 
less well predicted by the model, although a similar pattern was observed (data 
not shown). 
In order to perform a global analysis of all detected features and how they 
respond to the variation of a given factor, it is necessary to generate a common 
peak matrix from all 19 LC-MS runs. This requires correction of retention time 
shifts between the different LC-MS analyses. However, Correlation Optimized 
Warping using the Total Ion Chromatogram (COW-TIC) was not successful, 
due to the major differences in chromatographic patterns when changing 
certain factors (Figure 5a). Poor time alignment of chromatograms lead to 
mismatched peaks and resulted in misinterpretations. The failure of the COW-
TIC algorithm to align the chromatograms is due to the fact that some factors 
have a large effect on the measured peak profiles leading to very high 
analytical variability and to rather diverse TICs in spite of the fact that the 
serum sample was taken from the same patient (no biological variance 
included in the fractional factorial design experiment). Applying the COW 
algorithm not to the TIC but to a 2-dimensional extent of all detected peaks in 
the retention time and m/z dimensions (2D-COW), thus taking the 3-
dimensional structure of the data into account, resulted in proper alignment of 
most peaks (see Figure 5b for an example). Chapter V 
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Figure 4. Multiple Linear Regression model of the peptide derived from Apolipoprotein A (doubly 
charged ion of peptide VSFLSALEEYTK, accession number P02647, m/z 694.4). A) Correlation of 
the predicted with the observed peak area (R2 = 0.905; N=19 experiments), b) coefficient of factors 
obtained in the MLR model. 
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Fig. 5. Time alignment of the 19 chromatograms of the fractional factorial design study (the 
example of one peptide peak at appr. 107 min retention time (m/z 619) is shown) using the COW-
TIC algorithm (a) or COW in conjunction with a newly developed algorithm that aligns peaks in 2-
dimensions (retention time and m/z) (b). 
 
This allowed automatic processing of thousands of peaks in the datasets 
and the subsequent evaluation of the effect of the selected factors on the overall 
pattern. Correlation plots with hierarchical clustering of the aligned peak Factorial design of serum protein profiling by LC-MS 
148 
matrixes from the study of the different factors showed that the level of 
hemolysis is the most important factor affecting the overall correlation between 
LC-MS datasets (Figure 6).  
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Figure. 6 Correlation plots with hierarchical clustering of two fractional factorial design studies 
(see Table 2) for (a) male serum, and (b) female serum. Note that samples with low or high 
hemolysis levels, respectively, cluster together. 
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Figure 7. Sum of relative standard deviation (SRSD) after correction with the mean of 
corresponding factors for each level for all 7 factors (a,  male) and (b, female). 
 
Further analysis of the contribution of each factor to the overall sum of 
relative standard deviation (SRSD) between the datasets was carried out by 
correcting the contribution of each factor by the mean of each level. The factor 
showing the lowest SRSD has the greatest influence on peak intensity for 
largest number of peaks, and may thus be considered to be the most important 
preanalytical factor in the design with respect to the analysis of depleted from 
the 6 most abundant protein and trypsin-digested serum samples (Figure 7). 
Again the level of hemolysis stands out as being highly relevant. In order to 
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assess the relative importance of the remaining factors, the most important 
factor was discarded from the list of factors and the aligned peak matrix 
corrected with the most important factor was retained to determine the second 
most important factor. These iterations resulted in a list of factors ordered by 
their importance (Figure 8). The most important factors were: hemolysis level > 
trypsin-to-protein ratio > stopping the trypsin digestion with acid. Factors such 
as clotting time, type of blood collection tube, stability of sample in the 
autosampler or freez-thaw cycles had rather small effects on the resulting LC-
MS data. The results concerning clotting time corroborate our findings 
described in Chapter IV. 
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Figure 8. Differences of the SRSD (log scale; log SRSD) after recursive correction with the mean of 
factor effect having the highest influence on SRSD using all peptide peaks of the 2D-COW aligned-
peak matrices for male (a) or female serum (b). 
 
4. Conclusions 
The main result of this study is that the hemolysis level, which is a 
parameter that needs to be controlled during blood collection (responsibility of 
medical sciences; see Figure 1), makes the largest contribution to variability in 
the datasets. This implies that sera with high hemolysis levels have to be 
discarded from further analysis because this level cannot be set a priori but is 
largely influential on the expected differences in concentrations of potential 
biomarkers. Determining this relationship will be a matter of future studies. It 
i s ,  h o w e v e r ,  w i s e  t o  t a k e  s p e c i a l  c a r e  t o  a v o i d  h e m o l y s i s  d u r i n g  b l o o d  
collection and the preparation of serum. The other two most important factors, 
trypsin-to-protein ratio and stopping digestion with acid, can be easily 
controlled by the analytical chemist. 
Our results describe only a partial evaluation of the multivariate data 
obtained from the fractional factorial design study of depleted and trypsin-
digested serum samples. We only evaluated the main effect of each factor on 
the final data and more detailed analyses of the data need to apply multivariate 
statistical methods (e.g. Partial Least Squares methods) to obtain additional 
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information about possible interactions between two factors. Beside the factor 
and interaction order we would like to assess the significance level of the main 
factors and multiple factor interactions. As the design of the experiments has a 
resolution of IV, meaning that at least 3 out of two factor-interactions are 
confounded, a full factorial design, of the 3 main factors should be performed. 
This work is presently ongoing. 
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Chapter VI. 
 
Comparative analysis of cervical cancer patients (long-term 
survivors) before and after treatment 
 
 
N.I. Govorukhina, A. Hesseling, P. Horvatovich, M. de Vries, F. Suits, K.A. 
ten Hoor, A.G.J. van der Zee, R. Bischoff 
 
1. Introduction 
Cervical cancer is one of the most common malignant diseases of women 
worldwide [1]. It is more common in developing countries, where 83% of cases 
occur and where cervical cancer accounts for 15% of newly diagnosed female 
cancers while in developed countries it accounts for 3,6 % of all new cancer 
cases [2]. It was shown that 99% of cervical squamous cell carcinomas are 
linked to Human Papilomavirus (HPV) infection [3]. Especially “high-risk” 
strains such as 16 and 18 [4] are associated with the development of high-grade 
intraepithelial squamous lesions (HSIL) and may eventually lead to cervical 
cancer [5]. 
Squamous cell carcinoma antigen (SCC-ag) is a tumor marker in serum for 
patients with squamous cell carcinoma of the cervix. Concentration of SCC-ag 
in the serum is the good  marker for monitoring response to therapy. SCC-ag 
levels return to normal upon complete remission after treatment (threshold 
below 1.9 µg/L) while SCC-ag levels raise again in patients with recurrent 
disease. Measuring SCC-ag levels has, however, no predictive value, does not 
contribute to better survival [6] but provides useful information for 
management of the  disease [7]. SCC-ag is also not very disease-specific, since it 
was shown that squamous cell carcinoma antigen 1 (SCC-ag 1) was up-
regulated not only in the uterine cervix cancer but also in lung cancer, cancer of 
the esophagus and skin cancer [8-11] as well as in cancer of the tongue [12]. It 
was shown previously that TGFβ1 (transforming growth factor β1) is produced Comparative analysis of cervical cancer patients (long-term survivors) before and after treatment 
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by cervical cancer cells inducing PAI-1 expression (plasminogen activator 
inhibitor-1) [13]. PAI-1 expression has been correlated with decreased survival 
in breast cancer and associated with poor prognosis in cervical cancer [13]. 
Thus there is a continuing need for better biomarkers to assist in early 
diagnosis of cervical cancer, in staging of the disease and in following up on 
therapeutic efficacy. 
In this study we compared serum from patients with cervical cancer 
obtained before and after treatment that resulted in complete/partial remission 
or stable disease. Efficient depletion of high-abundance proteins (6 or 20) was 
combined with two complementary analytical approaches: gel electrophoresis 
(1D or 2D) or Liquid Chromatography-Mass Spectrometry (LC-MS). Dedicated 
algorithms for data pre-processing were developed and applied followed by 
multivariate statistical analysis (Principal Components Analysis, PCA). 
 
2. Methods 
2.1. Description of samples 
Serum samples from cervical cancer patients were obtained at the 
Department of Gynecological Oncology (University Medical Centre Groningen, 
The Netherlands) and stored at – 80 oC in aliquots. Most of the patients (Table 
1) showed no recurrence of disease after therapy (except patient 22: partial 
remission and patient 23: stable disease: tumor remains without progression). 
The diagnosis was done by histological analysis and gynecological 
examination: inspection and palpation of the genitalia and SCC-ag test. 
Patients with remission have no complains and normal SCC-ag level. All 
patients used in this study had advanced disease (stage III or IV) according to 
the International Federation of Gynecology and Obstetrics (FIGO) classification 
[14] and belonged to a group of long-term survivors. The level of the 
Squamous cell carcinoma antigen-1 (SCCag) was determined by ELISA [6]. 
 
2.2. Preparation of serum samples 
Depletion of the 6 most abundant serum proteins (on a Multiple Affinity 
Removal column (4.6 x 50 mm, # 5185-5984, www.chem.agilent.com), digestion 
of the remaining proteins in depleted serum with trypsin, capillary LC-MS 
analysis (Atlantis dC 18 (1.0 x 150 mm, 3 μm) with Atlantis dC 18 in-line trap column 
for cap-LC-MS (Waters, Milford, Massachusetts, USA, www.waters.com) were 
performed as previously described (15).  
Depletion of the 20 most abundant proteins was performed according to 
the manufacturer’s instructions (ProteoPrep 20 Plasma Immunodepletion Kit 
(PROT20), www.sigma-aldrich.com). 8μL of serum were depleted on a spin 
column. The depletion procedure was repeated 5-times (40μL of original 
serum) and followed by final (second) depletion of samples after first depletion 
to rise the level of depletion to >99% (www.sigma-aldrich.com). The depleted 
sera were pre-fractionated by high-temperature reversed-phase HPLC (see Chapter VI 
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below) followed by 1D- or 2D-gel electrophoresis. Protein concentrations were 
determined with the Micro BCA™  Protein assay reagent kit 
(www.piercenet.com) and calculated for an average protein molecular weight 
of 50 kDa. BSA was used as the calibration standard. 
 
2.2.1. Pre-fractionation of depleted serum by high-temperature reversed-
phase HPLC 
0.48 g of urea (#084K0063, Sigma, www.sigmaaldrich.com) and 13μL of 
glacial acetic acid (#1.00063.1000, www.darmstadt.merk.de), were added to 
~300μg (about 300μL) of depleted serum according to the manufacturer’s 
instructions (www.agilent.com/chem/bioreagents). Solvent A (97% H2O/0.1% 
TFA (# 28902, www.pierce.com)) was added further to a final volume of 1mL 
and the sample was injected onto a Macroporous Reversed-Phase mRP-C18 
column (Agilent, 4.6 x 50mm, # 5188-5231 ). Prefractionation was performed at 
80 oC  and pH <4.5 at a flow rate of 0.75mL/min with UV detection at 280nm 
using a gradient from 3 to 30% of solvent B (97% AcN/0.1% TFA) in 6 min, to 
55% solvent B in 40 min and finally up to 100% B in 53 min. The volume of the 
collect fractions was 0.75mL (1min fractions). The proteins in these fractions 
were further analyzed by SDS-PAGE in a pair-wise manner with the same 
fraction from a given patient before and after treatment next to each other.  
 
2.2.3. SDS-PAGE 
SDS PAGE was performed in a Mini-Protein III cell (Bio-Rad, 
www.biorad.com) using 12,5% gels with 0.1% SDS according to the 
manufacturer’s instructions. All chemicals were from Bio-Rad. Samples were 
boiled in sample buffer containing 0.02M DTT for 1 min, cooled down and 
applied directly to the gel. PageRuler™ Prestained Protein Ladder (#SM0671, 
www.fermentas.com) were used. Proteins were stained with Coomassie 
Brilliant Blue R concentrate (Sigma, www.sigmaaldrich.com) diluted and used 
as prescribed by the manufacturer. 
 
2.2.4. In-gel digestion  
Performed according to protocol of Shevchenko et all. [16]. Trypsin 
(sequencing grade modified trypsin, # V5111, www.promega.com) was used 
(10µg/mL) for digestion overnight at 37°C with shaking at 450 rpm. 
 
2.5. 2D gel electrophoresis  
Isoelectric focusing (IEF; first dimension) was performed by loading 250 µL 
(250µg) of serum  after depletion of six most abundant proteins 
(www.chem.agilent.com) onto a ReadyStrip  (IPG strip pH 4-7; Bio-Rad #163-
2099, www.biorad.com) and rehydrated overnight [17]. The IPG strip was 
placed in the focusing tray and IEF was performed at 50µA/strip (150 V) for 30 
min, 300 V for 1 hour, 600 V for 1 hour and 8000 V to reach a total of 35.000 Comparative analysis of cervical cancer patients (long-term survivors) before and after treatment 
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V•hours) at 20oC. For the second dimension electrophoresis  (SDS-PAGE) the 
IPG strip was equilibrated in buffer containing 0.05 M Tris-HCl pH 8.8, 6 M 
urea, 30% w/v glycerol and 2% w/v SDS with 1% (w/v) Dithiothreitol (DTT) 
(Sigma #D0632, www.sigmaaldrich.com) for 15 min, followed by incubation 
with the same buffer containing 4% iodoacetamide (Sigma #11149) for another 
15 minutes in the dark [18]. Equilibrated IPG strips were placed on top of a 
precast 12.5% polyacrylamide gel (Bio-Rad #345-0102, www.biorad.com)  and 
fixed with a 0.5 % agarose solution containing 25 mM Tris, 192mM glycine, 
0.1% SDS and a trace bromophenolblue. Reference marker PageRuler™ 
Prestained Protein  Ladder (Fermentas, #SM0671, www.fermentas.com) was 
used. Electrophoresis was performed at room  temperature, 100 V for 2.5 hours. 
After electrophoresis, the gel was fixed with a 40% methanol, 10% acetic acid 
solution for 30 min followed by Coomassie Brilliant Blue staining (Page Blue 
(Fermentas, #R0571, www.fermentas.com) at room temperature for 3 hours 
and subsequent overnight destaining in milliQ water. Gels were analyzed and 
scanned using the PDQuest  Image analysis program (Bio-Rad, 
www.biorad.com). Differentially expressed spots were excised from the gel for 
in-gel digestion (see above) and mass spectrometric analysis. To be able to 
detect low-abundance proteins, the gels were destained and stained using a 
mass-spec-compatible silver staining method [19]. In-gel digestion performed 
as in 2.2.4. 
 
2.3. Matrix-Assisted Laser Desorption Ionization (MALDI) Mass 
Spectrometry (MS) analysis 
MALDI-MS analysis of in-gel digested protein bands (1D SDS-PAGE) or 
spots (2D gel electrophoresis) was performed in the positive ionization mode 
using a Voyager DE Pro instrument (Applied Biosystems, 
www.appliedbiosystems.com). Spectra were acquired in reflectron mode with 
delayed extraction considering only mono-isotopic molecular masses for 
protein identification. The spectra were internally calibrated using the tryptic 
auto-digestion peaks at m/z 842.5099 and 2211.1046 amu. For identification  0.5 
μL of the digestion mixture were directly spotted on a stainless-steel MALDI 
target plate and 0.5 μL of a 5 mg/mL α-cyano-4-hydroxycinnamic acid (CHCA)  
in 50% acetonitrile (AcN)/0.1%TFA were added on top of the deposit. If this 
yielded no useful spectra, 5 μL of the remaining tryptic digests were purified 
using C18 Stage tips (Proxeon, www.proxeon.com) according to the 
manufacturer’s instructions. Peptides were eluted in 2 μL of a 5 mg/mL α-
cyano-4-hydroxycinnamic acid (CHCA) in 50% AcN/0.1%TFA and directly 
spotted on the stainless-steel target plate. Expasy's aldente was used for 
identification (http://www.expasy.org/cgibin/aldente/help.pl) Type of 
search: MS/MS Ion Search; Enzyme: Trypsin; Variable modifications: 
Oxidation (M), Mass values: Monoisotopic; Protein Mass: Unrestricted; Peptide Chapter VI 
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Mass Tolerance: ± 0.2 Da; Fragment Mass Tolerance: ± 0.2 Da; Max Missed 
Cleavages: 1.  
Identification of proteins after in-gel digestion was done also on nano-LC-
MS system (Agilent) equipped with a microfluidics (chip-cube) interface (cat. 
n° G4240A) including a chip (cat. n° G4240-62001) with a 40 nL trap column (75 
µm × 11 mm) and a 75 µm × 43 mm analytical column both containing C-18SB-
ZX 5 µm chromatographic material. The interface contains a nanoelectrospray 
tip (2 mm length with conical shape: 100 µm OD × 8 µm ID) and was coupled 
on-line to an MSD-Trap-SL ion-trap mass spectrometer. Injections (2µL were 
performed with an autosampler (Agilent, cat. n° G1389A) equipped with an 
injection loop of 8 µL (this includes the dead volume up to the trapping 
column) and a thermostated cooler maintaining the samples in the autosampler 
at 4°C during the analysis. All parameters for LC-MS analysis are described in 
Chapter III. MS spectra were deconvoluted with respect to charge state and 
isotopes. The resulting spectra were saved in  mascot (Matrix Science, London, 
U.K.) generic file format and submitted to a Web based version of the 
Phenyx36 search engine (v2.1) for UniProt_Sprot (r. 48.8 of 10-Jan-2006) 
queries. 
 
2.4. Stable-isotope labeling (iTRAQ)  
Changing of buffer and concentration of samples for iTRAQ labeling of 
depleted serum were done by ultrafiltration (Concentrators, Spin 5K MWCO, 4 
mL, # 51855991, www.chem.agilent.com) using 5 mL of 10% AcN with 0.1% 
TFA in water. Samples were evaporated to dryness in a CentriVapConcentrator 
(www.labconco.com), before labeling. Samples were resolved in 25μL of 1M 
Triethylammonium bicarbonate. iTRAQ labeling was performed according to 
the manufacturer’s protocol (Applied Biosystems, iTRAQ Reagents 
Application Kit-Plasma (Amine-Modifying Labeling Reagents for Plasma 
Sample Applications)) with modification of the trypsin-to-protein ratio (1:14 
instead 1:5.75 w/w enzyme-to-substrate). Sequencing grade modified trypsin 
was from Promega (# V5111, www.promega.com). iTRAQ labeling was 
performed twice for patients 30 and 25 (both with complete remission after 
treatment; see Table 1) by derivatizing the peptide mixture with the isobaric 
tags 114 (patient 30, pre-therapy), 115 (patient 25, pre-therapy), 116 (patient 30, 
post-therapy) and 117 (patient 25, post-therapy). 
 
2.5. Pre-fractionation by Strong-Cation Exchange HPLC 
In order to remove excess, unbound iTRAQ reagent and to simplify the 
mixture before nanoLC-MS-MS analysis, the peptide mixture was washed and 
fractionated off-line using a strong cation exchange (PolySULFOETHYL A) 
column (4.6x 200mm column (www.doi.wiley.com) operated at 0.2 mL/min 
flow rate using an AKTA Explorer Purifier 10 with a frac-900 fraction collector. 
The mobile phase was comprised of two buffers: A: 5mM KH2PO4/H3PO4 pH Comparative analysis of cervical cancer patients (long-term survivors) before and after treatment 
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3, 25% Acetonitrile [AcN] and B: 5mM KH2PO4/H3PO4 pH 3, 25% can, 1.0 M 
KCl. The salt gradient varied in three segments: 15%B (12 column volumes 
(CVs)), 50%B (3CVs), 100%B (5CVs), KCl (10mM/min). The resulting 50 
fractions were pooled in 20 fractions based on intensity and dried in a 
CentriVapConcentrator (LABCONCO) prior to mass spectrometric analysis. 
 
2.6. Cap-LC-MS 
All cap-LC-MS analyses were performed on an Agilent 1100 capillary HPLC 
system coupled on-line to an SL ion-trap mass spectrometer 
(www.home.agilent.com) equipped with an Atlantis™ dC 18 (1.0 × 150 mm, 3 
μm) column that was protected by an Atlantis™ dC 18 in-line trap column (3 
μm, 2.1 mm × 20 mm guard column). 40 µL of the pretreated (depleted and 
digested) fractions corresponding to ~8 µg or 160 pmol of total protein digest 
(calculated based on a 50kDa protein) were injected. The autosampler (# 
G1367A) was equipped with a 100 µL injection loop and a temperature-
controlled cooler (# G1330A) maintaining the samples at 4°C. The HPLC 
system had the following additional components: capillary pump (#, G1376A), 
solvent degasser (#, G1379A), UV detector (# G1314A) and column holder (#, 
G1316A). The sample was injected and washed in the back-flush mode for 30 
min (0.1% aq. formic acid (FA) and 3% AcN at a flow rate of 50 µL/min). 
Peptides were eluted in a linear gradient from 0 to 70% (0.5%/min) AcN 
containing 0.1% FA at a flow rate of 20 µL/min. After each injection the in-line 
trap and the analytical column were equilibrated with eluent A for 20 min 
prior to the next injection. 
The following settings were used for mass spectrometry during LC-MS. 
Nebulizer gas: 16.0 psi N2, drying gas: 6.0 L/min N2, skimmer: 40.0 V, 
Ionisation voltage: 3500 V, cap. exit: 158.5 V, Oct. 1: 12.0V, Oct. 2: 2.48 V, Oct. 
RF: 150 Vpp (Voltage, Peak Power Point), Lens 1: -5.0 V, Lens 2: -60.0 V, Trap 
drive: 53.3, T: 325°C, Scan resolution: enhanced (5500 m/z per second scan 
speed). Target mass: 600. Scan range: 100-1500 m/z. Spectra were saved in 
centroid mode. LC-MS chromatographic data were analyzed with Bruker Data 
Analysis software, version 2.1 (Build 37), [15].  
Label-free LC-MS data were first analyzed with the data analysis software 
provided by the instrument manufacturer, (version 3.3, build 146; Bruker 
Daltonics, Bremen, Germany). For the analysis label-free data (as well as of 
iTRAQ data analysis) Matlab (version 7.4.0.287 (R2007a), Mathworks, Natick, 
MA, USA) were used. For PCA calculation and visualization the PLS toolbox 
(version 3.5.2, Eigenvector Research Inc., Wenatchee, Washington, USA) were 
used under Matlab. 
 
2.7. nanoLC-MS-MS analysis of iTRAQ-labeled  samples   
Dried SCX fractions were resuspended in 50 μL 2%AcN/0.1%formic acid 
(FA) and analyzed by nanoLC–MS-MS with electrospray ionization (ESI) Chapter VI 
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(QSTAR-XL hybrid quadrupole-time-of-flight mass spectrometer, Applied 
Biosystems, Foster City, USA). 10 μL of the resuspended SCX fractions were 
loaded onto a 0.3 mm x 0.5cm C18-Pepmap trapping column 
(www.dionex.com) at a flow rate of 10 μL/min (2%AcN/0.1%FA). After 30 
min of washing, the trap column was switched into the Agilent 1100 nanoflow 
system and peptides were separated on a 75 μm x 15 cm C18 PepMap column 
(Dionex) at 300 nL/min. Peptides were eluted from the column using a 105 
minute gradient  from 95%A to 50%A (A: H2O/AcN/FA (950:50:1), B: AcN/ 
H2O /FA (950/50/1)). The column was connected to a nanospray emitter 
(360/20 μM ID, 10 μm tip; NewObjective, doi.wiley.com). The typical ion-spray 
voltage applied was 2200V. Data was acquired using an independent data 
acquisition (IDA) protocol where, for each cycle, the 3 most abundant multiply-
charged peptides (2 to 4 charges) in the MS scan with m/z values between 350 
and 1500 amu  reaching a threshold of 30 counts were selected for MS/MS. The 
collision energy was adjusted to gain more information in the reporter ion 
region. Each peptide was selected twice, and then dynamically excluded for 60 
seconds. Data were processed using Analyst QS 1.1/BioAnalyst software with 
protein identification and quantification (ProQUANT/ProGroup programs).  
 
2.8. Label-free data analysis and multivariate statistics 
For (pre-)processing and multivariate statistical analysis of the original 
Bruker Daltonics capillary LC-MS data, the files were converted into ASCII-
format with the Bruker data analysis software and saved in centroid mode. 
Centroid data were smoothed and reduced using a normalized two-
dimensional Gaussian filter, with rounding the nominal m/z ratios to 1 m/z 
unit (the original data had a resolution of 0.1 m/z unit). In the retention time 
dimension no data reduction was performed. This meshing procedure reduced 
the number of available data points by roughly a factor 10 and corrected for 
shifting m/z values as a result of different loadings of the ion-trap during 
elution of abundant peptides, a phenomenon that is common for ion-trap mass 
spectrometers [20,21]. After meshing the data files of all chromatograms, they 
were time-aligned (warped) to a reference data file using Correlation 
Optimized Warping (COW) [22] based on TICs constructed from signals in the 
range 100-1500 m/z. The accuracy of correcting retention time shifts in this 
manner was manually checked by visualization before and after time 
alignment of the 4 most intensive peaks for 10 equal segments between 60-155 
min. 
A modified M-N rule was applied for peak detection by first calculating a 
median local baseline using a sliding window technique that was applied 
separately to each m/z trace. A median window size of 1200 data points, 
corresponding to 20.17 min, was used with a moving rate of 10 points and a 
minimum median value of 200 counts. According to the M-N rule, a threshold 
of M-times the local baseline was used and a peak was assigned if within one Comparative analysis of cervical cancer patients (long-term survivors) before and after treatment 
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m/z trace the signal exceeded this threshold for at least N consecutive points 
[23]. For each detected chromatographic peak the m/z value, the mean 
retention times of the three highest measured intensities within the mass 
spectrum of this peak reduced by the local baseline were stored in a peak list 
created for every chromatogram. 
We used a similar approach as Radulovic et al. [23] to obtain optimal 
settings for M and N. Different values for M (1.5-4) and N (4-8) were applied to 
two blank LC-MS runs and two LC-MS runs of depleted, trypsin-digested 
serum samples. Settings were used at which the ratio between the number of 
peaks (between 60-155 min) in the samples relative to the blank 
chromatograms was highest and at which a minimal number of peaks was 
extracted from the noise in the blank chromatogram (M = 2 and N = 5 in our 
case). 
In order to combine peak lists from different samples into one common 
matrix, one-dimensional peak matching was performed by using the sliding 
window technique, in which the same m/z traces were evaluated for peaks 
that are proximate in time (step size 0.1 min; search window 1.0 min; maximal 
accepted standard deviation for all retention times within a group of matched 
peaks 0.75 min). Missing peak allocation was performed by extracting the 
background subtracted local signal of the given m/z trace at the given 
retention time. The generated peak matrix, created from the peak lists of the 
individual samples, consisted of a peak(row)-sample(column)-intensity(value) 
matrix. This peak matrix was used for multivariate statistical analysis. All data 
preprocessing work was done on a personal computer equipped with a dual 
core +3800 MHz AMD 64 X2 processor equipped with 4 GB of RAM. 
 
2.9. Classification and multivariate statistical methods 
To select the most discriminating peaks between serum sampled before (A) 
and after treatment (B), the Nearest Shrunken Centroid (NSC) classification 
algorithm was applied [24,25]. NSC regularizes data whereby class-specific 
centroids are “shrunken” toward the overall (non-class-specific) centroid, 
which has the effect of eliminating the influence of the most weakly 
discriminating peaks, thereby reducing the risk to overfit the data [25]. This 
algorithm selects those peaks that are most relevant for the discrimination of 
the predefined classes. NSC is used in conjunction with leave-one-out cross-
validation (LOOCV) to find the shrinkage value that gives the minimal 
LOOCV error [26]. In LOOCV one observation per class is iteratively omitted 
from the data set that is used to construct the classification model, which is 
then used to classify the omitted observation. The selected peaks at the highest 
shrinkage value giving the lowest LOOCV error were employed for 
construction of the final classification model. The selected peaks were then 
subjected to auto-scaling (all variables have zero mean and unit variance) and Chapter VI 
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Principal Components Analysis (PCA) and visualized using biplots of the first 
two principal components [27,28]. 
 
2.10. Analysis of iTRAQ data 
The total number of identified proteins were 117 and 131. The reporter ion 
ratios of two samples obtained at one time point (between 25A-30A and 25B-
30B named as reference set) and thus presenting differences mostly related to 
biological variance considered as noise were natural log-transformed and 
median-subtracted. Gaussian curves were fitted on the smoothed histograms 
(smoothing using Savitzky-Golay with 2 degree of polynomial) of the above-
mentioned data and standard deviations (SD) were determined. Differences in 
the natural log-transformed and median-subtracted reporter ion ratios (in ion 
ratio corresponding time point A were used as denominator for each sample) 
were considered to be significant when their respective mean ratio of patient 25 
and 30 exceeded 2-times the SD determined on the ratios reference set. 2SD 
resulted in a confidence level of 95.4%. Using that value 11 and 7 proteins were 
found to be significantly different in the reference set. When comparing 
samples before treatment with samples after treatment, 24 and 14 proteins 
were found to be significantly different, in the two replicats 
 
3. Results 
3.1. Label-free data analysis and multivariate statistics 
20 serum samples obtained from 10 cervical cancer patients before (A) and 
after (B) therapy (Table 1) were analyzed. 
Depletion of serum samples on multiple Affinity Removal column (Agilent) 
allowed to remove the 6 most abundant proteins (albumin, IgG, antitrypsin, 
IgA, transferrin and haptoglobin). The resulting depleted sera were digested 
and analyzed by capLC-MS (an equivalent of appr. 2μL of the original serum 
were injected). After processing the LC-MS data to obtain a common, aligned 
peak matrix (see Chapter IV),  datasets obtained from samples at time points A 
and B, respectively, were compared using the Nearest Shrunken Centroid 
(NSC) classification algorithm [24,25]. The NSC algorithm selected 51 peaks (at 
a shrinkage of 2.88) contributing to the discrimination between pre- and post-
treatment samples. The relative abundance (time point A is considered as 
100%) of these peaks is shown in Figure 1. Comparative analysis of cervical cancer patients (long-term survivors) before and after treatment 
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Table 1. Cervical cancer patients (long-term survivors) before (A) and after (B) 
treatment used for comparative serum analysis. Samples B were collected 7-11 
months after treatment.  
 
Patient 
number 
Serum 
number 
SCC  level 
(ELISA), μg/L 
Stage of the cancer 
(FIGO), [14] 
Follow-up 
21A 911837  3,6   
21B 921094  0,4 
IIIb 
complete remission 
22A 971468  26,5   
22B 981748  1,4 
IVa 
partial remission 
23A 951089  44,9   
23B 961080  6,9 
IVa 
stable disease 
24A 870921  6,2   
24B 880986  1,3 
IIIb 
complete remission 
25A 890702  42,0   
25B 900226  0,2 
IIIb 
complete remission 
26A 900694  6,6   
26B 910122  0,6 
IIIb 
complete remission 
27A 921695  2,2   
27B 930861  0,8 
IIIb 
complete remission 
28A 930095  6,5   
28B 931482  1,1 
IIIb 
complete remission 
29A 931355  9,1   
29B 940841  0,9 
IIIb 
complete remission 
30A  890552 12,6   
30B 940841  0,9  IIIa/b  complete remission 
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Figure 1. Relative abundance (all values obtained from time point A were set to 100%) of the 51 
NSC-selected peaks (shrinkage 2.88) that contribute to discrimination between time points A (pre-
treatment) and B (post-treatment) are shown with their relative standard deviations (10 patient 
samples in each dataset). 
 
None of the observed differences reached statistical significance 95% when 
analyzed in a univariate manner. It is noteworthy that all intensities of peaks 
from time point B were higher than those at time point A, indicating that there 
is an underlying normalization problem that requires further attention. 
Although statistical significance was not reached, there were quantitative 
differences for certain peptides with extracted m/z values of: 606, 408, 532, 613, 
675, 527, 1231, and 968 (Figure 2: upper traces, patients before treatment (A), 
lower traces patients after treatment (B)). 
Principal component analysis (PCA biplot) of all 13531 peaks (Figure 3a) 
and of the 51 NSC-selected peaks (Figure 3b) resulted in some clustering in the 
case of the 51 selected peaks. Whether clustering is due to the above-mentioned 
normalization problem or to a real discrimination between the samples awaits 
further data processing and statistical analyses. A correlation map of the same 
10 patient samples before (A) and after treatment (B) using all 13531 peaks 
(variables) showed high correlation coefficients for all samples (>0.7) indicating 
a high similarity between the analyzed samples (Figure 4). 
 
3.2. Stable-isotope (iTRAQ) labeling 
In order to evaluate whether more subtle differences could be detected 
between pre- and post-treatment serum samples, stable-isotope labeling using 
the commercially available iTRAQ reagents [29] were performed in duplicate Comparative analysis of cervical cancer patients (long-term survivors) before and after treatment 
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on two patient sera (patients 30 and 25; see Table 1) obtained before and after 
treatment. Samples were depleted as described above and proteins (50 µg) 
were reduced, alkylated and digested with trypsin (see Methods). Peptides 
were subsequently derivatized with the isobaric tags 114 (patient 30, pre-
therapy), 115 (patient 25, pre-therapy), 116 (patient 30, post-therapy) and 117 
(patient 25, post-therapy). All samples were labeled in separate reactions and 
mixed together for further work-up, separation by strong cation-exchange 
HPLC (20 fractions) and nanoLC-MS-MS analysis. All 20 fractions were 
analyzed separately by LC-MS-MS. 131 or 117 proteins  were identified with a 
confidence higher than 95% in  experiments one and two, respectively, and 
quantified relative to each other using the reporter ions (m/z 
114(30A)/115(25A)/116(30B) and 117(25B)) after MS-MS fragmentation of 
selected multiply-charged precursor ions. 
1 0  p r o t e i n s  f r o m  1 3 1  w e r e  u p - r e g u l ated after medical treatment: these 
included Apolipoprotein B-100 (P04114), Apolipoprotein A-IV (P06727), Serum 
albumin (P02768), Apolipoprotein A-I (P02647), Lumican (P51884), C4b-
binding protein alpha chain (P04003), Apolipoprotein A-II (P02652), 
Tetranectin (P05452), Properdin (P27918) and Fibrinogen alpha chain (P02671). 
Down regulation of proteins after therapy were shown in both experiments for 
4 proteins: Alpha-1-antichymotrypsin (P01011), Platelet basic protein (P02775), 
Leucine-rich alpha-2-glycoprotein (P02750), Ig heavy chain V-III region TUR 
(P01779). Figure 6 shows examples of LC-MS-MS spectra after iTRAQ labeling 
of up- (Figure 6A, Apolipoprotein II.) and down- regulated (Figures 6B and C, 
Platelet basic protein) proteins. 
Serum albumin should be removed during depletion step, one of the reason of 
its identification could be due to partial fragmentation of protein. 
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Figure 2. Extracted ion chromatograms of 8 signals from a total of 51 that were selected by the NSC 
algorithm to contribute to the discrimination between pre- (A) and post-treatment (B) serum 
samples from cervical cancer patients (late-stage survivors, see Table 1).  
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Figure 3. PCA biplot based on all (A, 13531 variables) and on the 51 NSC-selected variables (B, 
shrinkage 2.88) from 10 serum samples collected at the time of diagnosis of advanced stage of 
cervical cancer ( ) and 7-11 months after treatment ( ). NSC-selected variables ( ). 
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Figure 4.  Correlation plots of serum samples from 10 patients collected at the time of diagnosis of 
advanced stage of cervical cancer (A) and 7-11 months after treatment (B) using all 13531 variables 
and using the NSC selected 51 variables that were obtained using an MN rule with M = 2, N = 5 for 
peak picking. 
 
The LC-MS-MS data analyzed using the ProQuant software with quantification the reporter ions 
and calculation of the ratio relatively to a preset the patient 30, pre-therapy as denominator (114). 
The bias was applied for correction of the systematic error in the iTRAQ ratio due to experimental 
error. In experiment 1 the bias applied were: 1 for 114 signal, 1.22 for 115; 1,13 for 116 and 1.23 for 
117 and  1; 1,23; 1,043; 0.92 respectively in experiment 2. Based on those ratios the bar graphs were 
created (Figure 5, exp. 1) 
 
(A) (B) 
(A) (B) Chapter VI 
  167
-1
-0.8
-0.6
-0.4
-0.2
0
0.2
0.4
0.6
0.8
1
A
P
O
B
H
U
M
A
N
 
(
P
0
4
1
1
4
)
A
L
B
U
H
U
M
A
N
 
(
P
0
2
7
6
8
)
A
P
O
A
4
H
U
M
A
N
 
(
P
0
6
7
2
7
)
A
P
O
A
1
H
U
M
A
N
 
(
P
0
2
6
4
7
)
A
A
C
T
H
U
M
A
N
 
(
P
0
1
0
1
1
)
L
U
M
H
U
M
A
N
 
(
P
5
1
8
8
4
)
S
C
Y
B
7
H
U
M
A
N
 
(
P
0
2
7
7
5
)
C
4
B
P
H
U
M
A
N
 
(
P
0
4
0
0
3
)
A
P
O
A
2
H
U
M
A
N
 
(
P
0
2
6
5
2
)
A
2
G
L
H
U
M
A
N
 
(
P
0
2
7
5
0
)
T
E
T
N
H
U
M
A
N
 
(
P
0
5
4
5
2
)
H
V
3
R
H
U
M
A
N
 
(
P
0
1
7
7
9
)
P
R
O
P
H
U
M
A
N
 
(
P
2
7
9
1
8
)
F
I
B
A
H
U
M
A
N
 
(
P
0
2
6
7
1
)
iTRAQ - Advanced disease - series II.
 
 
30A
25A
30B
25B
 
Figure 5. Proteins showing significant difference in patient sample before (30A, 25A) and after 
(30B, 25B) treatment using iTRAQ quantification.  
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Figure 6. A: Up-regulated peptide (m/z 630,9, RT 43,417 min) derived from Apolipoprotein AII 
[SPELQAEAJ (P02652)]. B: Down-regulated peptide (m/z 671.7, RT 65,276 min) derived from 
Platelet basic protein [GJEESLDSDLYAELR (P02775)]. C: Another down-regulated peptide (m/z 
620,0, RT 55,594 min) derived from Platelet basic protein [GTHCNQVEVIATLJ (P02775)]. J: 
abbreviation for iTRAQ-Lys. 
 
3.3. Pre-fractionation of proteins in depleted serum by high-temperature 
reversed-phase HPLC on an mRP column followed by gel electrophoresis 
In order to enhance the concentration sensitivity of our comparative 
proteomics method and since we did not get a clear-cut separation of groups 
before and after therapy (based on the analysis of trypsin-digested, depleted 
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serum by cap-LC-MS), we decided to perform a more thorough pre-
fractionation of depleted serum on a recently developed macroporous 
reversed-phase HPLC column at elevated temperature under denaturing 
conditions (mRP column; Agilent) followed by 1D (Patients 21, 24, 25 and 30) 
or 2D gel electrophoresis (Patient 30). Pre-fractionation (50 fractions) of 
depleted serum in a gradient of AcN containing 0.1% TFA allowed to reduce 
complexity significantly (Figure 7A,B). 
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Figure 7. (A): Pre-fractionation of depleted serum from patient 30 (before treatment: left panel; after 
treatment: right panel) on an mRP column using an increasing gradient of AcN/0.1% TFA. (B): 
Example of 1D gel electrophoresis of some collected fractions (19-20, 31, 37, 40-43) demonstrate that 
complexity has been greatly reduced relative to original serum (lane 2).  
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Figure 8. 1D gel electrophoresis of mRP column fractions (patients 25 and 30):  
31A: A- patient before treatment, fraction #31 (mRP column)  
31B: B- patient after treatment, fraction #31 (mRP column) 
34A: A-patient before treatment, fraction #34 (mRP column) 
34A: B-patient after treatment, fraction #34 (mRP column). 
Arrows  (1-4) indicate Apolipoprotein A1. 
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Due to the high reproducibility of the reversed-phase separation, fractions 
could be compared by SDS-PAGE in a pair-wise manner between sera before 
and after treatment obtained from the same patient (Figure 8). In most of the 
fractions patterns were the same, however, clear differences of protein patterns 
were observed in a few fractions (Figure 8).  
Apolipoprotein A1 was identified in fractions 31 and 34 before and after 
treatment for all four examed patients (21, 24, 25 and 30; all complete 
remission). In all four cases the amount of ApoA1 was higher in samples after 
treatment. Interestingly, ApoA1 eluted in two different fractions that were well 
separated from each other, while it was absent in fractions 32 and 33. This is 
most likely due to modifications. To gain further insight into the 
microheterogenity of Apo A1, mRP fractions 31 and 34 (pre/post therapy) 
were compared by 2D gel electrophoresis (Figure 9). 
After in-gel digestion of all spots and LC-MS-MS analysis, it was confirmed 
that all spots contained ApoA1.  This confirmed that Apo A1 was indeed 
heterogenous with respect to its isoelectric point. The same number of ApoA1 
spots were observed in fractions 31 before and after therapy (Figure 9A,B), 
while fractions 34 showed two additional spots after treatment (Figure 9C,D) 
and the abundance of ApoA1 in fraction 34 increased after treatment, 
confirming earlier results obtained by SDS-PAGE (see Figure 8). An example of 
the identification of ApoA1 in spot (*) (Figure 9D) by MALDI-TOF-MS is given 
as Figure S1 (supplementary material). 
Another possibility to reduce complexity of serum samples is to remove 
more of the high-abundant proteins. The recently released ProteoPrep 20 
Plasma Immunodepletion column (PROT20, Sigma-Aldrich), removes the 20 
most abundant proteins from human serum (~97-99% of total protein content). 
This could allow to visualize  further low-abundance proteins, which co-
migrate during 1D gel electrophoresis and are thus masked by high-abundant 
proteins. Unfortunately only spin column are presently available on the 
market, which renders the depletion step time consuming. Serum (pre-/post-
therapy) from patient 30 served again as initial test material for this 
immunodepletion step. Depleted serum (corresponding to 40µL of original 
serum) was pre-fractionated on the mRP column (Figure 10) followed by 1D 
gel electrophoresis. Not all 20 proteins (according description of column) were 
removed completely after depletion, since Haptoglobin precursor, Transferrin 
precursor, IgHG2_human, were identified after in-gel digestion of the 
corresponding bands. Comparative analysis of cervical cancer patients (long-term survivors) before and after treatment 
170 
 
 
Figure 9. 2D gel electrophoresis (zoom-in) of fractions 31 before treatment (A), after treatment (B) 
and fractions 34 before treatment (C); after treatment (D) after pre-fractionation on mRP column. 
The same spots observed in fraction 31 (A,B), but in fraction 34 two more spots are present (D) after 
therapy. 
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Figure 10. . Pre-fractionation of serum depleted of the 20 most abundant proteins on an mRP 
column using a gradient of increasing AcN/0.1% formic acid. Depleted serum of patient 30 before 
(A) and after (B) treatment. 
 
While the overall chromatogram (Figure 10) does not show any major 
differences between pre- and post-treatment samples, gel electrophoretic 
analysis of the collected fractions showed that Vitronectin/Serum-spreading 
factor (P04004), Beta-1B-glycoprotein/Hemopexin (P02790), Complement 
factor H Precursor (P08603), Zinc-alpha-2-glycoprotein precursor (P25311) 
were present in serum prior to treatment and absent or down regulated after 
therapy (Figure 11). 
B 
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Figure 11. 1D gel electrophoresis of mRP column fractions (patient 30 before and after treatment; 
pair-wise analysis (from left to the right)) 
1: Zinc-alpha-2-glycoprotein (P25311) score 231(mascot), 102.05 (Phenyx), p=4.56E-41, fraction 17. 
2, 4: Serum-spreading factor (P04004), fractions 21 (B) and 22 (C), score  7.55 (Phenyx), p= 7.68E-11 
and 36.5, p=5.8E-14, respectively.  
3, 5: Hemopexin (P02790), fractions 21 (B) and 22 (C), score 102,68 (Phenyx), p= 3,14E-28 and 
103,45, З=1,01E-32  
6-7: Complement factor H: a and b, respectively (P08603), fraction 15, score 102,68 (Phenyx), p= 
3,14E-28 and 103,45, З=1,01E-32 
 
4. Discussion 
Pre-processing and multivariate statistics of LC-MS data obtained from 
advanced stage patients with cervical cancer did not allow us to detect 
significant differences in peak areas or intensities for pre- or post- therapy 
samples after depletion of the 6 most abundant serum proteins followed by 
trypsin-digestion and cap-LC-MS.  
Stable-isotope labeling (iTRAQ) and additional prefractionation of the 
digest by strong cation-exchange HPLC detected four different 
Apolipoproteins that were found to be up- regulated in serum from 2 patients 
after treatment. They were: Apolipoprotein B-100 (P04114), Apolipoprotein A-
IV (P06727), Apolipoprotein A-I (P02647) and Apolipoprotein A-II (P02652). 
Apo A-IV is a major component of HDL (high density lipoprotein) and 
chylomicrons [30]. Apo A-II stabilizes the structure of HDL [31,32]. Apo B-100 
plays a role as a recognition signal for the cellular binding by the apoB/E 
receptor [33,34]. Apo-A-I is important in the reverse transport of cholesterol 
from tissues to the liver and also as a cofactor for lecithin cholesterol 
acyltransferase (LCAT) [35]. Up-regulation of Apo-A-I after treatment agreed 
well with results of 1D gel electrophoretic analysis after pre-fractionation on an Chapter VI 
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mRP column (Figure 8, fraction 34) and with subsequent 2D gel analysis 
(Figure 10C, 10D). Apo A-I has been shown to inhibit herpes simplex virus-
induced cell fusion [36], inhibits HIV-induced syncytium formation [37]. It has 
previously been shown that changes in the amounts of isoforms of 
Apolipoprotein A-1 could be a useful biomarker for HIV patients (diagnosis 
and effect of therapy) [38]. It is thus conceivable that increasing amounts of 
Apo A-I and changes in its isoforms, as detected by 2D gel electrophoresis in 
patient 30, could be a marker for patient recovery after medical treatment. 
Fibrinogen (Fibrinogen alpha chain (P02671) forms monomers that 
polymerize into fibrin after cleavage by thrombin and that promote platelet 
aggregation [39]. Tetranectin is involved in packaging of molecules for 
exocytosis [40]. Properdin stabilizes the C3/C5 convertase enzyme complexes 
(regulation  of the complement pathway) [41]. 
Lumican (P51884) is a small proteoglycan that regulates the fibrillar and 
suprafibrillar organization of collagen in the periodontal ligament [42]. C4b-
binding protein alpha chain (P04003) controls activation of the complement 
pathway and interacts with the anticoagulant protein S and with a component 
of serum amyloid P [43]. 
Serum albumin (P02768) is the main protein in plasma and serum, 
regulating the colloidal osmotic pressure of blood, binding to Ca2+, Na+, K+, 
fatty acids, hormones, bilirubin and other compounds [44,45]. C-reactive 
protein (CRP) was down-regulated in experiment 2. CRP is associated with 
host defense including agglutination, bacterial capsular swelling, phagocytosis 
and  is a well-known “acute-phase” protein that is up-regulated upon 
inflammation [46]. It is thus expected to be down-regulated when a patient’s 
health improves. 
With respect to our search for potential biomarkers, down-regulated 
proteins after therapy are of special interest. Alpha-1-antichymotrypsin 
(P01011), Platelet basic protein (P02775), Leucine-rich alpha-2-glycoprotein 
(P02750) and Ig heavy chain V-III region TUR (P01779) were down-regulated in 
both iTRAQ labeling experiments. Leucine-rich alpha-2-glycoprotein is most 
probably a membrane-associated or membrane-derived protein, associated 
with binding properties [47,48], Alpha-1-antichymotrypsin inhibits neutrophil 
cathepsin G and mast cell chymase. Both proteins are involved in the 
conversion of angiotensin-1 (inactive) to the angiotensin-2 (active) [49]. Alpha-
antichymotrypsin belongs to “acute-phase” proteins and likely being related to 
generally improved health after successful treatment. Platelet basic protein 
(contains antibacterial proteins TC-1 and TC-2) stimulates DNA synthesis, 
mitosis, glycolysis and the secretion of plasminogen [50,51]. Ig heavy chain V-
III region TUR contains 1 Ig-like (immunoglobulin-like) domain and this chain 
was isolated from an IgA1 myeloma protein [52]. The variable region 
sequences of five human immunoglobulin heavy chains of the VH3 subgroup 
form a multifunctional locus that is needed both for the IgG and the IgA class. Comparative analysis of cervical cancer patients (long-term survivors) before and after treatment 
174 
It is hard to say why this protein should be increased in cervical cancer samples 
and decrease after successful therapy but one possibility is that it is connected 
to the immune response against viral infections, as was shown for other 
diseases caused by an underlying infection [53,54]. 
After depletion of 20 of the most abundant serum proteins, it was possible 
to load a bigger volume of the original serum (in our case 40μL) on the high-
temperature reversed-phase pre-fractionation column in order to improve 
concentration sensitivity and to reach into a range, where known potential 
tumor markers have been identified (ng/mL range). 30-50 fold increase in the 
relative amount of low abundant proteins could be reached on ProteoPrep 20 
Plasma Immunodepletion (PROT20) column, as example we were able to 
detect E1 protein: Human papillomavirus type 31 (W1WL31) after depletion of 
20 proteins followed by mRP fractionation (fraction 31) in serum Patient 25 
with confidence 95% (data are not shown).  
Vitronectin/Serum-spreading factor (P04004), Beta-1B-glycoprotein/ 
Hemopexin (P02790), Complement factor H Precursor (P08603) and Zinc-
alpha-2-glycoprotein precursor (P25311) were all present in serum samples 
prior to treatment and absent or down-regulated in  post-treatment samples 
(Figure 12 and Figure S2 in supplementary materials). Human Zinc-alpha-2-
glycoprotein was previously found in benign and malignant breast tissues [55]. 
It is quite likely that this protein is an indicator of tumor development. 
Recently, the analysis of the plasma proteome from a mouse model of 
intestinal cancer has been described [56]. Interestingly, these authors found 
that the levels of some apolipoproteins, hemoglobins, fibronectin and 
immunoglobulins changed upon tumor progression. This indicates that some 
of our findings could reflect cancer development, rather than a more generic 
response to medical treatment. 
In order to group the identified proteins that change in response to 
successful treatment according to functional classes, we used  a Gene Ontology 
approach accessed through the WebGestalt server 
(http://bioinfo.vanderbilt.edu/webgestalt). It appeared that a group of 
proteins (Apolipoprotein A-II, Complement component 4 alpha chain binding 
protein (up-regulated after treatment) and Vitronectin, Platelet basic protein 
(chemokine (C-X-C motif) ligand 7), Complement factor H, Zink-alpha-2-
glycoprotein, Hemopexin (down-regulated after treatment) were clustered in 
categories related to the immune system/response or inflammatory and 
response to injury. It is quite likely therefore to assume that the observed 
changes are part of a coordinated common function. Whether any of them is 
specific for cancer and cervical cancer, in particular, remains to be investigated. 
This requires the analysis of additional patients preferably using the 
ProteoPrep 20 Plasma Immunodepletion c o l u m n  i n  t h e  f o r m a t  o f  a n  H P L C  
rather than a spin column. We are also in the process to perform more 
extensive longitudinal comparisons of samples from the same patient. Chapter VI 
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Figure S1. Example of a MALDI spectrum that served to identify Apolipoprotein A-I(1-242), 
P02647 in one spot after 2D gel electrophoresis as indicated with an  asterisk (*) in Figure 9. M.W. 
28kDa;  Score: 90.36, Hits: 13, sequence coverage: 52%. 
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Figure S2. 2D gel electrophoresis of 6 protein depleted serum of patient 30 before (A, above) and 
after (B, below) medical treatment. White circles (above): Hemopexin _Human (P02790) Score: 
34,17; 31% of coverage (left spot); Hemopexin _Human (P02790) Score: 13.68; 24% of coverage 
(right  spot).Chapter VII 
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This thesis describes the analysis of serum samples of cervical cancer 
patients before and after treatment using LC-MS of trypsin-digested serum 
followed by data processing and statistical data analysis. Paired samples from 
the same patients before treatment and after remission were selected in order 
to optimize the chance of discovery cancer-related changes in the proteome. 
While we did not discover major changes in the serum proteome, some 
changes in protein composition were found in samples taken before and after  
treatment. It is thus demonstrated that the described methods are applicable to 
highly complex body fluids such as serum and that further studies into the 
relevance of the discovered changes of the serum proteome are warranted.  
At present, we are able to discriminate serum proteins in healthy (patients 
after successful treatment) and cancer patients at a concentration which is still 
considered to represent “classical serum or plasma proteins” [1]. Changes in 
those proteins reflect the condition of patients in general. We have to reach 
lower concentration ranges for disease-specific biomarkers (ng/mL range). For 
this purpose, protein enrichment will be very helpful (e.g. an enrichment 
strategy for less abundant serum glycoproteins). 
Proteins such as cytokines, growth factors, cycling dependent kinases 
(CDKs) and inhibitors of cell cycling belong to the very low-abundance 
proteins in the cell. Although DNA microarray studies demonstrate that they 
are very important in the diagnosis of malignant disease [2], the staging of 
cancer and the characterization of the cell cycling in general, these proteins are 
not readily detectable in proteomics studies. Part of the problem originates 
from the source of the samples: cell cycle controlling proteins are localized in Summary and perspectives 
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the nucleus. It may thus be of interest to select the most appropriate type of 
tissue and to perform subfractionation of cell organelles prior to MS analysis.  
The problem of biological variance of protein concentrations that are 
unrelated to disease is very common and well recognized in cancer biomarker 
studies. In our case it is necessary to analyze additional patient samples and to 
perform more extensive longitudinal studies to discriminate between actual 
cancer markers and unrelated confounding effects. 
The importance of genome-wide searches for disease markers in cancer has 
been proven with DNA microarray studies [3]. Microarrays are increasingly 
important tools for the diagnosis and classification of various cancers [4-6]. 
Expression profiles with microarrays in their present form are capable to detect 
nanogram quantities of mRNA, but say very little about the corresponding 
protein levels in normal and malignant tissues 
The technology of oligonucleotide-based arrays  is well developed and 
well understood, which is not the case for attempts to create similar protein 
microarrays [7]. In this respect, the LC-MS approach offers additional 
possibilities to the protein-chip concept. The performance of mass 
spectrometers has been steadily improving in recent years and present modern 
LC-MS systems are capable of analyzing complex protein/peptides samples 
generating thousands of peaks. Whether these analyses are comprehensive is 
still doubtful (limitation of proteomics methods with respect to concentration 
sensitivity) but it is fair to assume that a considerable part of the proteome can 
be covered. It has become increasingly clear that the successful integration of 
sample preparation, protein/peptide separation and data analysis is key to an 
overall successful biomarker discovery strategy. 
Data pre-processing and statistical analysis of comprehensive LC-MS 
profiles is a rather new field. In collaboration with other groups, we are 
working on further improving our statistical analysis platform, since it is a 
crucial step in the discrimination of samples and the search for potential 
biomarkers. 
By nature, cervical cancer is a localized disease at its early stage and will 
therefore quite often escape the general immune response mediated by natural 
killer cells and T-cells circulating in blood. Because of such a limited exchange 
between proteins of the cervical epithelium and blood, finding specific 
biomarkers seems more promising in comparative studies of cervical cancer 
and healthy tissue. Work along this line has been initiated using Laser 
Dissection Microscopy in conjunction with mass spectrometry. 
Although an effective vaccine against Human Papillomavirus (HPV) will 
most probably decrease the incidence of cervical cancer significantly, early 
diagnosis still remains relevant. Moreover, finding biomarkers for cervical 
cancer can help in other cases where HPV virus seem to be involved. As an 
example, HPV 16 was found in lung carcinoma cases in Chile [8] and Korea [9]. Chapter VII 
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It is thus quite likely that this virus can infect other kinds of epithelia than the 
cervix alone.  
Finally, I would like to stress that only well-integrated, multi-disciplinary 
studies will have the potential to discover relevant and new biomarkers in 
cervical cancer, resulting in earlier diagnosis and thereby better treatment of 
patients with cervical neoplasia. Summary and perspectives 
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Samenvatting 
 
In dit proefschrift wordt de analyse van serum monsters van patiënten met 
baarmoederhalskanker vóór en na behandeling beschreven. Hierbij werd 
gebruik gemaakt van LC-MS in combinatie met door trypsine behandeld 
serum waarna de gegevens werden verwerkt en vervolgens statistisch getoetst. 
Bij een aantal patiënten werden simultaan serummonsters van vóór 
behandeling en na herstel van de kanker vergeleken om een zo groot mogelijke 
kans te hebben kankergerelateerde veranderingen in het proteoom te vinden. 
Hoewel we geen grote veranderingen in het serumproteoom vonden, zagen we 
in de vergelijking van monsters genomen vóór en na de behandeling 
veranderingen van de eiwitsamenstelling. Zo is aangetoond dat de beschreven 
methodes toepasbaar zijn voor zeer ingewikkelde lichaamsvloeistoffen zoals 
serum en dat verdere studies naar de relevantie van de ontdekte 
veranderingen van het serum proteoom hierdoor nodig zijn. 
Op dit moment zijn we in staat om serumeiwitten te onderscheiden van 
gezonde (patiënten na succesvolle behandeling) en kankerpatiënten, bij een 
concentratie waarin de “klassieke serum- of plasma eiwitten” nog 
vertegenwoordigd zijn [1]. Veranderingen in de samenstelling van deze 
eiwitten weerspiegelen de algemene conditie van patiënten. Voor 
ziektespecifieke biomarkers is een (detectie methode met een) hogere resolutie 
(ng/mL) nodig. Voor dit doel is het verrijken van eiwitten wenselijk 
bijvoorbeeld een verrijkingsstrategie voor de in lage concentratie aanwezige 
glycoproteines. Eiwitten zoals cytokines, groeifactoren, “cycling-dependent 
kinasen”(CDK’s) en remmers van de celcyclus, horen bij de groep eiwitten die 
in zeer lage concentraties in een cel aanwezig zijn. Hoewel DNA microarray 
studies erg belangrijk zijn bij de diagnose van kwaadaardige ziekten [2], bij de 
identificatie van de stadia van kanker en het kenschetsen van de celcyclus in 
het algemeen, zijn in proteoomstudies deze eiwitten zijn niet makkelijk 
aantoonbaar. Een deel van dit probleem komt voort uit de aard van de 
monsters: celcyclus sturende eiwitten bev i n d e n  z i c h  i n  d e  c e l k e r n .  H e t  k a n  
daarom van belang zijn om het meest geschikte weefsel te selecteren en een 
fractionering van celorganellen uit te voeren voor de MS analyse. 
Het probleem van biologische variatie van eiwitconcentraties die niet 
gerelateerd zijn aan een ziekte is een algemeen en veel voorkomend fenomeen 
in kanker biomarker studies. In ons geval is het noodzakelijk om aanvullende 
patiëntmonsters te analyseren en om uitgebreider en breder onderzoek te doen 
naar het onderscheid tussen echte kanker merkers en gevonden effecten die 
niet ziektegerelateerd zijn. 
Het belang van het genoom breed zoeken naar biomarkers in kanker is 
aangetoond met DNA microarray studies [3]. DNA microarrays worden in 
toenemende mate gebruikt als instrumenten voor de diagnose en classificatie 
van verschillende soorten van kanker [4-6]. Door de huidige expressie Summary and perspectives 
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profilering zijn we in staat om nanogram hoeveelheden mRNA te detecteren 
maar dit zegt niet genoeg over het bijbehorende eiwitniveaus in normaal en in 
maligne weefsels. 
De technologie van op oligonucleotiden gebaseerde DNA microarrays is 
goed ontwikkeld en begrepen, hetgeen nog lang niet het geval is bij een 
vergelijkbaar eiwit microarray systeem [7]. 
In dit kader levert de LC-MS benadering aanvullende mogelijkheden ten 
opzichte van het eiwitchip concept. De werking van massa spectrofotometers is 
de afgelopen jaren gestaag verbeterd en de huidige moderne LC-MS systemen 
zijn in staat complexe eiwit/peptide monsters te analyseren en duizenden 
pieken te genereren. Het valt te betwijfelen of deze analyses veelzeggend zijn 
(beperking van proteomics methoden wat betreft de concentratie gevoeligheid) 
maar het is redelijk aanneembaar dat een aanzienlijk deel van het proteoom 
bestreken kan worden. Het wordt in toenemende mate duidelijk dat een 
succesvolle integratie van monsterbereiding, eiwit/peptide scheiding en data 
analyse de sleutel is naar een algemeen succesvolle strategie voor het 
ontdekken van biomarkers. 
Voorbewerking van data en statistische analyse van uitgebreide LC-MS 
profielen zijn een relatief nieuw onderzoeksgebied. In samenwerking met 
andere groepen werken we aan verdere verbetering van ons statistisch 
analytisch platform omdat dit een cruciale stap is in zowel het onderscheiden 
van monsters als de zoektocht naar potentiële biomarkers. 
Van nature is baarmoederhalskanker in het eerste stadium een 
gelokaliseerde ziekte waardoor het vaak ontsnapt aan een algemene 
immunorespons die wordt verzorgd door natuurlijke “killer cellen”en T-cellen 
die in het bloed voorkomen. Door de beperkte uitwisseling tussen eiwitten van 
de epitheelcellen in de baarmoederhals en bloed, lijkt het vinden van specifieke 
biomarkers veelbelovend in vergelijkende studies van baarmoederhalskanker 
en gezond weefsel. Dit werk is geïnitieerd door de combinatie van Laser 
Dissection Microscopie en massa spectrometrie. 
Hoewel een effectief vaccin tegen Humaan Papillomavirus (HPV) het 
voorkomen van baarmoederhalskanker waarschijnlijk significant zal 
verminderen, blijft een vroege diagnose nog steeds relevant. Bovendien kan het 
vinden van biomarkers voor baarmoederhalskanker helpen in andere gevallen 
waarbij het HPV virus schijnt te zijn  betrokken.HPV 16 is bijvoorbeeld 
gevonden in gevallen van longkanker in Chili [8] en Korea [9]. Het is daarom 
aannemelijk dat dit virus andere epitheelweefselsoorten dan alleen die van de 
baarmoederhals kan infecteren. 
Ten slotte wil ik benadrukken dat alleen goed geïntegreerde, 
multidisciplinaire studies potentie hebben om relevante en nieuwe biomarkers 
in baarmoederhalskanker te ontdekken die zouden kunnen resulteren in een 
vroegtijdige diagnose en daarmee betere behandeling van patiënten met 
neoplasia in de baarmoederhals. Chapter VII 
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